syndrome	score	normalized_score
DRAVET SYNDROME	2.6655187	100.0
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1; CFEOM1	2.02066968	75.80774728761048
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	2.0	75.03230046744748
CHILDHOOD ABSENCE EPILEPSY	1.52074085	57.05234219516074
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	1.3427971389999998	50.376579200138416
MYOCLONIC-ASTASTIC EPILEPSY	1.219235154	45.741009207701296
DIGEORGE SYNDROME; DGS	1.214277098	45.55500203393809
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.193694	44.78280343709463
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	1.161339877	43.56900129794626
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1521162600000001	43.22296669687593
COFFIN-LOWRY SYNDROME; CLS	1.013505352	38.02281904831506
BARBER-SAY SYNDROME; BBRSAY	1.00454545	37.68667801880362
EHLERS-DANLOS SYNDROME, TYPE I	1.00246914	37.608782860911845
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	1.0	37.51615023372374
STRABISMUS, SUSCEPTIBILITY TO	1.0	37.51615023372374
BROWN SYNDROME	1.0	37.51615023372374
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	37.51615023372374
MYOCLONIC EPILEPSY OF LAFORA	0.93444076	35.05661993667499
LAFORA DISEASE	0.7787753399999999	29.216652653759283
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706170999999999	28.910586896276513
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2	0.7621951	28.59462587900809
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.75246914	28.2297453024809
CRANIOSYNOSTOSIS 4; CRS4	0.75	28.13711267529281
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.7485789639999999	28.083800875229276
EARLY MYOCLONIC ENCEPHALOPATHY	0.7123949239999999	26.726314994526206
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.6880720949999999	25.81381608765303
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.687759466	25.80208745112162
ROLANDIC EPILEPSY	0.6114546	22.939422634701458
SARCOIDOSIS	0.6	22.509690140234245
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.5939684000000001	22.28340772848452
APERT SYNDROME	0.5640058400000001	21.15932782613756
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.559021229	20.972324411004884
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.55799462	20.933809993529593
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.551887498	20.704694287081914
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.542764608	20.362438575276176
RING CHROMOSOME 7 SYNDROME	0.53421193	20.04157502252751
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	20.00860095260259
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.772024109228724
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.5223362570000001	19.596045490132937
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.517808602	19.426185304946465
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.513296419	19.25690556963641
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.513190125	19.25291782796347
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.5080728050000001	19.06093568204943
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.50724638	19.029931397592524
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	19.022273225845314
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.506854682	19.015236396578274
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.505894661	18.979220104514745
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.504645888	18.932370949038926
RESTRICTIVE DERMOPATHY	0.50454545	18.928602901941748
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.504058454	18.91033268684253
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.50368435	18.89629774497549
CREST SYNDROME	0.50243902	18.849577757604926
DEXTROCARDIA	0.500545554	18.77854220268648
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.5	18.75807511686187
INHALATIONAL ANTHRAX	0.5	18.75807511686187
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1H; CSNB1H	0.5	18.75807511686187
AMYLOIDOSIS	0.5	18.75807511686187
BRANCHIOOTORENAL SYNDROME 1	0.5	18.75807511686187
PAROXYSMAL HEMICRANIA	0.5	18.75807511686187
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.75807511686187
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.45217429	16.96383859546737
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.43278905	16.236579019310575
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.42491444899999997	15.941154305163943
SPINOCEREBELLAR ATAXIA TYPE 10	0.417099218	15.64795692485669
XK APROSENCEPHALY SYNDROME	0.4166663	15.631715508129806
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.412435299	15.47298463897477
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.400768229	15.035281088067402
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.39943714	14.985343753168944
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.388919794	14.590773420572889
ELSAHY-WATERS SYNDROME; ESWS	0.37745199399999996	14.160545712922593
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.37382101399999995	14.024325321746945
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.37324765	14.002814911784336
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.372818322	13.986708178036794
CANAVAN DISEASE	0.37159698999999996	13.940888503239538
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.676884352752804
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.412686243769365
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.412686243769365
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.3574324239999999	13.40948851718804
CENTRALOPATHIC EPILEPSY	0.35470090000000004	13.307012252437023
CONGENITAL TRACHEAL STENOSIS	0.3505744	13.15220185849756
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.34778266	13.047466521244067
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.347561382	13.039165022552645
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.34701582799999997	13.018697936728039
POTOCKI-SHAFFER SYNDROME	0.34632893299999995	12.992928280713242
OROFACIODIGITAL SYNDROME TYPE 3	0.3455281	12.962884109573123
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.34417538000000003	12.912135262828958
ACITRETIN/ETRETINATE EMBRYOPATHY	0.34400393	12.905703118871386
ESOPHAGEAL ATRESIA	0.341840185	12.824527736383917
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.769569014841279
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.34037525	12.769569014841279
ZIMMERMANN-LABAND SYNDROME	0.338419869	12.696210647481108
SPINOCEREBELLAR ATAXIA TYPE 42	0.338012375	12.680923041357767
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.33734615100000004	12.655928881684456
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.33717915	12.649663647079274
COG4-CDG	0.336288194	12.616238407931634
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.33570697299999996	12.594433233576638
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.334328025	12.542700413244145
EPIDERMAL NEVUS SYNDROME	0.333878554	12.525837991682446
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.333874419	12.525682862401228
WAGR 11P13 DELETION SYNDROME	0.333333	12.505370905857834
NEUROMYELITIS OPTICA	0.333333	12.505370905857834
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.505370905857834
PLACENTAL INSUFFICIENCY	0.333333	12.505370905857834
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.505370905857834
POLYARTERITIS NODOSA	0.3208333	12.036430282781359
DOORS SYNDROME	0.30480369399999996	11.435061175897959
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.302242952	11.338991994316155
JUVENILE HYALINE FIBROMATOSIS	0.30000000000000004	11.254845070117124
PALLISTER-HALL SYNDROME	0.297578424	11.163996861098743
TRICHOTHIODYSTROPHY	0.282024812	10.580485216629695
MARFAN SYNDROME; MFS	0.27848641	10.447737995610387
WILLIAMS-BEUREN SYNDROME; WBS	0.276966178	10.390704743508273
COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE	0.27066968	10.154484378593931
UNILATERAL POLYMICROGYRIA	0.26961356999999997	10.11486319717059
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.26138816	9.806277479876618
6P22 MICRODELETION SYNDROME	0.26129582	9.802813238564037
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.26055979700000004	9.775200489120563
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.26043922	9.770676904273829
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.26010593899999995	9.75817348420778
HYPEREKPLEXIA 1; HKPX1	0.25925926	9.726409347644044
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.259041584	9.71824298212577
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.25885369399999997	9.711194072658353
ALLAN-HERNDON-DUDLEY SYNDROME	0.258402435	9.694264572220034
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.256673729	9.629410178214096
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.25562995400000005	9.590251758503891
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25440366000000003	9.544245928569177
CEREBROOCULONASAL SYNDROME	0.25357173	9.513035117705233
INFANTILE MYOFIBROMATOSIS	0.2530914	9.49501498526347
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.252729947	9.48145466021304
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.250083158	9.382157326452074
SPINOCEREBELLAR ATAXIA TYPE 37	0.25	9.379037558430936
HYPERPARATHYROIDISM 2	0.25	9.379037558430936
CONGENITAL CONTRACTURAL ARACHNODACTYLY	0.25	9.379037558430936
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	0.25	9.379037558430936
UVEAL MELANOMA	0.25	9.379037558430936
DYSTONIA 6, TORSION	0.25	9.379037558430936
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	9.379037558430936
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.244418724	9.16964956951906
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.243045154	9.118118511042523
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.24000000000000002	9.003876056093699
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.23628762000000003	8.864601850289027
LENNOX-GASTAUT SYNDROME	0.23257131	8.725180206013937
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.23153846	8.686431650245035
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915000000002	8.475991933577507
CARDIOFACIOCUTANEOUS SYNDROME	0.21843996900000007	8.19502669405396
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.214346893	8.041470239919908
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.21318117	7.997736800721002
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.21293594	7.988536715199185
CRI-DU-CHAT SYNDROME	0.211807285	7.946193924657143
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.209498455	7.859575511513013
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.20840336	7.818491762972814
19P13.13 MICRODELETION SYNDROME	0.208171303	7.809785877698026
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.2051883	7.697875089002378
JUVENILE MYOCLONIC EPILEPSY	0.2042519	7.662744965923518
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.202926178	7.613008980203366
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.20150709200000003	7.559770336632793
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.20128700000000002	7.551513332095553
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.20128700000000002	7.551513332095553
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.20099502500000002	7.54055955413106
TRANSALDOLASE DEFICIENCY	0.20054555400000001	7.5236971325693585
NASU-HAKOLA DISEASE	0.200541419	7.523542003288142
ROMANO-WARD SYNDROME	0.200541419	7.523542003288142
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.50323004674475
EPISODIC ATAXIA, TYPE 4	0.2	7.50323004674475
BETA-THALASSEMIA	0.2	7.50323004674475
BENIGN SCHWANNOMA	0.2	7.50323004674475
X-LINKED SPASTIC PARAPLEGIA TYPE 16	0.2	7.50323004674475
MALARIA	0.2	7.50323004674475
MULTIPLE MYELOMA	0.2	7.50323004674475
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.2	7.50323004674475
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.2	7.50323004674475
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.18481994999999998	6.933733010389311
DISTAL MONOSOMY 12Q	0.183905832	6.89943882216996
MYOCLONIC EPILEPSY OF INFANCY	0.181285814	6.801145833266899
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.181285814	6.801145833266899
BILATERAL POLYMICROGYRIA	0.17980204400000002	6.745480495034608
MUCOLIPIDOSIS TYPE II	0.17930934	6.72699613774985
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.179201484	6.7229497958502415
OCULOPHARYNGODISTAL MYOPATHY	0.1776316	6.664053791856722
ADNP SYNDROME	0.17558722899999996	6.587356862287253
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.17371549200000003	6.517136495797236
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.172695433	6.4788678091059735
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.16900477399999997	6.340408491600527
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.16876496000000002	6.3314115935483795
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.16876496000000002	6.3314115935483795
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.168623563	6.326106922453781
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.168435409	6.319048108722705
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.168159136	6.308683409349182
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.16686578	6.260161671347494
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.166667	6.252704211004036
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	6.252704211004036
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.166667	6.252704211004036
DERMATOLEUKODYSTROPHY	0.166667	6.252704211004036
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.166667	6.252704211004036
ADULT-ONSET NEMALINE MYOPATHY	0.166667	6.252704211004036
45,X/46,XY MIXED GONADAL DYSGENESIS	0.16599502500000002	6.227494295950729
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.161921074	6.074655338189899
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.16170549	6.066567456457913
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.16133601099999997	6.052706026785706
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.16103879999999998	6.04155581425859
BRANCHIOSKELETOGENITAL SYNDROME	0.15985282899999997	5.997062748049751
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.15816604499999995	5.9337811060939085
ATELOSTEOGENESIS TYPE II	0.15792874999999998	5.924878711224197
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.155863707	5.847406247797099
TUBEROUS SCLEROSIS COMPLEX	0.15569968	5.841252586222712
19P13.3 MICRODUPLICATION SYNDROME	0.155452484	5.831978743949536
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.155294822	5.826063872671387
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.15166969800000002	5.690063176071511
PHACE SYNDROME	0.15035330299999997	5.6406771034845855
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.14793138699999997	5.549816138975126
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.147406512	5.530124849621202
CHRISTIANSON SYNDROME	0.14735641	5.528245215462191
DISTAL MONOSOMY 7Q36	0.14715773899999998	5.520791844379107
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.14642842999999997	5.493430978368299
COMBINED SAPOSIN DEFICIENCY	0.146228178	5.485918294251697
PIEBALDISM	0.14604862999999998	5.479182344509532
LÉRI-WEILL DYSCHONDROSTEOSIS	0.14482163999999997	5.433150403334254
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.14389324200000003	5.3983204844895685
PACMAN DYSPLASIA	0.14285699999999998	5.3594446739390715
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.14285699999999998	5.3594446739390715
ANAUXETIC DYSPLASIA 2; ANXD2	0.14285699999999998	5.3594446739390715
MACROSOMIA-MICROPHTHALMIA-CLEFT PALATE SYNDROME	0.14285699999999998	5.3594446739390715
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.14285699999999998	5.3594446739390715
NON-ACQUIRED COMBINED PITUITARY HORMONE DEFICIENCY-SENSORINEURAL HEARING LOSS-SPINE ABNORMALITIES SYNDROME	0.14285699999999998	5.3594446739390715
GANGLIONEUROMA	0.14285699999999998	5.3594446739390715
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.3594446739390715
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.14285699999999998	5.3594446739390715
MUCKLE-WELLS SYNDROME	0.14215680000000003	5.333175865545421
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.140723233	5.2793939506033105
AICARDI SYNDROME; AIC	0.140387823	5.266810658653418
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.14037577400000004	5.266358626559253
PHOCOMELIA-ECTRODACTYLY-DEAFNESS-SINUS ARRHYTHMIA SYNDROME	0.1388889	5.2105768381966335
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.138755565	5.20557462230522
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.13756670399999998	5.160973134422204
LISSENCEPHALY, X-LINKED, 2	0.13508660700000003	5.067929442775998
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.13488834	5.060491228217607
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.13333753	5.002310807273647
NOONAN SYNDROME 7; NS7	0.13240932200000002	4.967488016497503
W SYNDROME	0.130336454	4.889721989194824
CLEFT LIP AND ALVEOLUS	0.12942322	4.85546096525228
AICARDI SYNDROME	0.129176675	4.846211545992905
NEUROFIBROMATOSIS TYPE 1	0.128661344	4.826878310776812
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.12726757	4.7745892760009525
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.125961538	4.725591983278902
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.125372869	4.703507388636966
311450 PALLISTER W SYNDROME;;W SYNDROME	0.125254709	4.699074480325349
SPONDYLOOCULAR SYNDROME; SOS	0.125	4.689518779215468
X-LINKED DYSTONIA-PARKINSONISM	0.125	4.689518779215468
RING CHROMOSOME Y SYNDROME	0.125	4.689518779215468
CRYPTORCHIDISM, UNILATERAL OR BILATERAL	0.125	4.689518779215468
LARYNGOTRACHEOESOPHAGEAL CLEFT	0.125	4.689518779215468
SCHINZEL-GIEDION SYNDROME	0.12443135000000001	4.668185220385062
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.12428699199999999	4.66276946396962
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.12097112000000002	4.538370711861823
COG8-CDG	0.11905982899999999	4.466666431565459
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.117930234	4.424288375842195
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.11736620500000002	4.403128179142019
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.11678371499999998	4.381275396792376
TURCOT SYNDROME WITH POLYPOSIS	0.11111099999999999	4.168456968619278
FOVEAL HYPOPLASIA 2; FVH2	0.11111099999999999	4.168456968619278
MICROCEPHALY, AUTOSOMAL DOMINANT	0.11111099999999999	4.168456968619278
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.11111099999999999	4.168456968619278
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.10955254000000002	4.10998954912603
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.10808421400000001	4.054903610317948
BECKWITH-WIEDEMANN SYNDROME	0.10744676	4.030988790286859
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.106784647	4.0061488595071575
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10675886400000001	4.005181580605681
MONOSOMY 13Q14	0.10560127000000001	3.9617531101920247
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.10294344900000002	3.862041898261679
3MC SYNDROME	0.10109607500000001	3.7927355377398033
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.10108697300000001	3.792394065740376
OROFACIODIGITAL SYNDROME TYPE 14	0.10081093400000002	3.78203814514601
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.100541419	3.771926979915767
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.100379965	3.7658698473959316
CONGENITAL ENTEROVIRUS INFECTION	0.10003236	3.7528290459939377
HEREDITARY ACROKERATOTIC POIKILODERMA	0.1	3.751615023372375
KAPOSI SARCOMA	0.1	3.751615023372375
MANTLE CELL LYMPHOMA	0.1	3.751615023372375
KIKUCHI-FUJIMOTO DISEASE	0.1	3.751615023372375
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.09993122	3.749034662559299
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.099357553	3.7275128852031694
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.09903390000000001	3.7153706706315743
8Q12 MICRODUPLICATION SYNDROME	0.09903351400000002	3.7153561893975837
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09895310400000001	3.7123395157572903
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.681154065810906
CRANDALL SYNDROME	0.09775640000000001	3.6674437887079923
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.09739969400000001	3.654061552822721
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.09698155600000002	3.638374624796293
SLC35A2-CDG	0.09572786900000002	3.591341114958227
RHEUMATOID ARTHRITIS	0.0952025	3.5716312926260847
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.09497095000000003	3.562944428039467
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.09486460400000002	3.5589547355267115
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.09452579200000001	3.5462438136337227
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0941662	3.532753306138877
BERNARD-SOULIER SYNDROME	0.09367863900000001	3.5144618944147727
GLANZMANN THROMBASTHENIA	0.09313722000000002	3.4941499378713803
BUTYRYLCHOLINESTERASE	0.09259256000000002	3.47371639148508
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.09250911900000001	3.470586006393428
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.092447104	3.468259442336683
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.09226190000000001	3.461311301248797
DUANE RETRACTION SYNDROME 1	0.09180788000000001	3.444278218719682
8Q22.1 MICRODELETION SYNDROME	0.09167594400000002	3.4393284879224453
SPONTANEOUS PERIODIC HYPOTHERMIA	0.091264599	3.4238964071045532
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.09112109900000001	3.4185128395460147
DDOST-CDG	0.09074678700000001	3.404470094319729
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.09047644399999999	3.3943278657170928
17Q23.1Q23.2 MICRODELETION SYNDROME	0.09001022499999999	3.376837123671276
TOWNES-BROCKS SYNDROME 1; TBS1	0.08901200400000002	3.339387714668819
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.08879658000000001	3.3313058355208693
OGDEN SYNDROME; OGDNS	0.08812551900000001	3.306130210228877
BRACHYTELEPHALANGY-DYSMORPHISM-KALLMANN SYNDROME	0.08787875000000002	3.2968723873518515
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.08767721	3.289311382433746
AMYOTROPHIC LATERAL SCLEROSIS 1	0.0875	3.2826631454508273
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.087197987	3.2713327803702903
TRISOMY 8P	0.08716296700000001	3.270018964789105
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.08714389800000001	3.2693035693202983
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.08685929300000002	3.2586262853830297
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.086797465	3.256306736846379
WHITE-SUTTON SYNDROME; WHSUS	0.08646851200000001	3.2439656866785445
12Q14 MICRODELETION SYNDROME	0.08610086900000001	3.2301731366581676
PEDIATRIC-ONSET GRAVES DISEASE	0.08587201400000001	3.2215873780964293
OROMANDIBULAR DYSTONIA	0.08577232000000001	3.2178472430150284
DUANE-RADIAL RAY SYNDROME; DRRS	0.08557365500000001	3.210394097028845
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.085555315	3.2097060508335584
SCLERODERMA	0.08458809900000001	3.173419830069098
JOHANSON-BLIZZARD SYNDROME	0.08456029000000001	3.172376543447248
ERMINE PHENOTYPE	0.08456029000000001	3.172376543447248
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.08452418200000002	3.1710219102946087
GAUCHER DISEASE TYPE 2	0.08437221000000002	3.165320505911289
MAXILLONASAL DYSPLASIA	0.08432832500000001	3.163674109658282
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.08387471900000001	3.146656558815364
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.08335780500000001	3.127263935533448
POSTORGASMIC ILLNESS SYNDROME	0.08333330000000001	3.1263446022719714
DIPROSOPUS	0.08333330000000001	3.1263446022719714
JUVENILE POLYPOSIS SYNDROME	0.08333330000000001	3.1263446022719714
THROMBOCYTOPENIA 6	0.08333330000000001	3.1263446022719714
ALKAPTONURIA	0.08333330000000001	3.1263446022719714
HEMOPHILIA B	0.08333330000000001	3.1263446022719714
176630 PRIMARY RELEASE DISORDER OF PLATELETS	0.08333330000000001	3.1263446022719714
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.08333330000000001	3.1263446022719714
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	0.08333330000000001	3.1263446022719714
MYH9-RELATED DISEASE	0.08333330000000001	3.1263446022719714
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.08333330000000001	3.1263446022719714
SCLEROSTEOSIS	0.08333330000000001	3.1263446022719714
POTOCKI-LUPSKI SYNDROME	0.08276422600000001	3.104995136593865
17P11.2 MICRODUPLICATION SYNDROME	0.08248825899999998	3.094641917162314
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.082112475	3.080543948162885
RETINITIS PIGMENTOSA	0.08115531000000001	3.044634802224423
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.07936212000000001	2.977361216786812
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.07932308899999999	2.975896923927039
TRICHOHEPATOENTERIC SYNDROME 1	0.07919067	2.9709290728292403
OROFACIODIGITAL SYNDROME TYPE 6	0.07892275100000001	2.9608777833747713
N SYNDROME	0.07875565400000001	2.9546089472191666
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.07870984900000001	2.952890519957711
ATAXIA-TELANGIECTASIA	0.07870984900000001	2.952890519957711
JUNG SYNDROME	0.07860878	2.9490988001697382
DYSKERATOSIS CONGENITA	0.07846367900000001	2.9436551692546753
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07843019200000001	2.9423988659317986
ETHYLMALONIC ENCEPHALOPATHY	0.07842605700000001	2.942243736650582
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.078389689	2.9408793492988816
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.07818681	2.9332681102556135
DERMATOMYOSITIS	0.07815009	2.9318905172190317
PYCNODYSOSTOSIS	0.07796739000000001	2.9250363165713305
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.077926228	2.9234920767954096
BANGSTAD SYNDROME	0.07746451900000001	2.9061705325871476
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.077156217	2.8946042284377898
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.07692310000000001	2.885858576043755
ATYPICAL WERNER SYNDROME	0.07692310000000001	2.885858576043755
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.07692310000000001	2.885858576043755
CLASSIC MYCOSIS FUNGOIDES	0.07692310000000001	2.885858576043755
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.07692310000000001	2.885858576043755
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.885858576043755
DERMOODONTODYSPLASIA	0.07692310000000001	2.885858576043755
CORTICOSTEROID-SENSITIVE ASEPTIC ABSCESS SYNDROME	0.07692310000000001	2.885858576043755
ERYTHROKERATODERMIA VARIABILIS	0.07692310000000001	2.885858576043755
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.07692310000000001	2.885858576043755
GEMIGNANI SYNDROME	0.07692310000000001	2.885858576043755
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07692310000000001	2.885858576043755
PAGOD SYNDROME	0.07692310000000001	2.885858576043755
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	2.885858576043755
ACQUIRED HYPERTRICHOSIS LANUGINOSA	0.07692310000000001	2.885858576043755
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.07692310000000001	2.885858576043755
PINEOCYTOMA	0.07692310000000001	2.885858576043755
PAPILLARY TUMOR OF THE PINEAL REGION	0.07692310000000001	2.885858576043755
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.076434687	2.867535200559651
HYDROXYKYNURENINURIA	0.07628195400000001	2.8618052463860044
NEONATAL LUPUS ERYTHEMATOSUS	0.0760413	2.852776834767657
LEIGH SYNDROME; LS	0.07594943100000001	2.8493302635618356
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.074439159	2.792670672316049
CLASSICAL EHLERS-DANLOS SYNDROME	0.073582115	2.7605176808551373
GABRIELE-DE VRIES SYNDROME	0.07346344	2.7560654517261507
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07293569200000001	2.736266378472603
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.07293569200000001	2.736266378472603
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.072869212	2.7337723048050653
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.072662584	2.726020417714571
DE BARSY SYNDROME	0.072411674	2.7166072404594273
LOWRY-MACLEAN SYNDROME	0.072192129	2.7083707572563642
AMISH INFANTILE EPILEPSY SYNDROME	0.07210795	2.70521268524584
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.07197001900000001	2.7000380451279526
TAKAYASU ARTERITIS	0.07197001900000001	2.7000380451279526
SCIMITAR SYNDROME	0.0715198	2.683147561485875
FRYNS MICROPHTHALMIA SYNDROME	0.0715198	2.683147561485875
IDIOPATHIC ACUTE EOSINOPHILIC PNEUMONIA	0.07142860000000001	2.67972608858456
RELAPSING POLYCHONDRITIS	0.07142860000000001	2.67972608858456
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED INTERMEDIATE	0.07142860000000001	2.67972608858456
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.07142860000000001	2.67972608858456
HAMAMY SYNDROME; HMMS	0.07137816	2.6778337739667704
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.070904759	2.6600735909299758
RAINE SYNDROME	0.06989535399999999	2.6222046013033036
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.06885522799999999	2.5831830780253013
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.06885522799999999	2.5831830780253013
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	2.5771231693103487
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.06869184	2.577053389270914
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.068173792	2.5576182226746336
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.06791203	2.5477979201571537
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.0676653	2.5385415604099872
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.06766172499999999	2.5384074401729015
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.067628238	2.537151136850025
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.067576379	2.5352055868150547
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.067505719	2.5325546956395395
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.06722686	2.5220929795015135
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.067212254	2.5215450186111994
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.067208119	2.5213898893299826
SECONDARY SYRINGOMYELIA	0.067208119	2.5213898893299826
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.06686331100000001	2.5084540206001935
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.06675062000000001	2.504226288114205
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.06673189199999999	2.503523685652627
COFS SYNDROME	0.066696059	2.502179369441303
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.5010779327865906
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.5010779327865906
SPINOCEREBELLAR ATAXIA TYPE 35	0.0666667	2.5010779327865906
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.5010779327865906
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.5010779327865906
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.0666667	2.5010779327865906
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.5010779327865906
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.0666667	2.5010779327865906
CEDNIK SYNDROME	0.06584187300000001	2.470133599137759
MUCOPOLYSACCHARIDOSIS TYPE 1	0.065809885	2.468933532524083
SUSAC SYNDROME	0.065716438	2.465427760833192
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.065427281	2.4545797033800594
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.065296319	2.4496665133131503
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0648148	2.4316017741687577
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0648148	2.4316017741687577
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.06459594	2.423390989528605
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.063914504	2.397826134177937
TARP SYNDROME	0.06376944600000001	2.392384116457334
TRISOMY 9P	0.063634969	2.387339057122353
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.063418954	2.379235005929615
DUPLICATION OF THE PITUITARY GLAND	0.063306064	2.37499980772973
DYSOSTOSIS, STANESCU TYPE	0.06308941500000001	2.3668719712977446
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.062885885	2.3592363092406745
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.062785885	2.355484694217302
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.062620694	2.349287363844043
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.06254479	2.3464397379767026
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.062514664	2.3453095264347614
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.061932269	2.3234603081193916
CRANIOSYNOSTOSIS 2	0.061834059000000004	2.319775847004938
49,XYYYY SYNDROME	0.061745814999999996	2.316465271843713
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.061520323	2.30800568009521
49,XXXYY SYNDROME	0.06148843999999999	2.306809552677308
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.06113030700000001	2.2933737812456547
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.060642469000000004	2.275071977547935
NON-DISTAL MONOSOMY 20Q	0.060455767	2.268067637266998
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.060325842	2.2631933514478813
ALG12-CDG	0.06005049	2.252863204448725
CAT-EYE SYNDROME	0.06005049	2.252863204448725
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.0600359	2.2523158438168154
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.059818525	2.2441607706597595
BALLER-GEROLD SYNDROME	0.059818525	2.2441607706597595
PFEIFFER SYNDROME TYPE 3	0.059364919	2.2271432198168415
AFRICAN IRON OVERLOAD	0.0588235	2.2068312632734486
MUSCULAR HYPERTROPHY-HEPATOMEGALY-POLYHYDRAMNIOS SYNDROME	0.0588235	2.2068312632734486
INIENCEPHALY	0.0588235	2.2068312632734486
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.0588235	2.2068312632734486
SPLIT HAND/FOOT MALFORMATION 1 (SHFM1)	0.0588235	2.2068312632734486
BLACKFAN-DIAMOND ANEMIA	0.0588235	2.2068312632734486
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.0588235	2.2068312632734486
YUNIS-VARON SYNDROME	0.05874668799999999	2.2039495727416956
16P13.2 MICRODELETION SYNDROME	0.058466898	2.1934529290678024
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.058319034	2.187905641029643
WIEDEMANN-STEINER SYNDROME	0.058041969	2.177511228865136
MUCOLIPIDOSIS TYPE IV	0.058027920000000004	2.1769841644705026
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.05777791	2.1676047517505697
CHROMOSOME 1P36 DELETION SYNDROME	0.057733346	2.1659328820315538
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.057594530000000005	2.160725040120709
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.05736129	2.1519747732401955
JUVENILE ABSENCE EPILEPSY	0.056942849999999996	2.136276515336396
TETRALOGY OF FALLOT	0.05684260000000001	2.1325155212754656
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.05684260000000001	2.1325155212754656
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.05677030899999999	2.129803441258919
AREDYLD SYNDROME	0.05655062500000001	2.1215617433109744
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.056517138	2.120305439988097
PEHO SYNDROME	0.05634782399999999	2.1139534305274243
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.056296128	2.1120139956249417
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.056002778	2.101008632953879
XQ12-Q13.3 DUPLICATION SYNDROME	0.055849589999999984	2.0952616089318745
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.055835029	2.094715336268322
APNEA, OBSTRUCTIVE SLEEP	0.0555984	2.085837927154666
GITELMAN SYNDROME	0.055555600000000004	2.084232235924663
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	2.084232235924663
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	2.084232235924663
POSTERIOR URETHRAL VALVE	0.055555600000000004	2.084232235924663
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.084232235924663
ABLEPHARON-MACROSTOMIA SYNDROME	0.055555600000000004	2.084232235924663
NAGER SYNDROME	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.084232235924663
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	2.084232235924663
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	2.084232235924663
ANOPHTHALMIA PLUS SYNDROME	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.084232235924663
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.055555600000000004	2.084232235924663
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.084232235924663
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.055312	2.0750933017277275
CYSTINOSIS, NEPHROPATHIC; CTNS	0.05507062	2.0660376533843112
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.055030103999999996	2.064517649041442
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.054840562999999995	2.0574068004099915
JOUBERT SYNDROME 2	0.054686962	2.0516442822179415
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.054680110999999997	2.05138725907269
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.054680110999999997	2.05138725907269
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.054657834	2.050551511793934
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.05461681399999999	2.049012599311346
VISCERAL STEATOSIS, CONGENITAL	0.054472847	2.0436115117106475
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.053613573	2.011374859234715
LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.053593138	2.010608216704689
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.053401328	2.0034122439283584
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0530914	1.9917849385187207
XP22.13P22.2 DUPLICATION SYNDROME	0.052767664	1.9796396101066558
BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD	0.0526646	1.9757730455989675
LARYNGEAL NEUROENDOCRINE TUMOR	0.0526316	1.9745350126412546
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.0526316	1.9745350126412546
CLEFT VELUM	0.0526316	1.9745350126412546
CLEFT LIP/PALATE	0.0526316	1.9745350126412546
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.052242751999999996	1.9599469326551715
COFFIN-SIRIS SYNDROME 1; CSS1	0.052029658	1.9519524661372665
ADENOMYOSIS	0.0517429	1.9411944099285445
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.05150031	1.9320933670433453
MENTAL RETARDATION, X-LINKED 98; MRX98	0.05135423299999999	1.9266131203656531
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.051186789999999996	1.920331303622068
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.9201185495340927
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.051148222	1.9188843807398537
PSEUDOTRISOMY 13 SYNDROME	0.050890837999999994	1.9092283239280967
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.05064477	1.8999967998723852
PRADER-WILLI SYNDROME	0.050497273999999995	1.8944633177775116
HISTIDINEMIA	0.05043863	1.8922632206632053
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.050259700000000004	1.8855504559018854
MONOSOMY 18Q	0.050149033	1.88139865610397
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.049983395	1.875184556011556
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.049970548	1.8747025860295035
SWEENEY-COX SYNDROME; SWCOS	0.049927773999999994	1.8730978702194059
PRIMROSE SYNDROME; PRIMS	0.049909968	1.8724298576483445
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.049781171	1.8675978900466916
COFFIN-LOWRY SYNDROME	0.04953260400000001	1.858272613131546
9P13 MICRODELETION SYNDROME	0.04953134499999999	1.858225380298401
ERYTHERMALGIA, PRIMARY	0.0494995	1.8570306784942086
TURNPENNY-FRY SYNDROME; TPFS	0.049470474	1.8559417347175244
CONGENITAL MYASTHENIC SYNDROME	0.049220159	1.8465508795717698
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.049220159	1.8465508795717698
TARP SYNDROME; TARPS	0.049217602	1.8464549507756223
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076854	1.841174627662526
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.048948913999999996	1.8363748114016234
16P13.11 MICRODELETION SYNDROME	0.048920284	1.835300724020432
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.04891196399999999	1.834988589650487
MICROHYDRANENCEPHALY; MHAC	0.04891057	1.8349362921370616
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.048818032	1.8314646226267333
COFFIN-SIRIS SYNDROME 3; CSS3	0.048789406	1.8303906853101424
COFFIN-SIRIS SYNDROME 4; CSS4	0.048789406	1.8303906853101424
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.048104140000000004	1.8046821431040798
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.04804403	1.8024270473135307
ZELLWEGER SYNDROME	0.047910719000000004	1.7974257318097226
COFFIN-SIRIS SYNDROME 2; CSS2	0.047794381000000004	1.793061177923832
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.047356654	1.7766393460304744
PERIVENTRICULAR NODULAR HETEROTOPIA	0.047324875	1.775447120292197
PITT-HOPKINS SYNDROME	0.047305678	1.7747269227561602
MARSHALL-SMITH SYNDROME; MRSHSS	0.047218793	1.7714673320431034
WHITE FORELOCK WITH MALFORMATIONS	0.04719277	1.7704910492655708
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.04685405	1.7577835788584038
CONO-SPONDYLAR DYSPLASIA	0.046655774	1.7503450266546623
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.046571062	1.747166958536063
TRISOMY 18P	0.046510090000000004	1.7448795238240125
PRADER-WILLI-LIKE SYNDROME	0.046346093	1.738726987734132
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.046317329000000004	1.7376478731888096
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.046161215	1.7317910769112221
PGM3-CDG	0.046054268999999995	1.7277788747083258
JOUBERT SYNDROME 7	0.045980417	1.7250082319812652
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.04596425899999999	1.7244020460257883
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.045956699999999996	1.7241184614461718
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.045877237	1.7211373156001495
LICHTENSTEIN SYNDROME	0.04574587000000001	1.7162089314923963
300270 ADRENOMYODYSTROPHY	0.044989964	1.687850248433823
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.04497356	1.687234833505389
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.6854321824866583
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.04485832999999999	1.6829118475139564
COG2-CDG	0.044621893999999995	1.6740416790172958
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.044439838	1.6672116387703453
COFFIN-SIRIS SYNDROME	0.044432957999999995	1.6669535276567369
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.044297953999999994	1.6618886973105835
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.044210292	1.6585999565487948
GLIOBLASTOMA	0.044019719000000006	1.6514503912503038
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.044019719000000006	1.6514503912503038
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.04398659399999999	1.650207668773811
WRINKLY SKIN SYNDROME	0.043948443999999996	1.6487764276423948
16P12.1P12.3 TRIPLICATION SYNDROME	0.043714470000000005	1.6399986239076099
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.04359198	1.6354032706654809
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.04357143	1.6346323137781777
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.043478300000000004	1.6311384347069111
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.043478300000000004	1.6311384347069111
HYPOPLASMINOGENEMIA	0.043478300000000004	1.6311384347069111
HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	0.043478300000000004	1.6311384347069111
FASCIAL DYSTROPHY, CONGENITAL	0.043478300000000004	1.6311384347069111
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.043478300000000004	1.6311384347069111
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.043478300000000004	1.6311384347069111
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.043478300000000004	1.6311384347069111
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.043478300000000004	1.6311384347069111
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.043478300000000004	1.6311384347069111
JUVENILE XANTHOGRANULOMA	0.043478300000000004	1.6311384347069111
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.043473047	1.630941362369733
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.043443123	1.6298187290901391
THROMBOCYTOPENIA 3	0.04337772	1.627365060316403
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.04312171000000001	1.6177605506950676
TREACHER-COLLINS SYNDROME	0.043096754	1.6168242976498346
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.04289368999999999	1.6092061181187736
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.04284412	1.6073464425516881
9Q33.3Q34.11 MICRODELETION SYNDROME	0.042731799	1.603132591041286
HALLERMANN-STREIFF SYNDROME; HSS	0.042712435	1.6024061283081603
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.04262823799999999	1.599247381006931
YOU-HOOVER-FONG SYNDROME; YHFS	0.042568982000000005	1.597024324008682
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.042448627	1.5925090677473022
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.042208118999999995	1.5834861334868895
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.042208118999999995	1.5834861334868895
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.042120554	1.5802010317916733
THROMBOCYTOPENIA 1	0.04206202	1.5780050614538927
SCHAAF-YANG SYNDROME; SHFYNG	0.041959528	1.5741599561841382
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.04194073	1.5734547275920445
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.041927954	1.5729754212566585
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.041719813999999994	1.5651668097470108
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.041713651	1.5649355977131205
DISTAL 17P13.1 MICRODELETION SYNDROME	0.041666699999999994	1.5631741769434968
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.041666699999999994	1.5631741769434968
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.04158245	1.5600134412863058
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.041543439999999994	1.558549936265688
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.041536444000000006	1.5582874732786534
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.041508436	1.5572367209429072
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.041432583	1.5543910083992285
7Q11.23 MICRODUPLICATION SYNDROME	0.041369646999999996	1.5520298919681186
COSTELLO SYNDROME; CSTLO	0.041033214	1.5394082209965363
XIA-GIBBS SYNDROME	0.040962712	1.5367632573727583
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.040703	1.5270198629632576
CONGENITAL ANALBUMINEMIA	0.040661459999999996	1.5254614420825485
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.040635208	1.524476568106613
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.04054487899999999	1.5210877717721507
DILATED CARDIOMYOPATHY WITH ATAXIA	0.040541419	1.5209579658923424
COG1-CDG	0.040531868	1.5205996491414597
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.04042505699999999	1.5165925116188452
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.040413568999999996	1.5161615260849606
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.040270134	1.5107803970761864
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.04024697000000001	1.5099113729721727
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.040186949999999985	1.5076596536351439
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.040044836	1.502328083460829
PERSISTENT MULLERIAN DUCT SYNDROME, TYPES I AND II	0.04	1.5006460093489498
KALLMANN SYNDROME-HEART DISEASE SYNDROME	0.04	1.5006460093489498
BARTSOCAS-PAPAS SYNDROME; BPS	0.04	1.5006460093489498
MEIER-GORLIN SYNDROME 8; MGORS8	0.04	1.5006460093489498
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.039972900000000006	1.499629321677616
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0397012	1.489436183659113
3MC SYNDROME 2	0.039525324	1.4828379932206066
MILD CANAVAN DISEASE	0.039504479999999995	1.4820560065851347
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.03947602	1.4809882969494832
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.039415884000000005	1.478732225739028
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0393503	1.4762717665420992
3P25.3 MICRODELETION SYNDROME	0.039287924999999994	1.4739316966712708
PRADER-WILLI SYNDROME; PWS	0.039074916	1.4659404190261356
SAETHRE-CHOTZEN SYNDROME	0.038999804	1.46312250594978
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.03893946499999999	1.4608588189608271
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.038890599	1.4590255547635063
LISSENCEPHALY 2; LIS2	0.038809544	1.455984683206312
HYPERLYSINEMIA, TYPE I	0.038805409	1.4558295539250954
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.038697187999999993	1.4517695186306514
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.038665359	1.4505754170848626
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.4451708779983423
FG SYNDROME TYPE 1	0.038443313	1.442245105990065
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.038340283999999995	1.4383798545476345
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0380747	1.4284161653039615
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.037998538	1.4255588602698603
SMITH-MAGENIS SYNDROME	0.037967827999999995	1.4244067392961828
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.03795184699999998	1.423807193699297
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.4212340735032172
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.03776281100000001	1.4167152907237157
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.037762811	1.4167152907237155
DYSTONIA, JUVENILE-ONSET	0.03760569	1.4108207156828425
PYRUVATE DEHYDROGENASE DEFICIENCY	0.037603402999999994	1.4107349162472578
SLC39A8-CDG	0.037501049	1.4068949882062356
MEIER-GORLIN SYNDROME 5; MGORS5	0.037391249999999994	1.4027757524267226
SPLENOGONADAL FUSION WITH LIMB DEFECTS AND MICROGNATHIA	0.037037	1.3894856562064262
NATHALIE SYNDROME	0.037037	1.3894856562064262
DK PHOCOMELIA SYNDROME	0.037037	1.3894856562064262
MCLEOD SYNDROME; MCLDS	0.037037	1.3894856562064262
PEYRONIE DISEASE	0.037037	1.3894856562064262
OVARIAN HYPERSTIMULATION SYNDROME	0.037037	1.3894856562064262
FAMILIAL SUPERNUMERARY NIPPLES	0.037037	1.3894856562064262
LABIA MINORA, INCOMPLETE ADHESION OF	0.037037	1.3894856562064262
URINARY BLADDER, ATONY OF	0.037037	1.3894856562064262
GALACTORRHEA	0.037037	1.3894856562064262
207620 APHALANGY WITH HEMIVERTEBRAE	0.037037	1.3894856562064262
HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1	0.037037	1.3894856562064262
LEUKEMIA, ACUTE MYELOCYTIC, WITH POLYPOSIS COLI AND COLON CANCER	0.037037	1.3894856562064262
TESTICULAR TORSION	0.037037	1.3894856562064262
GENITOURINARY TRACT ANOMALIES	0.037037	1.3894856562064262
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.037037	1.3894856562064262
MYOCLONUS AND ATAXIA	0.037037	1.3894856562064262
138790 GOITER, MULTINODULAR, CYSTIC RENAL DISEASE, AND DIGITAL ANOMALIES;;MULTINODULAR GOITER/CYSTIC RENAL DISEASE/DIGITAL ANOMALIES;;MNG/CRD/DA	0.037037	1.3894856562064262
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.037037	1.3894856562064262
MENTAL RETARDATION, BUENOS AIRES TYPE	0.03692911	1.3854380387577099
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.036907841	1.3846401077583887
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.036844049999999996	1.382246915018829
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.036821672	1.381407378608899
ACROCRANIOFACIAL DYSOSTOSIS	0.036750370000000004	1.378732402064934
ALPERS-HUTTENLOCHER SYNDROME	0.036592594	1.3728132539456581
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.03654973	1.3712051616820398
OCULODENTODIGITAL DYSPLASIA	0.036513989000000004	1.3698642969565362
PITT-HOPKINS-LIKE SYNDROME	0.036404533999999995	1.3657579667327038
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.036255719000000006	1.3601750008356726
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.036255719000000006	1.3601750008356726
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.036174832	1.3571404319917169
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.036159515999999996	1.3565658346347371
THUMBS, CONGENITAL CLASPED	0.0361093	1.3546819236346006
ISOTRETINOIN-LIKE SYNDROME	0.03610425	1.3544924670759204
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.03591533399999999	1.347405066038366
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.03582953	1.3441860302837119
CHANARIN-DORFMAN SYNDROME	0.035728130000000004	1.3403818926500124
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.035697465	1.339231459903095
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.3380603932735493
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.3380603932735493
VASCULAR EHLERS-DANLOS SYNDROME	0.035614664	1.3361250851475925
ALG13-CDG	0.035487208	1.331343426703403
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0354232	1.328942092959243
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.035272793999999996	1.3232994388671893
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.03522570999999999	1.3215330284495845
13Q12.3 MICRODELETION SYNDROME	0.03520599	1.3207932099669757
DEND SYNDROME	0.035067088999999996	1.315582179183361
ACHONDROPLASIA	0.03503332	1.3143152963061187
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.035028354	1.314128991104058
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.035024219	1.3139738618228416
MARFANOID HABITUS WITH SITUS INVERSUS	0.035002925000000004	1.3131749929197647
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.3063142269457726
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.034746612999999996	1.3035591534210582
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.034621177999999996	1.2988533151164912
BRACHYDACTYLY, TYPE A6	0.0344828	1.2936619052794491
LEUKOCYTE NUCLEAR APPENDAGES, HEREDITARY PREVALENCE OF	0.0344828	1.2936619052794491
234800 HEMANGIOMATOSIS, CUTANEOUS, WITH ASSOCIATED FEATURES	0.0344828	1.2936619052794491
FLOOD FACTOR DEFICIENCY	0.0344828	1.2936619052794491
OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT OF SPINE; OPLL	0.0344828	1.2936619052794491
PANNER DISEASE	0.0344828	1.2936619052794491
GIANT NEUTROPHIL LEUKOCYTES	0.0344828	1.2936619052794491
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.0344828	1.2936619052794491
ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC	0.0344828	1.2936619052794491
ANKYLOSING VERTEBRAL HYPEROSTOSIS WITH TYLOSIS	0.0344828	1.2936619052794491
HEMOPOIETIC PROLIFERATION	0.0344828	1.2936619052794491
%123550 CRYOGLOBULINEMIA, FAMILIAL MIXED;;MELTZER SYNDROME	0.0344828	1.2936619052794491
ACETOPHENETIDIN SENSITIVITY	0.0344828	1.2936619052794491
SULFHEMOGLOBINEMIA, CONGENITAL	0.0344828	1.2936619052794491
260570 PELGER-HUET-LIKE ANOMALY AND EPISODIC FEVER WITH ABDOMINAL PAIN	0.0344828	1.2936619052794491
MYELOPEROXIDASE DEFICIENCY	0.0344828	1.2936619052794491
MACROCYTOSIS, FAMILIAL	0.0344828	1.2936619052794491
MYELOMA, MULTIPLE	0.0344828	1.2936619052794491
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL RECESSIVE	0.0344828	1.2936619052794491
CALCIFICATION OF JOINTS AND ARTERIES; CALJA	0.0344828	1.2936619052794491
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.0344828	1.2936619052794491
SPINAL INTRADURAL ARACHNOID CYSTS	0.0344828	1.2936619052794491
CHROMOSOME 8Q22.1 DUPLICATION SYNDROME	0.0344828	1.2936619052794491
EOSINOPHILOPENIA	0.0344828	1.2936619052794491
CERVICAL VERTEBRAL BRIDGE	0.0344828	1.2936619052794491
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.0344828	1.2936619052794491
COUMARIN RESISTANCE	0.0344828	1.2936619052794491
FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 3	0.0344828	1.2936619052794491
ULNA METAPHYSEAL DYSPLASIA SYNDROME	0.0344828	1.2936619052794491
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.0344828	1.2936619052794491
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.0344828	1.2936619052794491
BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 1	0.0344828	1.2936619052794491
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.0344828	1.2936619052794491
VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX	0.0344828	1.2936619052794491
VACTERL ASSOCIATION WITH HYDROCEPHALUS	0.0344828	1.2936619052794491
FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 2	0.0344828	1.2936619052794491
HEMOGLOBIN, HIGH OXYGEN SATURATION OF	0.0344828	1.2936619052794491
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.034090654	1.278950097029895
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.034069249999999995	1.2781471013502925
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034069249999999995	1.2781471013502925
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.03406312399999999	1.2779172774139607
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.033882506	1.271141185391046
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.033545099999999994	1.2584830112052863
SPINOCEREBELLAR ATAXIA TYPE 34	0.03350343	1.2569197132250471
DENT DISEASE	0.033485089999999995	1.2562316670297604
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.033485089999999995	1.2562316670297604
TYSHCHENKO SYNDROME	0.033478854	1.2559977163169032
SECKEL SYNDROME	0.033253124999999994	1.2475292332407946
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.033185086	1.2449766718950426
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.033125390000000005	1.2427371077906904
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.033125390000000005	1.2427371077906904
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.033119779	1.2425266046717287
AYMÉ-GRIPP SYNDROME	0.033033548999999995	1.2392915870370744
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.033009697000000005	1.2383967518217
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.032942740000000005	1.2358847829505006
ALEXANDER DISEASE	0.032940124	1.235786640701489
APLASIA CUTIS-MYOPIA SYNDROME	0.0328877	1.2338198940416363
MENKES DISEASE	0.032852187	1.2324875829983861
NETHERTON SYNDROME; NETH	0.032803653999999995	1.2306668116790926
PROGRESSIVE HEMIFACIAL ATROPHY	0.032799519	1.2305116823978763
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.2305116823978763
TUBEROUS SCLEROSIS-1	0.032799519	1.2305116823978763
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.2305116823978763
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.032757091999999995	1.2289199846919099
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.032721321	1.2275779944818996
CRANIOFRONTONASAL SYNDROME; CFNS	0.032644352	1.2246904139145602
JOUBERT SYNDROME 30; JBTS30	0.032584371	1.2224401577073913
HURLER-SCHEIE SYNDROME	0.032533785	1.220542365731668
NEUROFERRITINOPATHY	0.032487550000000004	1.218807806525612
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.03242595399999999	1.216496961735815
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.032336973	1.2131587371718684
DESMOID TUMOR	0.0322581	1.2101997258544839
ROWLEY-ROSENBERG SYNDROME	0.0322581	1.2101997258544839
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.0322581	1.2101997258544839
SECKEL SYNDROME 2; SCKL2	0.0322581	1.2101997258544839
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.0322581	1.2101997258544839
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0322581	1.2101997258544839
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.0322581	1.2101997258544839
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0322581	1.2101997258544839
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.0322581	1.2101997258544839
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0322581	1.2101997258544839
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.0322581	1.2101997258544839
CRAMPS, FAMILIAL ADOLESCENT	0.0322581	1.2101997258544839
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0322581	1.2101997258544839
WEST SYNDROME	0.0322581	1.2101997258544839
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0322581	1.2101997258544839
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.0322581	1.2101997258544839
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.0322581	1.2101997258544839
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.0322581	1.2101997258544839
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	0.0322581	1.2101997258544839
WYBURN-MASON SYNDROME	0.032167493	1.2068005000302569
CORNELIA DE LANGE SYNDROME	0.032104769	1.2044473370229967
MUCOPOLYSACCHARIDOSIS, TYPE II	0.032080179	1.2035248148887494
8Q24.3 MICRODELETION SYNDROME	0.031995261	1.2003390184432021
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.031949322	1.1986155640176153
ISOLATED CEREBELLAR AGENESIS	0.031816939	1.1936490635012242
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.031791419	1.1926916513472596
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.031791419	1.1926916513472596
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.031674614000000004	1.1883095774192096
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.031581959	1.1848335185193035
15Q13.3 MICRODELETION SYNDROME	0.031337093	1.1756470888761728
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.03125	1.172379694803867
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.03125	1.172379694803867
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.1715134468949702
BAND HETEROTOPIA; BH	0.031138263000000003	1.1681877527252016
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.031117193999999997	1.167397324955927
JOUBERT SYNDROME 23; JBTS23	0.031081414	1.1660549971005645
EMANUEL SYNDROME	0.031023111	1.1638676929934877
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.030929033	1.1603382486117995
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.03083897	1.1569594315732994
GAUCHER DISEASE, TYPE I	0.03063722	1.1493905482636457
RAVINE SYNDROME	0.030535859999999998	1.1455879112759555
EPILEPSY, PYRIDOXINE-DEPENDENT	0.030529892	1.1453640148913606
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.030515281000000002	1.1448158664202959
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.030312559	1.1372105174126148
KEPPEN-LUBINSKY SYNDROME	0.030220454	1.1337550923953377
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.030129993	1.1303613439290447
AURICULOCONDYLAR SYNDROME	0.030078492000000002	1.1284292246758578
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.030030072	1.126612692681541
OSTEOPENIA AND SPARSE HAIR	0.029966328000000004	1.1242212632010424
16P11.2P12.2 MICRODELETION SYNDROME	0.029964894	1.1241674650416071
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.029960357	1.1239972542679968
WIEACKER-WOLFF SYNDROME	0.029732826	1.1154611670891674
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029710972999999998	1.1146413266581099
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.029672056	1.113181310639464
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.029671846	1.113173432247915
NIEMANN-PICK DISEASE TYPE B	0.0296313	1.1116523024205385
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.029609953	1.1108514451614993
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.029605404	1.1106807841940858
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.029566425	1.1092184421741254
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.02954584	1.1084461722215644
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.029532938	1.1079621388512488
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.029428713000000002	1.104052018093139
CHROMOSOME 17Q12 DELETION SYNDROME	0.029309025	1.099561785103965
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.029129812999999997	1.0928384407882787
DYSOSTEOSCLEROSIS	0.029112819	1.0922008913312071
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.029059427999999998	1.0901978665540781
SMITH-LEMLI-OPITZ SYNDROME	0.028935238000000002	1.0855387358565523
SOTOS SYNDROME	0.028929018000000004	1.0853053854020986
LINEAR NEVUS SEBACEUS SYNDROME	0.028888359	1.0837800162497453
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.028883853	1.0836109684767923
GANGLIOCYTOMA	0.028772825000000002	1.0794456253486424
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.028772825000000002	1.0794456253486424
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0738622842901084
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0738622842901084
CHERUBISM	0.0285714	1.0718889347878144
SCHEIE SYNDROME	0.0285714	1.0718889347878144
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.028534092	1.0704892822548948
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.028529956999999998	1.0703341529736783
PIERPONT SYNDROME	0.028457807999999998	1.0676274002504653
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.028430808000000002	1.0666144641941548
HAREL-YOON SYNDROME; HAYOS	0.028371237	1.0643795896085817
20Q11.2 MICRODUPLICATION SYNDROME	0.028359412999999997	1.063935998648218
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.028336468	1.0630751905811053
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.028323354000000002	1.0625832037869403
COFFIN-SIRIS SYNDROME 6; CSS6	0.028319332	1.0624323138307004
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.028266923000000003	1.060466129913101
JOUBERT SYNDROME	0.028129348000000002	1.0553048455446965
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.028129348000000002	1.0553048455446965
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.028102116	1.0542832057415317
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.02808962	1.0538144039282111
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.028027944	1.051500557846396
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.027982454	1.0497939481722638
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.027817929	1.0436216035550605
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	1.0421161179623315
OROFACIAL CLEFT 3	0.027777800000000002	1.0421161179623315
CLEFT CHIN	0.027777800000000002	1.0421161179623315
MENINGIOMA	0.027777800000000002	1.0421161179623315
DIMPLES, FACIAL	0.027777800000000002	1.0421161179623315
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	1.0421161179623315
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	1.0421161179623315
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	1.0421161179623315
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	1.0421161179623315
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	1.0421161179623315
15Q24 RECURRENT MICRODELETION SYNDROME	0.027777800000000002	1.0421161179623315
EDINBURGH MALFORMATION SYNDROME	0.027777800000000002	1.0421161179623315
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	1.0421161179623315
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.027777800000000002	1.0421161179623315
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	1.0421161179623315
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	1.0421161179623315
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	1.0421161179623315
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	1.0421161179623315
NASAL BONES, ABSENCE OF	0.027777800000000002	1.0421161179623315
CYANIDE, INABILITY TO SMELL	0.027777800000000002	1.0421161179623315
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0421161179623315
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	1.0421161179623315
DWARFISM, LEVI TYPE	0.027777800000000002	1.0421161179623315
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	1.0421161179623315
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.027701722	1.0392619642848502
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.027606303	1.0356822107456984
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.027583794000000002	1.0348377597200875
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.027546337	1.033432517280783
BAKER-GORDON SYNDROME; BAGOS	0.027465359	1.0303945344671566
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.027385789	1.027409374393059
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.027344438	1.0258580440647445
SHPRINTZEN-GOLDBERG SYNDROME	0.027141915	1.0182601607709598
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.027127451	1.0177175271739793
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0139489923668517
BENIGN OCCIPITAL EPILEPSY	0.027027	1.0139489923668517
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	1.0139489923668517
LISSENCEPHALY 5; LIS5	0.026767467	1.0042123133482426
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.026585159999999997	0.997372856547583
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.026585159999999997	0.997372856547583
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.026501390000000003	0.9942301286425043
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.026500660000000002	0.9942027418528336
1Q41Q42 MICRODELETION SYNDROME	0.026345289	0.9883738200748696
CROUZON SYNDROME	0.026191479	0.9826034610074206
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.02614809	0.9809756727649295
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.026039889	0.9769163877934903
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.026016861000000002	0.9760524658859081
DISTAL MONOSOMY 10Q	0.025987253	0.974941687709788
SUDDEN INFANT DEATH-DYSGENESIS OF THE TESTES SYNDROME	0.02596645	0.9741612392364759
4Q21 MICRODELETION SYNDROME	0.025566923999999998	0.9591725617981972
KLEEFSTRA SYNDROME	0.025464528000000004	0.9553310580788649
CLEIDOCRANIAL DYSPLASIA	0.025399755	0.9529010244797758
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.025253201	0.9474028825984226
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.025202472000000004	0.9454997258132163
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.025143956999999998	0.9433044682822898
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.025083953	0.9410533492036653
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.02506551	0.9403614388449049
CORNELIA DE LANGE SYNDROME 3	0.025054563	0.9399507495482962
SMITH-FINEMAN-MYERS SYNDROME	0.025002359000000002	0.937992256441495
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.02489935	0.9341277553220694
SIALURIA	0.024846451	0.9321431884908554
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.024802593	0.9304978051739049
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.024795684999999998	0.9302386436080902
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.024793499	0.9301566333036794
AGNATHIA-OTOCEPHALY COMPLEX	0.02477031	0.9292866712959097
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.024730213999999997	0.9277824237361381
LEBER OPTIC ATROPHY AND DYSTONIA	0.024710645	0.9270482701922144
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.024673037000000002	0.9256373628142247
HEART AND BRAIN MALFORMATION SYNDROME	0.024584711000000002	0.9223237113286807
1P36 DELETION SYNDROME	0.024566928000000002	0.9216565616290744
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.024520384000000003	0.919910409932596
168830 PASSOVOY FACTOR DEFECT	0.02450982	0.919514089321527
STORMORKEN SYNDROME; STRMK	0.02450982	0.919514089321527
VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1; VKCFD1	0.02450982	0.919514089321527
PSEUDOXANTHOMA ELASTICUM-LIKE DISORDER WITH MULTIPLE COAGULATION FACTOR DEFICIENCY	0.02450982	0.919514089321527
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.024267345	0.9104173607936047
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.024257039	0.910030719349296
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.024166228	0.9066238402304213
GAUCHER DISEASE, PERINATAL LETHAL	0.024155959	0.9062385868836712
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.02414227	0.9057250283031217
CHROMOSOME 18Q DELETION SYNDROME	0.024114402	0.9046795282284084
TRISOMY 20P	0.024087004999999998	0.903651698260455
CORNELIA DE LANGE SYNDROME 1	0.023999969	0.9003864426087126
BRANCHIOOCULOFACIAL SYNDROME	0.023994049	0.9001643469993289
ACROMELIC FRONTONASAL DYSPLASIA	0.023989203	0.8999825437352964
MUCOPOLYSACCHARIDOSIS TYPE 2	0.023884913	0.8960699844274213
MICRO SYNDROME	0.023843758000000003	0.8945260072645524
SOMATOMAMMOTROPINOMA	0.023800659999999998	0.8929091362217793
ACROMEGALY	0.023800659999999998	0.8929091362217793
ANGELMAN SYNDROME	0.023751526000000002	0.8910658176961955
CHOREOACANTHOCYTOSIS	0.023720689	0.8899089321714382
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.023621423000000003	0.8861848540023375
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.023621423000000003	0.8861848540023375
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.023615074	0.8859466639645035
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.023529389999999997	0.882732130147877
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.023474742	0.8806819475699045
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.02341335	0.8783787560747557
OROFACIODIGITAL SYNDROME TYPE 2	0.023357154	0.8762704984962215
AICARDI-GOUTIERES SYNDROME 7	0.023325111	0.8750683684942822
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.02327232	0.8730878534072938
DUBOWITZ SYNDROME	0.023131564	0.8678072301649957
MOEBIUS SYNDROME; MBS	0.023108700000000003	0.8669494609060518
STICKLER SYNDROME, TYPE III	0.02310087	0.8666557094497217
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.023045009	0.8645600197815159
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.023036209999999998	0.8642299151756091
CRANIOSYNOSTOSIS 6; CRS6	0.023009177000000002	0.863215741086341
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.022997754	0.862787194102221
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.022926647	0.8601195332075519
PELIZAEUS-MERZBACHER DISEASE	0.022906084	0.8593480886102958
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.022895932	0.8589672246531229
KOOLEN-DE VRIES SYNDROME	0.022821518000000002	0.8561754978496308
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.02280491	0.855552429626549
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.02280491	0.855552429626549
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.022797164	0.8552618295268386
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.022783692	0.8547564119508898
BIOTINIDASE DEFICIENCY	0.022760204	0.8538752326142001
HOLOPROSENCEPHALY	0.022757908	0.8537890955332635
WEILL-MARCHESANI SYNDROME 1; WMS1	0.022748255	0.8534269521350573
WEILL-MARCHESANI SYNDROME 2; WMS2	0.022748255	0.8534269521350573
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.022679198999999997	0.8508362368645171
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.022621256	0.8486624385715246
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.022608966999999997	0.8482014026013023
GLUTAMINE DEFICIENCY, CONGENITAL	0.022543907000000002	0.8457606018670963
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.8446087435064703
GAUCHER DISEASE, TYPE II	0.022505163	0.844307076142441
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.02247053	0.8430077793113963
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.02247053	0.8430077793113963
TENORIO SYNDROME; TNORS	0.022416412	0.8409774802930478
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.022313087	0.8371011240701483
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.022271625	0.8355456294491576
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.022245333	0.8345592548272125
DUBOWITZ SYNDROME	0.022169298	0.8317067143441914
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.022127626000000004	0.8301433413316517
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.022076651	0.8282309555734875
ACROCALLOSAL SYNDROME; ACLS	0.021985137000000002	0.8247977026009986
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.02196784	0.8241487857504057
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.8241416576818613
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.02194405	0.8232562765363456
CRANIOPHARYNGIOMA	0.021920273	0.8223642550322383
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.021896494000000002	0.8214721584958307
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.021878172	0.8207847875912482
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.021834824000000003	0.8191585375109169
HYPOCHONDROPLASIA	0.021828325	0.8189147200505478
OROFACIODIGITAL SYNDROME TYPE 4	0.021822154	0.8186832078874554
DYSTONIA 28, CHILDHOOD-ONSET	0.021822154	0.8186832078874554
HUNTINGTON DISEASE; HD	0.021818019	0.818528078606239
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.021807855	0.8181467644552635
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.021803212000000002	0.8179725769697284
HYPERCALCEMIA, INFANTILE, 1	0.021794838	0.817658416727671
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.021794838	0.817658416727671
SILVER-RUSSELL SYNDROME	0.021777915000000002	0.817023530917266
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.021756653	0.8162258625309964
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.021710072	0.8144783227369593
AL KAISSI SYNDROME; ALKAS	0.021631871	0.8115445222725318
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.021591054	0.8100132255684419
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.021559098	0.8088143594715731
MONOSOMY 18P	0.021428134	0.8039010943723637
BARATELA-SCOTT SYNDROME	0.021378854	0.8020522984888457
MONOSOMY 13Q34	0.021378684000000002	0.802045920743306
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.021374719	0.8018971692076293
NEONATAL MARFAN SYNDROME	0.02137343	0.8018488108899781
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.021346814999999998	0.8008503185515073
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.021299113999999997	0.7990607606692086
SPASTIC PARAPLEGIA TYPE 7	0.021291145	0.7987617944679961
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.021291145	0.7987617944679961
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.798583930399738
SPINOCEREBELLAR ATAXIA 12	0.0212766	0.7982161220628465
INFANTILE-ONSET ASCENDING HEREDITARY SPASTIC PARALYSIS	0.0212766	0.7982161220628465
PRIMARY BASILAR INVAGINATION	0.0212766	0.7982161220628465
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.0212766	0.7982161220628465
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.0212766	0.7982161220628465
KURU, SUSCEPTIBILITY TO	0.0212766	0.7982161220628465
X-LINKED RETINOSCHISIS	0.0212766	0.7982161220628465
3MC SYNDROME 1	0.0212766	0.7982161220628465
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.021270631999999998	0.7979922256782516
FRYNS SYNDROME	0.021251199	0.7972631743307597
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.021222518	0.7961871736259063
GAUCHER DISEASE	0.02121285	0.7958244674854467
JACOBSEN SYNDROME	0.021186908	0.7948512235160835
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.021150941	0.7935018801406272
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.021145622000000003	0.7933023317375341
LOEYS-DIETZ SYNDROME 5	0.02111412	0.7921204979728711
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.021013826	0.78835785320133
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.021004109	0.7879933087695089
GABRIELE-DE VRIES SYNDROME; GADEVS	0.020934984	0.7854000048846028
AGEL AMYLOIDOSIS	0.0208333	0.7815852126642369
611426 TENTED EYEBROWS	0.0208333	0.7815852126642369
UNIQUE GREEN PHENOMENON	0.0208333	0.7815852126642369
BLEPHAROCHALASIS AND DOUBLE LIP	0.0208333	0.7815852126642369
APNEA, CENTRAL SLEEP	0.0208333	0.7815852126642369
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.0208333	0.7815852126642369
GLAUCOMA - SLEEP APNEA	0.0208333	0.7815852126642369
OSTEOGENESIS IMPERFECTA, TYPE V	0.0208333	0.7815852126642369
CHROMOSOME XQ26.3 DUPLICATION SYNDROME	0.0208333	0.7815852126642369
PREPAPILLARY VASCULAR LOOPS	0.0208333	0.7815852126642369
OSTEOPETROSIS AND RELATED DISORDERS	0.0208333	0.7815852126642369
OCULAR CICATRICIAL PEMPHIGOID	0.0208333	0.7815852126642369
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.0208333	0.7815852126642369
DERMOIDS OF CORNEA	0.0208333	0.7815852126642369
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0208333	0.7815852126642369
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0208333	0.7815852126642369
MELANOMA, CUTANEOUS MALIGNANT	0.0208333	0.7815852126642369
MELKERSSON-ROSENTHAL SYNDROME	0.0208333	0.7815852126642369
IMINOGLYCINURIA	0.0208333	0.7815852126642369
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0208333	0.7815852126642369
CARNEY COMPLEX, TYPE 1; CNC1	0.0208333	0.7815852126642369
SEA-BLUE HISTIOCYTE DISEASE	0.0208333	0.7815852126642369
MYELINATED OPTIC NERVE FIBERS	0.0208333	0.7815852126642369
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0208333	0.7815852126642369
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0208333	0.7815852126642369
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0208333	0.7815852126642369
PUPIL, EGG-SHAPED	0.0208333	0.7815852126642369
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0208333	0.7815852126642369
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.0208333	0.7815852126642369
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0208333	0.7815852126642369
GLAUCOMA-SLEEP APNEA SYNDROME	0.0208333	0.7815852126642369
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0208333	0.7815852126642369
BEEMER LETHAL MALFORMATION SYNDROME	0.02083254	0.7815567003900592
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.020832394	0.7815512230321252
MOWAT-WILSON SYNDROME; MOWS	0.020821157000000003	0.7811296540519489
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.020758079	0.7787632103275058
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7781168445751291
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7781168445751291
CRANIOFRONTONASAL DYSPLASIA	0.020694025	0.776360150840435
WITTEVEEN-KOLK SYNDROME	0.020691086	0.7762498908748982
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.020652562	0.7748046187032941
METACHROMATIC LEUKODYSTROPHY	0.020587047	0.7723467481207318
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.020570423000000004	0.7717230796392465
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.020531564	0.770265239557314
RIN2 SYNDROME	0.020463824999999998	0.7677239330566317
FUMARASE DEFICIENCY; FMRD	0.020432962	0.7665660721119684
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.020427439999999998	0.7663589079303776
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.020326240000000002	0.762562273526725
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.02029612	0.7614322870816852
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.020247772	0.7596184562501851
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.020171063000000003	0.7567406298819065
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0201549	0.7561342563456787
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.02012467	0.7550001431241132
CUTIS LAXA	0.020106889	0.7543330684568074
SALT-AND-PEPPER SYNDROME	0.020043642	0.751960284502975
JOUBERT SYNDROME WITH OCULAR DEFECT	0.020018158	0.7510042229304188
JOUBERT SYNDROME WITH RENAL DEFECT	0.020018158	0.7510042229304188
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.019968193999999998	0.7491297660001409
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.019961181999999997	0.7488667027547021
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.019954873	0.7486300133628777
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.019950803	0.7484773226314263
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.019950166000000002	0.7484534248437276
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.019905611	0.7467818927700639
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.019889461	0.7461760069437894
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.019763364	0.7414453329477673
KLEEFSTRA SYNDROME	0.019721487	0.7398742691244298
PETERS PLUS SYNDROME	0.019719754000000003	0.7398092536360747
PMM2-CDG	0.019645853	0.7370367726176523
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.019616709	0.7359434019352407
AMISH LETHAL MICROCEPHALY	0.01961366	0.735829015193178
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.01958281	0.7346716419584677
STICKLER SYNDROME	0.019563015	0.7339290097645911
KAGAMI-OGATA SYNDROME	0.019544513	0.7332348859529667
1Q44 MICRODELETION SYNDROME	0.019537609	0.7329758744517532
19P13.12 MICRODELETION SYNDROME	0.019526458	0.7325575318604969
NOONAN SYNDROME	0.019460245	0.7300734750050714
CONGENITAL STATIONARY NIGHT BLINDNESS	0.019427129999999997	0.7288311276900814
GENITOPATELLAR SYNDROME	0.019416393	0.7284283167850221
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.019409319	0.7281629275382687
HHHH SYNDROME	0.019409319	0.7281629275382687
COPPER DEFICIENCY, FAMILIAL BENIGN	0.019409319	0.7281629275382687
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.019364192000000002	0.7264699362266716
PEROXISOME BIOGENESIS DISORDER 6B	0.019364192000000002	0.7264699362266716
2P15P16.1 MICRODELETION SYNDROME	0.019235347	0.7216361678498073
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.01920604	0.7205366820349075
BRITTLE CORNEA SYNDROME	0.019176824999999998	0.7194406477058293
BOHRING-OPITZ SYNDROME	0.019147411000000003	0.7183371476628546
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.019092429	0.716274434690704
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.019042031	0.7143836957512248
FACIOCARDIOMELIC SYNDROME	0.01900812	0.7131114855806489
DESANTO-SHINAWI SYNDROME	0.018990431000000002	0.7124478623991647
1Q21.1 MICRODELETION SYNDROME	0.018989348000000003	0.7124072324084616
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.018977514	0.7119632662865957
48,XXYY SYNDROME	0.018946728	0.7108082940855002
LISSENCEPHALY 1; LIS1	0.018944073000000002	0.7107086887066297
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.018893876	0.7088254905133474
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.7078509709948763
RAYNAUD DISEASE	0.0188679	0.7078509709948763
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.7078509709948763
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.7078509709948763
TRACHEOBRONCHOMEGALY	0.0188679	0.7078509709948763
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.7078509709948763
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.7078509709948763
CARPAL DISPLACEMENT	0.0188679	0.7078509709948763
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.7078509709948763
PUBIC BONE DYSPLASIA	0.0188679	0.7078509709948763
PRIMARY HYPEROXALURIA TYPE 1	0.0188679	0.7078509709948763
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.7078509709948763
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	0.7078509709948763
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.7078509709948763
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.7078509709948763
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0188679	0.7078509709948763
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.7078509709948763
SPINAL ARACHNOIDITIS	0.0188679	0.7078509709948763
CIRCUMVALLATE PLACENTA SYNDROME	0.0188679	0.7078509709948763
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.7078509709948763
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.7078509709948763
VAN DEN BOSCH SYNDROME	0.0188679	0.7078509709948763
TOE, MISSHAPEN	0.0188679	0.7078509709948763
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.7078509709948763
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.7078509709948763
LETTERER-SIWE DISEASE	0.0188679	0.7078509709948763
MONOPHALANGY OF GREAT TOE	0.0188679	0.7078509709948763
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	0.7078509709948763
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.7078509709948763
NEPHROSIALIDOSIS	0.0188679	0.7078509709948763
MEGAEPIPHYSEAL DWARFISM	0.0188679	0.7078509709948763
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.7078509709948763
VESICOURETERAL REFLUX 1	0.0188679	0.7078509709948763
KNUCKLE PADS	0.0188679	0.7078509709948763
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.7078509709948763
DERMOCHONDROCORNEAL DYSTROPHY	0.0188679	0.7078509709948763
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.018863829999999998	0.7076982802634249
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.018845686	0.7070175872335843
CRANIOLENTICULOSUTURAL DYSPLASIA	0.018834965000000002	0.7066153765869286
ZUNICH NEUROECTODERMAL SYNDROME	0.018792317	0.7050153878117607
PERLMAN SYNDROME	0.018786054	0.7047804241628468
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.01874068	0.7030781663621418
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.01874053	0.7030725389396068
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.01874053	0.7030725389396068
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.018727353999999998	0.7025782261441271
KNOBLOCH SYNDROME 1; KNO1	0.018723219	0.7024230968629108
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.018670658000000003	0.7004512104904762
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.018651378	0.6997278991139699
C SYNDROME	0.018616509000000003	0.6984197484714703
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.018602446	0.6978921588507334
RHEUMATIC FEVER	0.01857585	0.6968943793191172
WEAVER SYNDROME	0.018542146	0.6956299349916397
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6954199946149318
ENDOCARDIAL FIBROELASTOSIS	0.0185284	0.695114237990527
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.018499624000000003	0.6940346732514014
EMANUEL SYNDROME	0.018495146	0.6938666759306548
MOSAIC TRISOMY 15	0.01846839	0.6928628938150012
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.018459997	0.6925480207660896
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.018402654	0.6903967321632373
RIDDLE SYNDROME	0.018402654	0.6903967321632373
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.018402654	0.6903967321632373
8P INVERTED DUPLICATION/DELETION SYNDROME	0.018400074	0.6902999404956341
MERCURY POISONING	0.018398519000000002	0.6902416028820209
OCULODENTODIGITAL DYSPLASIA; ODDD	0.018398519000000002	0.6902416028820209
ADRENOLEUKODYSTROPHY	0.018398519000000002	0.6902416028820209
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.018398519000000002	0.6902416028820209
JUVENILE HUNTINGTON DISEASE	0.018398519000000002	0.6902416028820209
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.018398519000000002	0.6902416028820209
MEGALENCEPHALY WITH DYSMYELINATION	0.018398519000000002	0.6902416028820209
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.018383064	0.6896617907801585
MOWAT-WILSON SYNDROME	0.018313579000000003	0.6870549810811684
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.01830946	0.6869004520583555
OROFACIODIGITAL SYNDROME VI	0.018300862	0.686577888198646
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.018236425	0.6841604600260356
DEAFNESS AND MYOPIA; DFNMYP	0.018181799999999998	0.6821111403195182
STICKLER SYNDROME, TYPE V; STL5	0.018181799999999998	0.6821111403195182
VAN DEN BOSCH SYNDROME	0.018181799999999998	0.6821111403195182
APLASIA CUTIS CONGENITA, HIGH MYOPIA, AND CONE-ROD DYSFUNCTION	0.018181799999999998	0.6821111403195182
CONE-ROD DYSTROPHY 18	0.018181799999999998	0.6821111403195182
MYOPIA 25, AUTOSOMAL DOMINANT	0.018181799999999998	0.6821111403195182
EPIPHYSEAL DYSPLASIA OF FEMORAL HEAD, MYOPIA, AND DEAFNESS	0.018181799999999998	0.6821111403195182
SINUS NODE DISEASE AND MYOPIA	0.018181799999999998	0.6821111403195182
%225200 ECTOPIA LENTIS ET PUPILLAE;;ECTOPIA LENTIS WITH ECTOPIA OF PUPIL	0.018181799999999998	0.6821111403195182
MYOPIA 26, X-LINKED, FEMALE-LIMITED; MYP26	0.018181799999999998	0.6821111403195182
%613969 MYOPIA 19, AUTOSOMAL DOMINANT; MYP19	0.018181799999999998	0.6821111403195182
RETINITIS PIGMENTOSA 51; RP51	0.018181799999999998	0.6821111403195182
MYOPIA 5	0.018181799999999998	0.6821111403195182
MYOPIA 17	0.018181799999999998	0.6821111403195182
LETHAL CONGENITAL CONTRACTURE SYNDROME 2	0.018181799999999998	0.6821111403195182
WEILL-MARCHESANI SYNDROME	0.018181799999999998	0.6821111403195182
%300843 BORNHOLM EYE DISEASE; BED;;MYOPIA, HIGH, WITH NONPROGRESSIVE CONE DYSFUNCTION	0.018181799999999998	0.6821111403195182
MENTAL RETARDATION, X-LINKED 92	0.018181799999999998	0.6821111403195182
JUVENILE GLAUCOMA	0.018181799999999998	0.6821111403195182
MYOPIA 3	0.018181799999999998	0.6821111403195182
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.018152532000000002	0.6810131176344778
49,XXXXY SYNDROME	0.018137678	0.680455852738906
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.018137152	0.680436119243883
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.018086289999999998	0.6785279728106953
PERMANENT NEONATAL DIABETES MELLITUS	0.018074054	0.6780689251964355
TRANSIENT NEONATAL DIABETES MELLITUS	0.018074054	0.6780689251964355
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.018070140999999998	0.677922124500571
KAGAMI-OGATA SYNDROME	0.018067031	0.6778054492733441
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.018035251000000002	0.6766131860189164
TETRASOMY 9P	0.017999751	0.6752813626856192
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.01793371	0.6728037586080338
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.01792744	0.6725685323460684
PROGRESSIVE NON-FLUENT APHASIA	0.0178571	0.6699296463386283
ATAXIA-PANCYTOPENIA SYNDROME	0.0178571	0.6699296463386283
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.0178571	0.6699296463386283
NEPHROPATHIC INFANTILE CYSTINOSIS	0.0178571	0.6699296463386283
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.0178571	0.6699296463386283
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.0178571	0.6699296463386283
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.0178571	0.6699296463386283
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.0178571	0.6699296463386283
FAMILIAL DYSAUTONOMIA	0.017850654	0.6696878172342217
MICROPHTHALMIA, LENZ TYPE	0.017839004000000002	0.6692507540839988
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.017815041	0.6683517545759481
KLEEFSTRA SYNDROME 2; KLEFS2	0.017764185999999998	0.666443870755812
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.017713635000000002	0.6645473918453471
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.017635771	0.6616262343235485
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.017610643999999998	0.6606835660166256
RETT SYNDROME; RTT	0.017609213999999998	0.6606299179217914
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.017581944	0.6596068525049177
MELAS	0.017528500000000002	0.6576018393718267
6Q25 MICRODELETION SYNDROME	0.017514923	0.6570924826001034
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.017474563000000002	0.6555783307766704
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.017470098	0.6554108211658767
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.017441674	0.6543444621116333
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.017439982	0.6542809847854378
PEROXISOME BIOGENESIS DISORDER 3B	0.017439982	0.6542809847854378
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.017416792	0.6534109852615179
MICROFORM HOLOPROSENCEPHALY	0.017389714	0.6523951229454891
FETAL ALCOHOL SYNDROME	0.017375834	0.651874398780245
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.017343293000000003	0.6506535857354895
PALLISTER-KILLIAN SYNDROME	0.017311217	0.6494502177005925
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.017292603	0.6487518920801418
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.017263048	0.6476431022599841
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6468309526397246
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6468309526397246
ALCOHOL DEPENDENCE	0.0172414	0.6468309526397246
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.6468309526397246
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6468309526397246
SICKLE CELL ANEMIA	0.0172414	0.6468309526397246
PALMOMENTAL REFLEX	0.0172414	0.6468309526397246
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6468309526397246
CERVICAL RIB	0.0172414	0.6468309526397246
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6468309526397246
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.6468309526397246
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6468309526397246
MYOPATHY, CONGENITAL	0.0172414	0.6468309526397246
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6468309526397246
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.6468309526397246
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.6468309526397246
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6468309526397246
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6468309526397246
269800 SENILE PLAQUE FORMATION	0.0172414	0.6468309526397246
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6468309526397246
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6468309526397246
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6468309526397246
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6468309526397246
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.6468309526397246
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6468309526397246
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6468309526397246
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6468309526397246
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.6468309526397246
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6468309526397246
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6468309526397246
MOTION SICKNESS	0.0172414	0.6468309526397246
CARDIAC ARRHYTHMIA	0.0172414	0.6468309526397246
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.6468309526397246
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6468309526397246
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.6468309526397246
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6468309526397246
TRANSSEXUALITY	0.0172414	0.6468309526397246
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.6468309526397246
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.6468309526397246
DIASTEMATOMYELIA	0.0172414	0.6468309526397246
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6468309526397246
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6468309526397246
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.017231953	0.6464765375684666
APLASIA CUTIS CONGENITA-INTESTINAL LYMPHANGIECTASIA SYNDROME	0.01717504	0.6443413809102145
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	0.01714492	0.643211394465175
THYMIC TUMOR	0.01714492	0.643211394465175
TEMTAMY SYNDROME	0.017139204	0.642996952150439
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.017129268	0.6426241916817167
DUANE RETRACTION SYNDROME	0.017090813	0.6411815081244788
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.017061881	0.6400960908659168
RFT1-CDG	0.017019863	0.6385197372653961
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.017002675	0.6378749096751788
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.016964787000000002	0.6364534977751236
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.016936683	0.6353991438889549
SCHWARTZ-JAMPEL SYNDROME	0.016936114999999998	0.6353778347156221
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.016921044	0.6348124288154497
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.016894428	0.633813898960829
ACID PHOSPHATASE DEFICIENCY	0.016894428	0.633813898960829
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.01685379	0.6322893176476309
CAMPOMELIC DYSPLASIA	0.016795378	0.6300979242801785
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.016794494	0.630064760003372
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.016754411	0.6285610001535537
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.01674055	0.628040988795164
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.016716283999999998	0.6271306218935924
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.016712751	0.6269980773348168
DESMOSTEROLOSIS	0.01667664	0.6256433316337267
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.016653794	0.624786237665487
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.016653794	0.624786237665487
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.016653251	0.6247658663959101
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.016653251	0.6247658663959101
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.016622203	0.6236010649634535
16Q24.3 MICRODELETION SYNDROME	0.016621504	0.6235748411744401
NEUROFACIODIGITORENAL SYNDROME	0.01661172	0.6232077831605534
PAI SYNDROME	0.01659365	0.6225298663258301
HARTSFIELD SYNDROME	0.01659365	0.6225298663258301
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.01657005	0.6216444851803141
ADENYLOSUCCINASE DEFICIENCY	0.016540251	0.6205265414194994
LARYNGOTRACHEAL ANGIOMA	0.016505640000000002	0.61922806994376
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.016432681999999997	0.6164909666550079
MENTAL RETARDATION, X-LINKED 41	0.016432492	0.6164838385864635
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.016432492	0.6164838385864635
MUENKE SYNDROME	0.016430033	0.6163915863730388
HEREDITARY METHEMOGLOBINEMIA	0.016423409	0.6161430793938906
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.016420577999999998	0.6160368711725789
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.016396896	0.615148413702744
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.016395283	0.615087900152417
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.6115698981965498
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6115698981965498
FAMILIAL LAMBDOID SYNOSTOSIS	0.01629874	0.6114659784604025
6Q TERMINAL DELETION SYNDROME	0.016263268	0.6101352055793119
RICHIERI COSTA-DA SILVA SYNDROME	0.016261190000000002	0.6100572470191263
22Q11.2 DELETION SYNDROME	0.016197558	0.6076700193474539
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.016179087	0.6069770585364868
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.01613762	0.6054213763347449
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.016111832	0.6044539098525177
2Q32Q33 MICRODELETION SYNDROME	0.016103254	0.6041320963158128
SARCOSINEMIA	0.016079514	0.6032414629092642
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	0.01606237	0.6025982860296571
WEBB-DATTANI SYNDROME; WEDAS	0.016037173	0.6016529915922181
WILLIAMS SYNDROME	0.016001635	0.600319742645212
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.015971080999999998	0.5991734741909708
TONNE-KALSCHEUER SYNDROME; TOKAS	0.015969682	0.5991209890967938
PITT-HOPKINS SYNDROME	0.015951846999999998	0.5984518885573753
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.015926454	0.5974992409544905
MYOCLONIC-ATONIC EPILEPSY	0.015920425	0.5972730560847312
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.015920425	0.5972730560847312
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.01590957	0.5968658182739444
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.01590957	0.5968658182739444
CK SYNDROME	0.015887811	0.5960495043610088
EPILEPSY, HOT WATER, 1	0.015887128	0.596023880830399
SEVERE CANAVAN DISEASE	0.015845513	0.5944626462384225
8Q21.11 MICRODELETION SYNDROME	0.015807520000000002	0.5930372951425928
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.015769024	0.5915930734231953
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.015764889	0.5914379441419789
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.015721093	0.5897948868263426
MALAN OVERGROWTH SYNDROME	0.015717714	0.589668119754703
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.01569499	0.5888156027567918
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.015694824	0.588809375075853
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.015682051000000002	0.5883301812889178
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.01566324	0.587624464986871
BRONCHOPULMONARY DYSPLASIA	0.015649740000000002	0.5871179969587159
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.015620467	0.586019786692924
SHORT RIB-POLYDACTYLY SYNDROME	0.015619630000000002	0.5859883856751785
MONOSOMY 9P	0.015617328000000002	0.5859020234973404
DONNAI-BARROW SYNDROME	0.015604313000000002	0.5854137508020485
CRANE-HEISE SYNDROME	0.015602770000000002	0.5853558633822379
FEMORAL-FACIAL SYNDROME	0.015575555000000001	0.584334861353627
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.015531153999999998	0.5826691067670994
PENTASOMY X	0.015508814	0.5818309959708781
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.015470953999999999	0.5804106345230292
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.015470953999999999	0.5804106345230292
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.015470601	0.5803973913219967
ELEJALDE DISEASE	0.015470601	0.5803973913219967
SALLA DISEASE	0.015470601	0.5803973913219967
MARDEN-WALKER SYNDROME	0.015429242000000001	0.5788457608644803
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.015422149000000001	0.5785796588108725
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.015411031999999998	0.578162591768724
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.015411031999999998	0.578162591768724
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.015411031999999998	0.578162591768724
21Q22.11Q22.12 MICRODELETION SYNDROME	0.015398738999999998	0.5777014057339008
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.015371751000000001	0.5766889198713933
ANGELMAN SYNDROME	0.015357099	0.5761392332381687
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.015348409000000002	0.5758132178926377
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.015319883999999999	0.5747430697072206
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.015309912999999998	0.5743689961732401
FRONTONASAL DYSPLASIA	0.015299840000000002	0.5739910959919359
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.015299840000000002	0.5739910959919359
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.015277464999999999	0.5731516721304563
RING CHROMOSOME 14 SYNDROME	0.015268961999999999	0.5728326723050189
MEHMO SYNDROME; MEHMO	0.015264821	0.5726773179269011
FAMILIAL THROMBOCYTOSIS	0.015247318999999999	0.5720207102655105
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.015247318999999999	0.5720207102655105
LEUKOCYTE ADHESION DEFICIENCY	0.015247318999999999	0.5720207102655105
SCRUB TYPHUS	0.015247318999999999	0.5720207102655105
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.015244781000000002	0.5719254942762174
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.015239830000000003	0.5717397518164102
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.015229734	0.5713609887636504
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.015229563000000002	0.5713545735019605
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.015216380000000002	0.5708599980934294
ACROOSTEOLYSIS DOMINANT TYPE	0.015209185000000002	0.5705900693924977
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.015205659	0.5704577874467734
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.015185015	0.5696833040413485
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.015171569000000001	0.569178861885306
WARBURG MICRO SYNDROME 1	0.015169768000000002	0.569111295298735
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.015150294	0.5683807057890834
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.015134262999999998	0.5677792843846866
TRISOMY 18	0.015107744000000003	0.5667843935966386
AICARDI-GOUTIÈRES SYNDROME	0.015017937999999998	0.5634152182087486
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.014992121	0.5624466637581647
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5599435486984203
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5599435486984203
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.014917224000000001	0.5596368166541095
VELO-FACIAL-SKELETAL SYNDROME	0.014913450000000002	0.5594952307031273
MARFAN SYNDROME	0.014904895000000001	0.559174280037878
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.014888831	0.5585716206005233
STUVE-WIEDEMANN SYNDROME	0.014881833	0.5583090825811877
9Q21.13 MICRODELETION SYNDROME	0.014871644000000002	0.5579268305264564
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.014865477999999998	0.5576955059441151
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.014865477999999998	0.5576955059441151
LINEAR VERRUCOUS NEVUS SYNDROME	0.014829974000000003	0.5563635325462171
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.014802693000000002	0.5553400544516909
FACIOCARDIORENAL SYNDROME	0.014772964999999999	0.5542247743375427
HYPERPROLINEMIA, TYPE I	0.014769800999999999	0.5541060732382032
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.014751470000000001	0.5534183646882688
ADENYLOSUCCINATE LYASE DEFICIENCY	0.014749367	0.5533394682243273
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.014717441000000003	0.5521417276119654
WOLF-HIRSCHHORN SYNDROME	0.014710328000000003	0.5518748752353531
FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, WITH NORMAL PROTEINC AND PROTEIN C INHIBITOR	0.0147059	0.5517087537221179
ANTITHROMBIN, FAMILIAL HEMORRHAGIC DIATHESIS DUE TO	0.0147059	0.5517087537221179
MALAKOPLAKIA	0.0147059	0.5517087537221179
BROOKE-SPIEGLER SYNDROME	0.0147059	0.5517087537221179
HERMANSKY-PUDLAK SYNDROME 3; HPS3	0.0147059	0.5517087537221179
ACUTE MYELOMONOCYTIC LEUKEMIA	0.0147059	0.5517087537221179
BETA-THALASSEMIA-X-LINKED THROMBOCYTOPENIA SYNDROME	0.0147059	0.5517087537221179
PECHET FACTOR DEFICIENCY	0.0147059	0.5517087537221179
PLATELET FACTOR 3 DEFICIENCY	0.0147059	0.5517087537221179
GLYCOGEN STORAGE DISEASE IA	0.0147059	0.5517087537221179
THROMBOCYTOPENIA WITH ELEVATED SERUM IGA AND RENAL DISEASE	0.0147059	0.5517087537221179
ACQUIRED IDIOPATHIC SIDEROBLASTIC ANEMIA	0.0147059	0.5517087537221179
HEMOPHILIA B	0.0147059	0.5517087537221179
188030 THROMBOCYTOPENIC PURPURA, AUTOIMMUNE; AITP;;IMMUNE THROMBOCYTOPENIC PURPURA; ITP;;IDIOPATHIC THROMBOCYTOPENIC PURPURA	0.0147059	0.5517087537221179
APLASIA CUTIS CONGENITA WITH INTESTINAL LYMPHANGIECTASIA	0.0147059	0.5517087537221179
BODY SKIN HYPERLAXITY DUE TO VITAMIN K-DEPENDENT COAGULATION FACTOR DEFICIENCY	0.0147059	0.5517087537221179
FACTOR VIII DEFICIENCY	0.0147059	0.5517087537221179
PARKES WEBER SYNDROME	0.0147059	0.5517087537221179
LEISHMANIASIS	0.0147059	0.5517087537221179
LYSINURIC PROTEIN INTOLERANCE	0.0147059	0.5517087537221179
DISORDER OF BILE ACID SYNTHESIS	0.0147059	0.5517087537221179
AFIBRINOGENEMIA, CONGENITALHYPOFIBRINOGENEMIA, CONGENITAL, INCLUDED	0.0147059	0.5517087537221179
HYPERHEPARINEMIA	0.0147059	0.5517087537221179
ATHROMBIA, ESSENTIAL	0.0147059	0.5517087537221179
FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF	0.0147059	0.5517087537221179
CAR FACTOR DEFICIENCY	0.0147059	0.5517087537221179
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 2	0.0147059	0.5517087537221179
REFRACTORY ANEMIA	0.0147059	0.5517087537221179
MYELODYSPLASTIC SYNDROME ASSOCIATED WITH ISOLATED DEL(5Q) CHROMOSOME ABNORMALITY	0.0147059	0.5517087537221179
SITOSTEROLEMIA	0.0147059	0.5517087537221179
TYROSINEMIA, TYPE I; TYRSN1	0.0147059	0.5517087537221179
EISENMENGER SYNDROME	0.0147059	0.5517087537221179
CLASSIC GALACTOSEMIA	0.0147059	0.5517087537221179
WOLFRAM SYNDROME 2; WFS2	0.0147059	0.5517087537221179
THROMBOCYTOPENIA, CYCLIC	0.0147059	0.5517087537221179
HEMOCHROMATOSIS, NEONATAL	0.0147059	0.5517087537221179
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.014703716	0.5516268184500075
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.014703362000000001	0.5516135377328248
DUPLICATION/INVERSION 15Q11	0.014698917	0.5514467784450359
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.014693624999999998	0.5512482429779989
WARBURG MICRO SYNDROME 2; WARBM2	0.01467548	0.5505675124320081
NEONATAL ADRENOLEUKODYSTROPHY	0.014653359	0.5497376176726879
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.014622963999999999	0.5485973142863338
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.014602755	0.5478391504062606
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.014562190000000003	0.5463173077720296
LAURIN-SANDROW SYNDROME	0.014562190000000003	0.5463173077720296
MOSAIC TRISOMY 8	0.014556565	0.5461062794269649
FOCAL DERMAL HYPOPLASIA; FDH	0.014556565	0.5461062794269649
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.014540584	0.5455067338300797
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.014539450999999998	0.5454642280318649
PYRIDOXINE-DEPENDENT EPILEPSY	0.014512174	0.5444409000019396
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.014488685	0.5435596831490996
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.01446267	0.5425837005007694
CRANIOFACIOFRONTODIGITAL SYNDROME	0.01446267	0.5425837005007694
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.014449493999999998	0.5420893877052898
PEHO-LIKE SYNDROME; PEHOL	0.014449493999999998	0.5420893877052898
TRISOMY 13	0.014425204	0.5411781204161127
JOUBERT SYNDROME 21	0.014421321999999999	0.5410324827209053
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.014410213000000002	0.540615715807959
SCHIZENCEPHALY	0.014380503000000003	0.5395011109845151
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.014367724000000002	0.5390216921006783
FRONTORHINY	0.014288555000000001	0.5360515760028246
CHROMOSOME 16P13.3 DELETION SYNDROME	0.014269838	0.5353493862188999
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.014252878	0.534713112310936
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.014246722	0.5344821628900972
HURLER SYNDROME	0.014246159000000001	0.5344610412975156
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.014244153999999998	0.534385821416297
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.014244153999999998	0.534385821416297
SHUKLA-VERNON SYNDROME; SHUVER	0.014243611	0.5343654501467201
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.014235810000000002	0.5340727866587468
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.014233998999999999	0.5340048449106735
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.014225558000000003	0.5336881710865508
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.014197653000000001	0.5326412829142787
611961 STEVENSON-CAREY SYNDROME	0.014176788	0.5318585084396519
ADAMS-OLIVER SYNDROME 1; AOS1	0.014159721000000002	0.5312182203036131
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.014138275	0.5304136489457005
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.014126193999999998	0.5299604163347268
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.01409773	0.5288925566344742
300064 MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM;;MENTAL RETARDATION, X-LINKED, HYDE-FORSTER TYPE	0.01409773	0.5288925566344742
CODAS SYNDROME	0.014080885999999999	0.5282606345999373
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.014027045	0.5262407275552035
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.014012840000000002	0.5257078106411335
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.013996416999999999	0.525091682905845
INFANTILE SIALIC ACID STORAGE DISEASE	0.013946431	0.5232164006202621
TEMPLE SYNDROME	0.013914493	0.5220182098140974
OCULOCEREBROCUTANEOUS SYNDROME	0.013876619000000001	0.5205973231401454
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.013874429	0.5205151627711335
2Q23.1 MICRODELETION SYNDROME	0.013873219000000001	0.5204697682293506
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.013835283	0.5190465555540842
PRIMARY CUTIS VERTICIS GYRATA	0.013834949000000003	0.5190340251599062
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.013827822	0.5187666475571904
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.013820141	0.518478486007245
ROBERTS SYNDROME	0.013807344000000001	0.5179983918327041
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.013780091000000001	0.5169759641903845
RESTRICTIVE DERMOPATHY, LETHAL	0.013750950000000001	0.5158827060564235
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.013746791000000001	0.5157266763876015
CARTILAGE-HAIR HYPOPLASIA	0.013740125	0.5154765937301434
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.013735679	0.5153097969262044
HEREDITARY FOLATE MALABSORPTION	0.013705053	0.5141608273091464
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.513918735591688
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.013698599999999998	0.513918735591688
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.513918735591688
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.513918735591688
HYDROLETHALUS	0.01362737	0.5112464602105399
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.01362737	0.5112464602105399
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.01362737	0.5112464602105399
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.01362059	0.5109921007119553
GORLIN SYNDROME	0.013608875000000001	0.5105525990119673
TEEBI-SHALTOUT SYNDROME; TBSH	0.01360229	0.5103055551626781
PACHYGYRIA, FRONTOTEMPORAL	0.013561449000000001	0.5087733580709827
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.013541068000000002	0.5080087414130691
HERMANSKY-PUDLAK SYNDROME	0.01351839	0.5071579501580687
14Q12 MICRODELETION SYNDROME	0.013513954000000002	0.506991528515632
XP21 MICRODELETION SYNDROME	0.013498563000000002	0.5064141174473847
VICI SYNDROME	0.013497353000000002	0.506368722905602
JUBERG-MARSIDI SYNDROME	0.0134821	0.5057964890660869
INTELLECTUAL DISABILITY, WOLFF TYPE	0.013440823999999999	0.5042479724490396
DISTAL MONOSOMY 3P	0.013439859000000002	0.5042117693640642
OROFACIODIGITAL SYNDROME IX; OFD9	0.013428533999999999	0.5037868989626673
OROFACIODIGITAL SYNDROME VIII; OFD8	0.013428533999999999	0.5037868989626673
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.013427343000000001	0.5037422172277389
ROIFMAN SYNDROME; RFMN	0.013405012000000001	0.5029044440768695
SCHOLTE SYNDROME; SHLTS	0.013401327999999999	0.5027662345794085
MENTAL RETARDATION, X-LINKED 19	0.013401327999999999	0.5027662345794085
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.013398503	0.5026602514549983
BRESEK SYNDROME	0.013353878999999999	0.5009861307669685
XQ28 (MECP2) DUPLICATION	0.013353213	0.5009611450109128
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.013345706	0.5006795112711084
MECKEL SYNDROME	0.013335200000000002	0.5002853665967529
TRIPLOIDY	0.013335200000000002	0.5002853665967529
ACROCALLOSAL SYNDROME	0.013335200000000002	0.5002853665967529
DIABETIC EMBRYOPATHY	0.013335200000000002	0.5002853665967529
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.013282073	0.49829224608328576
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.013276207000000002	0.49807217634601486
48,XXXY SYNDROME	0.013258898	0.49742280930161925
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.013258193	0.4973963604157045
MEND SYNDROME	0.013257961	0.49738765666885026
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.013248209	0.49702179917177103
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.013244535	0.4968839648358123
15Q OVERGROWTH SYNDROME	0.013228874000000002	0.49629642440700195
TORIELLO-LACASSIE-DROSTE SYNDROME	0.01322235	0.4960516690428771
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.013215313000000001	0.49578766789368245
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.013201237	0.4952595905629925
LOEYS-DIETZ SYNDROME 3; LDS3	0.013190125	0.49484271110159544
HALL-RIGGS SYNDROME	0.013176064	0.49431519651315897
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.013175992	0.4943124953503421
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.013171857	0.49415736606912575
TEMPLE-BARAITSER SYNDROME	0.013142576999999999	0.4930588931902823
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.013135389	0.4927892271024023
DISTAL MONOSOMY 1Q	0.013135173000000002	0.4927811236139518
HALLERMANN-STREIFF SYNDROME	0.01311835	0.49214998941856986
SHASHI-PENA SYNDROME; SHAPNS	0.013103096	0.4915777180629046
FONTAINE PROGEROID SYNDROME; FPS	0.013070782999999999	0.4903654587004023
RAYNAUD-CLAES SYNDROME; MRXSRC	0.013060796	0.4899907849080181
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.013034879	0.4890184788424107
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.013034879	0.4890184788424107
BETA-UREIDOPROPIONASE DEFICIENCY	0.013034879	0.4890184788424107
CRANIOFACIAL DYSSYNOSTOSIS	0.013027019999999999	0.48872363941772384
BOHRING-OPITZ SYNDROME	0.013021873	0.4885305437924709
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.013020030000000002	0.4884614015275902
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.013001391999999999	0.487762175519534
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.013001391999999999	0.487762175519534
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.013001391999999999	0.487762175519534
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.013001391999999999	0.487762175519534
FRONTONASAL DYSPLASIA 1; FND1	0.012993850000000001	0.48747922871447125
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.012981209	0.4870049870593668
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.012981209	0.4870049870593668
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.012962111	0.48628850362220316
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.01292465	0.48488311111829757
2Q23.1 MICRODUPLICATION SYNDROME	0.012883414	0.4833360951472597
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.012843426000000002	0.48183589933171367
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.012818553	0.48090276012695016
FIBROCHONDROGENESIS	0.012793869999999999	0.4799767489907312
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.012785253	0.4796534723241672
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.012775436000000001	0.4792851762773227
SIMPSON-GOLABI-BEHMEL SYNDROME	0.012765208000000002	0.4789014610927323
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.012755873	0.47855124783030034
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.012755873	0.47855124783030034
BARAITSER-WINTER SYNDROME 1; BRWS1	0.012731721000000001	0.47764515776985556
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.01272129	0.4772538268067675
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.012713907	0.476976845069592
NEMALINE MYOPATHY 2; NEM2	0.012693305	0.4762039373424768
RECOMBINANT CHROMOSOME 8 SYNDROME	0.012641856000000002	0.47427376892910195
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.012639773000000002	0.4741956227881651
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.012632675	0.47392933315380603
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.012613803	0.47322132836659525
OCULO-PALATO-CEREBRAL SYNDROME	0.012593754000000002	0.4724691670705594
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.012589619000000002	0.4723140377893429
3-HYDROXYISOBUTYRIC ACIDURIA	0.012589619000000002	0.4723140377893429
FRONTAL ENCEPHALOCELE	0.012589619000000002	0.4723140377893429
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.012589619000000002	0.4723140377893429
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.012574810999999998	0.47175849863668184
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.012565336999999998	0.4714030706293675
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.012553101	0.47094402301510774
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.012534761000000002	0.47025597681982134
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.012534761000000002	0.47025597681982134
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.012534761000000002	0.47025597681982134
ASPARTYLGLUCOSAMINURIA; AGU	0.012531332000000001	0.47012733394066986
FACIOCARDIORENAL SYNDROME	0.012490939999999999	0.46861198160042916
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.012484299	0.4683628368467271
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.012428919000000002	0.46628519244678357
JABERI-ELAHI SYNDROME; JABELS	0.012417046000000001	0.46583976319505854
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.012399192000000002	0.4651699498487856
MYHRE SYNDROME	0.012391233	0.4648713588090754
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.012376904000000001	0.46433378989237634
HELSMOORTEL-VAN DER AA SYNDROME	0.012350681	0.4633500038847974
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.012350681	0.4633500038847974
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.012349472	0.46330464685916484
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.012349472	0.46330464685916484
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.01234909	0.4632903156897755
ISOLATED PLAGIOCEPHALY	0.012317183999999998	0.4620933254004183
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.012294709	0.4612501499239154
GERMAN SYNDROME	0.012279964	0.46069697428871914
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.012277216	0.46059387990787687
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.012276246	0.4605574892421502
CHROMOSOME 17P13.1 DELETION SYNDROME	0.012266372000000001	0.46018705477474237
LELIS SYNDROME	0.0121951	0.4575132037152844
RHYNS SYNDROME; RHYNS	0.0121951	0.4575132037152844
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.0121951	0.4575132037152844
ACHROMATOPSIA	0.0121951	0.4575132037152844
X-LINKED INTELLECTUAL DISABILITY, MILES-CARPENTER TYPE	0.0121951	0.4575132037152844
609612 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, WITH SYNERGISTIC DIVERGENCE;;CONGENITAL FIBROSIS SYNDROME WITH SYNERGISTIC DIVERGENCE;;EXTERNAL OPHTHALMOPLEGIA WITH SYNERGISTIC DIVERGENCEEXTERNAL OPHTHALMOPLEGIA, SYNERGISTIC DIVERGENCE, JAW WINKING, ANDOCULOCUTANEOUS HYPOPIGMENTATION, INCLUDED	0.0121951	0.4575132037152844
CATARACT 48; CTRCT48	0.0121951	0.4575132037152844
MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4	0.0121951	0.4575132037152844
COMBINED HAMARTOMA OF THE RETINA AND RETINAL PIGMENT EPITHELIUM	0.0121951	0.4575132037152844
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.0121951	0.4575132037152844
HENNEKAM-BEEMER SYNDROME	0.012135484	0.4552766409029508
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.012121604000000001	0.45475591673770666
MONOSOMY 22Q13.3	0.012080103000000002	0.45319895898685697
MENTAL RETARDATION, X-LINKED 90	0.012065771	0.45266127752170715
ISOLATED DANDY-WALKER MALFORMATION	0.012048200000000002	0.4520020812459505
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.012048200000000002	0.4520020812459505
DISTAL TRISOMY 14Q	0.012048200000000002	0.4520020812459505
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.012048200000000002	0.4520020812459505
LOWRY-WOOD SYNDROME	0.012048200000000002	0.4520020812459505
HOLZGREVE SYNDROME	0.012048200000000002	0.4520020812459505
DISTAL MONOSOMY 13Q	0.012048200000000002	0.4520020812459505
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.012039854	0.45168897145609965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.012039854	0.45168897145609965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.012039854	0.45168897145609965
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.012031908	0.45139086812634255
OKAMOTO SYNDROME	0.012028579	0.4512659768622145
OCCIPITAL HORN SYNDROME	0.012020099000000001	0.4509478399082326
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.012014547	0.4507395502421349
COFFIN-SIRIS SYNDROME 8; CSS8	0.012011932	0.4506414455092737
HYPOPHOSPHATASIA, INFANTILE	0.011989207000000002	0.4497888909952124
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.011989207	0.44978889099521235
MARTSOLF SYNDROME	0.01195063	0.44834163046764597
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.011933436	0.44769657778052735
LIG4 SYNDROME	0.011914074	0.44697019007970196
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.011908625	0.4467657645770785
DISTAL MONOSOMY 10P	0.011904379999999999	0.4466065085193362
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.011904379999999999	0.4466065085193362
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.011885838999999999	0.4459109215778527
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.011875730999999999	0.4455317083312903
WARBURG MICRO SYNDROME 3; WARBM3	0.011870079	0.4453196670501693
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.011865560999999998	0.4451501690834133
POTOCKI-SHAFFER SYNDROME	0.011849929000000002	0.44456371662295985
2Q37 MICRODELETION SYNDROME	0.011827913	0.44373776105941415
PELGER-HUET ANOMALY; PHA	0.011800494	0.4427091057361557
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.011785669	0.4421529288089407
5Q35 MICRODUPLICATION SYNDROME	0.011782489	0.44203362745119745
ROBINOW-SORAUF SYNDROME	0.011771629999999998	0.4416262395758094
SUMMITT SYNDROME	0.011771629999999998	0.4416262395758094
ROIFMAN-CHITAYAT SYNDROME	0.011769454	0.44154460443290083
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.011752369	0.44090364100615764
CHROMOSOME 2Q37 DELETION SYNDROME	0.011750603	0.4408373874848449
BRAIN-LUNG-THYROID SYNDROME	0.011728944000000002	0.44002482518693276
XQ25 MICRODUPLICATION SYNDROME	0.011704530999999999	0.4391089434112767
XQ25 DUPLICATION SYNDROME	0.011704530999999999	0.4391089434112767
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.01169828	0.43887442995616577
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.01169828	0.43887442995616577
RAHMAN SYNDROME	0.011683924000000002	0.43833584810341053
GLYCINE ENCEPHALOPATHY	0.0116689	0.437772205462299
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.0116689	0.437772205462299
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.011655	0.43725073097405026
LARSEN-LIKE SYNDROME	0.011653102000000002	0.4371795253209067
MICROCORNEA, MYOPIC CHORIORETINAL ATROPHY, AND TELECANTHUS; MMCAT	0.01163765	0.4365998257674951
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.01163765	0.4365998257674951
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 3	0.01163765	0.4365998257674951
HEREDITARY HYPEREKPLEXIA	0.011633949	0.4364609784954801
ZTTK SYNDROME; ZTTKS	0.011630506	0.43633181039022545
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.011605131000000001	0.4353798380780447
ATKIN-FLAITZ SYNDROME	0.011596004	0.43503742817486146
CLARK-BARAITSER SYNDROME	0.011596004	0.43503742817486146
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.011594804	0.434992408794581
MONOSOMY 5P	0.011594065	0.43496468435955826
3C SYNDROME	0.011545719000000001	0.43315092856035864
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.011524394	0.43235089665662446
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.011518116000000002	0.43211537026545727
MARSHALL SYNDROME	0.01151811	0.43211514516855576
CHAR SYNDROME	0.011506404000000001	0.4316759811139198
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.4312218856314908
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.011494299999999999	0.4312218856314908
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.011494299999999999	0.4312218856314908
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.011494299999999999	0.4312218856314908
STÜVE-WIEDEMANN SYNDROME	0.011481275	0.43073323777469663
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.011471423000000001	0.430363628662594
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.011433954	0.4289579360294865
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.011429774	0.42880111852150954
KBG SYNDROME	0.011427348	0.4287101043410425
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.011382686999999999	0.4270345955554542
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.011376452000000002	0.426800682358747
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.011369795	0.426550937346641
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.011320006999999998	0.4246830832588044
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.011320006999999998	0.4246830832588044
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.011307771000000001	0.42422403564454464
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.011307771000000001	0.42422403564454464
NORRIE DISEASE	0.011296814	0.4238129711864337
COHEN SYNDROME	0.011277818	0.42310031439659385
MUCOPOLYSACCHARIDOSIS TYPE 3	0.011251964	0.42213037184845115
CRANIOECTODERMAL DYSPLASIA 1	0.011246800000000001	0.4219366384486442
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.0112239	0.4210775186082919
ABETA AMYLOIDOSIS, IOWA TYPE	0.01121095	0.42059168446276524
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.01121095	0.42059168446276524
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.011208765	0.42050971167450457
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.011159169	0.41864906068751273
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.011129753000000001	0.41754548561223753
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.011111773	0.4168709452310352
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.011105351	0.4166300165142342
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.011105351	0.4166300165142342
GM1 GANGLIOSIDOSIS	0.011100964000000001	0.41646543316315887
X SMALL RINGS	0.011100704	0.4164556789640981
INFANTILE REFSUM DISEASE	0.011085893000000001	0.4159000272629864
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.011085893000000001	0.4159000272629864
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.011071853999999999	0.4153733380298551
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.01104925	0.4145253229699721
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.011038312	0.4141149713187156
C SYNDROME	0.011035066000000001	0.41399319389505695
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.011027669	0.4137156869317781
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.011008373	0.41299177529686815
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.010993945000000001	0.412450492281296
OROFACIODIGITAL SYNDROME I; OFD1	0.010988519000000002	0.4122469296501279
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.010988519000000002	0.4122469296501279
OROFACIODIGITAL SYNDROME TYPE 1	0.010988519000000002	0.4122469296501279
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.010976697	0.41180341372206475
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.010972386	0.41164168159840714
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.010960458000000001	0.4111941889584193
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.010958981999999999	0.4111388151206743
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.010958981999999999	0.4111388151206743
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.010958939000000001	0.4111372019262143
KOOLEN-DE VRIES SYNDROME; KDVS	0.010952866	0.4109093663458448
PROGRESSIVE BIFOCAL CHORIORETINAL ATROPHY	0.01094372	0.41056624363580724
HYPEREKPLEXIA 2; HKPX2	0.01094372	0.41056624363580724
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.010925869000000001	0.40989654283798505
INFANT BOTULISM	0.010912390000000001	0.4093908626489846
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.01090197	0.40899994436354925
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.010898654	0.4088755408093742
CHÉDIAK-HIGASHI SYNDROME	0.010890893	0.40858437796741026
OCULOCEREBRORENAL SYNDROME OF LOWE	0.010882284	0.4082614014300482
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.010875006999999999	0.4079883964047973
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.010869608	0.40778584670968543
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.010856433000000002	0.4072915714303562
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.010847724	0.40696484327797067
INTERMEDIATE NEMALINE MYOPATHY	0.01084238	0.4067643569711217
SEVERE CONGENITAL NEMALINE MYOPATHY	0.01084238	0.4067643569711217
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.010820441	0.40594129015114394
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.01080667	0.40542465524627536
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.010778587999999999	0.40437112671541187
NIEMANN-PICK DISEASE TYPE C	0.010772373	0.40413796384170936
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.010772123	0.40412858480415087
OROFACIODIGITAL SYNDROME XVI; OFD16	0.010766352	0.4039120791011521
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.010766352	0.4039120791011521
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.010766352	0.4039120791011521
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.010766352	0.4039120791011521
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.010762217	0.40375694981993565
RETT SYNDROME, CONGENITAL VARIANT	0.010759594	0.4036585449578726
ASPARTYLGLUCOSAMINURIA	0.010747464	0.4032034740555375
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.010742993	0.40303573934784254
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.010726925	0.4024329298458871
GALLOWAY-MOWAT SYNDROME	0.010717323	0.4020726997713429
CONGENITAL TOXOPLASMOSIS	0.010717323	0.4020726997713429
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.010714759	0.4019765083621436
DISTAL MONOSOMY 15Q	0.010711503	0.40185435577698264
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.010710128	0.4018027710704111
TEMPLE SYNDROME	0.010685385	0.4008745089651782
3Q13 MICRODELETION SYNDROME	0.01068321	0.4007929113384198
ACROFRONTOFACIONASAL DYSOSTOSIS	0.01066363	0.4000583451168435
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.010662731	0.4000246180977834
HURLER SYNDROME	0.010605114	0.39786305006976697
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.010591888	0.39736686146677574
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.010591888	0.39736686146677574
14Q22Q23 MICRODELETION SYNDROME	0.010567984	0.39647007541158885
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.010566219	0.39640385940642625
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.01054626	0.39565507456391136
SSR4-CDG	0.010544656	0.3955948986589365
20Q11.2 MICRODELETION SYNDROME	0.010544474000000002	0.395588070719594
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.010544474000000002	0.395588070719594
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.010540339000000001	0.3954329414383775
NEURONAL CEROID LIPOFUSCINOSIS	0.010540339000000001	0.3954329414383775
L-2-HYDROXYGLUTARIC ACIDURIA	0.010540339000000001	0.3954329414383775
METACHROMATIC LEUKODYSTROPHY	0.010540339000000001	0.3954329414383775
MENKES DISEASE	0.010540339000000001	0.3954329414383775
FRONTOFACIONASAL DYSPLASIA	0.01052652	0.3949145057582976
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.010526299999999999	0.39490625220524617
CHROMOSOME 5Q12 DELETION SYNDROME	0.010523091000000002	0.3947858628791463
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.010523091000000002	0.3947858628791463
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.010523091000000002	0.3947858628791463
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.010523091000000002	0.3947858628791463
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.010521881	0.3947404683373634
GAUCHER DISEASE TYPE 3	0.01050459	0.39409177658367206
PROTEUS SYNDROME	0.010485844	0.39338849883139065
QAZI-MARKOUIZOS SYNDROME	0.010481158999999999	0.3932127356675456
MEHMO SYNDROME	0.010462819	0.3925246894722592
SCLEROSTEOSIS 1; SOST1	0.01043922	0.3916393458428936
CHROMOSOME 9P DELETION SYNDROME	0.010430457	0.3913105918183955
GOLDBERG-SHPRINTZEN SYNDROME	0.010426822	0.3911742206122959
GENITOPATELLAR SYNDROME; GTPTS	0.010397112000000002	0.390059615788852
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.01038445	0.38958458629459247
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.01038445	0.38958458629459247
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.010368	0.38896744562324775
MICROPHTHALMIA, SYNDROMIC 3	0.010367732000000001	0.38895739129498513
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.01034906	0.3882568897378211
PROPIONIC ACIDEMIA	0.010346233	0.3881508315811103
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.010346233	0.3881508315811103
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.010346233	0.3881508315811103
GRANULOMATOSIS WITH POLYANGIITIS	0.010345339	0.3881172921428014
EBOLA HEMORRHAGIC FEVER	0.010345339	0.3881172921428014
VIRAL HEMORRHAGIC FEVER	0.010345339	0.3881172921428014
PULMONARY ARTERIOVENOUS MALFORMATION	0.010345339	0.3881172921428014
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.010345339	0.3881172921428014
MICROPHTHALMIA, SYNDROMIC 12	0.01034384	0.388061055433601
ARTERIAL TORTUOSITY SYNDROME	0.010328189	0.38747389016629297
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.010311606	0.3868517598469671
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.010308374	0.38673050764941175
RING CHROMOSOME 12 SYNDROME	0.010307134	0.38668398762312195
JACOBSEN SYNDROME	0.010306888	0.38667475865016443
BRANCHIO-OCULO-FACIAL SYNDROME	0.01030217	0.38649775745336173
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.010268941	0.3852511332972453
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.010268941	0.3852511332972453
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.010266230000000001	0.3851494270139617
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.010266230000000001	0.3851494270139617
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.010260119	0.3849201658198834
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.010247124000000002	0.38443264344759626
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.010247124	0.38443264344759615
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.010227764	0.3837063307790713
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.010220798	0.38344499327654313
ADAMS-OLIVER SYNDROME	0.010190109	0.3822936601420204
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.010165147000000001	0.3813571819998863
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.010149033000000002	0.38075264675502
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.010140838000000001	0.38044520190385467
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.010135736	0.3802537945053621
RUBINSTEIN-TAYBI SYNDROME	0.010129393	0.38001582956442964
1P21.3 MICRODELETION SYNDROME	0.010106894	0.3791717537003211
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.010106861000000002	0.37917051566736343
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.010059832	0.37740616863802157
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.010059504	0.37739386334074493
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.010043258999999999	0.37678441348019803
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.01001726	0.3758090310902715
NANCE-HORAN SYNDROME	0.01001726	0.3758090310902715
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.010005258000000001	0.3753587622551664
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.009998920000000001	0.3751209848949851
FRYNS SYNDROME; FRNS	0.009997639000000001	0.37507292670653564
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.009981672	0.3744739063357537
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.009981672	0.3744739063357537
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.009980462	0.37442851179397096
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.009977537000000002	0.37431877705453737
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.009964098000000001	0.37381459751154633
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.009957518	0.3735677412430084
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.009956347	0.3735238098310847
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.009943939	0.37305830943898466
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.009914045	0.3719368016438977
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.009910452	0.371802006116108
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00989304	0.3711487749082384
LANDAU-KLEFFNER SYNDROME	0.009858903	0.3698680860877097
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.009858903	0.3698680860877097
ARGININEMIA	0.009858903	0.3698680860877097
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.009858903	0.3698680860877097
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.009805741	0.36787365250898446
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.009804814	0.36783887503771784
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.009804814	0.36783887503771784
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.009804814	0.36783887503771784
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.009804814	0.36783887503771784
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.36783887503771784
KRABBE DISEASE	0.009804814	0.36783887503771784
JOUBERT SYNDROME 33; JBTS33	0.009804814	0.36783887503771784
FACTOR XIII, A SUBUNIT, DEFICIENCY OF	0.00980392	0.36780533559940887
WISKOTT-ALDRICH SYNDROME	0.00980392	0.36780533559940887
LINEAR IGA DERMATOSIS	0.00980392	0.36780533559940887
BLEEDING DISORDER, PLATELET-TYPE, 19; BDPLT19	0.00980392	0.36780533559940887
DENGUE FEVER	0.00980392	0.36780533559940887
%605735 BLEEDING DISORDER, PLATELET-TYPE, 12; BDPLT12;;PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1 DEFICIENCY, PLATELET;;PGHS1 DEFICIENCY;;PLATELET CYCLOOXYGENASE 1 DEFICIENCY;;PLATELET COX1 DEFICIENCY	0.00980392	0.36780533559940887
FAMILIAL HYPERALDOSTERONISM TYPE II	0.00980392	0.36780533559940887
FAMILIAL HYPOFIBRINOGENEMIA	0.00980392	0.36780533559940887
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.00980392	0.36780533559940887
GIANT CELL ARTERITIS	0.00980392	0.36780533559940887
BLEEDING DISORDER, PLATELET-TYPE, 18; BDPLT18	0.00980392	0.36780533559940887
EVANS SYNDROME	0.00980392	0.36780533559940887
ACUTE PROMYELOCYTIC LEUKEMIA	0.00980392	0.36780533559940887
IMMUNE THROMBOCYTOPENIC PURPURA	0.00980392	0.36780533559940887
600903 WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	0.00980392	0.36780533559940887
THROMBOCYTOPENIA 5; THC5	0.00980392	0.36780533559940887
ECTOPIC ALDOSTERONE-PRODUCING TUMOR	0.00980392	0.36780533559940887
ADRENOCORTICAL CARCINOMA WITH PURE ALDOSTERONE HYPERSECRETION	0.00980392	0.36780533559940887
PURPURA SIMPLEX	0.00980392	0.36780533559940887
COMBINED DEFICIENCY OF FACTOR V AND FACTOR VIII	0.00980392	0.36780533559940887
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.00980392	0.36780533559940887
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.00980392	0.36780533559940887
BLEEDING DISORDER, PLATELET-TYPE, 15; BDPLT15	0.00980392	0.36780533559940887
FAMILIAL HYPERALDOSTERONISM TYPE I	0.00980392	0.36780533559940887
MICROSCOPIC POLYANGIITIS	0.00980392	0.36780533559940887
POLYCYTHEMIA VERA	0.00980392	0.36780533559940887
IDIOPATHIC APLASTIC ANEMIA	0.00980392	0.36780533559940887
SEBASTIAN SYNDROME	0.00980392	0.36780533559940887
FAMILIAL HYPERALDOSTERONISM TYPE III	0.00980392	0.36780533559940887
VON WILLEBRAND DISEASE, TYPE 2; VWD2	0.00980392	0.36780533559940887
BLEEDING DISORDER, PLATELET-TYPE, 20	0.00980392	0.36780533559940887
FAMILIAL AFIBRINOGENEMIA	0.00980392	0.36780533559940887
RELAPSING FEVER	0.00980392	0.36780533559940887
FAMILIAL DYSFIBRINOGENEMIA	0.00980392	0.36780533559940887
HERMANSKY-PUDLAK SYNDROME 4; HPS4	0.00980392	0.36780533559940887
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.00980392	0.36780533559940887
PRIMARY FAMILIAL POLYCYTHEMIA	0.00980392	0.36780533559940887
GRAY PLATELET SYNDROME	0.00980392	0.36780533559940887
CONGENITAL PROTHROMBIN DEFICIENCY	0.00980392	0.36780533559940887
BLEEDING DISORDER, PLATELET-TYPE, 17; BDPLT17	0.00980392	0.36780533559940887
VON WILLEBRAND DISEASE, TYPE 3; VWD3	0.00980392	0.36780533559940887
TYPHOID	0.00980392	0.36780533559940887
KAPOSIFORM LYMPHANGIOMATOSIS	0.00980392	0.36780533559940887
WALDENSTRÖM MACROGLOBULINEMIA	0.00980392	0.36780533559940887
BLEEDING DISORDER, PLATELET-TYPE, 8; BDPLT8	0.00980392	0.36780533559940887
PRIMARY UNILATERAL ADRENAL HYPERPLASIA	0.00980392	0.36780533559940887
SEVERE HEMOPHILIA A	0.00980392	0.36780533559940887
PLATELET SIGNAL PROCESSING DEFECT	0.00980392	0.36780533559940887
MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS	0.00980392	0.36780533559940887
ACQUIRED VON WILLEBRAND SYNDROME	0.00980392	0.36780533559940887
CONGENITAL FACTOR II DEFICIENCY	0.00980392	0.36780533559940887
BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT; BSSA2	0.00980392	0.36780533559940887
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.00980392	0.36780533559940887
CONGENITAL FACTOR XI DEFICIENCY	0.00980392	0.36780533559940887
BLEEDING DISORDER, PLATELET-TYPE, 11; BDPLT11	0.00980392	0.36780533559940887
CONGENITAL FACTOR V DEFICIENCY	0.00980392	0.36780533559940887
+173470 INTEGRIN, BETA-3; ITGB3;;PLATELET GLYCOPROTEIN IIIA; GP3A;;GP IIIA;;PLATELET FIBRINOGEN RECEPTOR, BETA SUBUNIT;;CD61THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE, INCLUDED; NAIT, INCLUDED;;POSTTRANSFUSION PURPURA, INCLUDED; PTP, INCLUDED	0.00980392	0.36780533559940887
JUVENILE NASOPHARYNGEAL ANGIOFIBROMA	0.00980392	0.36780533559940887
FACTOR V DEFICIENCY	0.00980392	0.36780533559940887
BLEEDING DISORDER, PLATELET-TYPE, 14; BDPLT14	0.00980392	0.36780533559940887
CONGENITAL FACTOR X DEFICIENCY	0.00980392	0.36780533559940887
CONGENITAL FACTOR XIII DEFICIENCY	0.00980392	0.36780533559940887
CONGENITAL FACTOR VII DEFICIENCY	0.00980392	0.36780533559940887
EPISTAXIS, HEREDITARY	0.00980392	0.36780533559940887
PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	0.00980392	0.36780533559940887
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.009800679	0.36768374575650137
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.009800679	0.36768374575650137
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.36768374575650137
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.36768374575650137
HYPOADRENOCORTICISM, FAMILIAL	0.009800679	0.36768374575650137
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.009800679	0.36768374575650137
PETERS-PLUS SYNDROME; PTRPLS	0.009775148	0.3667259209248842
METAPHYSEAL ACROSCYPHODYSPLASIA	0.009772685	0.3666335186468585
CAFFEY DISEASE	0.009766955	0.36641855110601934
OROFACIODIGITAL SYNDROME XIV; OFD14	0.009749182	0.3657517765679153
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.009744362	0.3655709487237887
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.009707012000000001	0.3641697205125592
VACTERL/VATER ASSOCIATION	0.00969036	0.3635450015788672
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00969036	0.3635450015788672
ATELOSTEOGENESIS, TYPE I; AO1	0.00969036	0.3635450015788672
DIETHYLSTILBESTROL SYNDROME	0.00969036	0.3635450015788672
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.009687468	0.36343650487239126
MACHADO-JOSEPH DISEASE TYPE 1	0.0096854	0.36335892147370796
MACHADO-JOSEPH DISEASE TYPE 3	0.0096854	0.36335892147370796
MACHADO-JOSEPH DISEASE TYPE 2	0.0096854	0.36335892147370796
PARKINSONIAN-PYRAMIDAL SYNDROME	0.0096854	0.36335892147370796
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.0096854	0.36335892147370796
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.0096854	0.36335892147370796
PARKINSON DISEASE, LATE-ONSET; PD	0.0096854	0.36335892147370796
MARDEN-WALKER SYNDROME	0.009671939000000001	0.36285391657541183
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.009665866	0.3626260809950424
DIAMOND-BLACKFAN ANEMIA 1	0.00964869	0.36198170359862797
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.009602747	0.36025809910844
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.009602394	0.36024485590740746
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.009602394	0.36024485590740746
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.009602394	0.36024485590740746
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.009585649	0.35961664797174375
BASAL CELL NEVUS SYNDROME	0.009552585	0.35837621398041597
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.009520649	0.3571780982065518
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00951457	0.3569500375292809
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.009490333	0.35604075859606615
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.009490333	0.35604075859606615
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.009490333	0.35604075859606615
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.009490333	0.35604075859606615
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.009490333	0.35604075859606615
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.009490333	0.35604075859606615
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.009489408	0.3560060561570999
BLINDNESS-SCOLIOSIS-ARACHNODACTYLY SYNDROME	0.009469605	0.3552631238340216
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.009466173	0.3551343684064194
WILSON-TURNER SYNDROME	0.009466173	0.3551343684064194
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.009455920999999999	0.3547497528342232
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.009455920999999999	0.3547497528342232
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00945189	0.3545985252326311
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.009448415	0.3544681566105689
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.009436118	0.3540068205111448
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.009422016	0.35347776776054884
ROTHMUND-THOMSON SYNDROME	0.009420499	0.3534208557606443
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.009398385	0.3525912236143757
X-LINKED INTELLECTUAL DISABILITY, SIDERIUS TYPE	0.009374225	0.35168483342472895
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.009367673	0.3514390276083976
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.009366311	0.35138793061177925
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.009364898	0.35133492029149904
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.009364898	0.35133492029149904
NEMALINE MYOPATHY 10	0.009364898	0.35133492029149904
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.009360741	0.35117896565497747
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.009340738	0.35042853010185226
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.009324699	0.3498268085682536
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.009323739000000001	0.3497907930640292
OPITZ G/BBB SYNDROME	0.009323214	0.34977109708515647
ABETAL34V AMYLOIDOSIS	0.009317484000000001	0.3495561295443173
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.009317484000000001	0.3495561295443173
PINEOBLASTOMA	0.009313349	0.3494010002631008
CRYPTOCOCCOSIS	0.009313349	0.3494010002631008
2Q33.1 DELETION SYNDROME	0.009313349	0.3494010002631008
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.009313349	0.3494010002631008
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.009313349	0.3494010002631008
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.009313349	0.3494010002631008
ABETA AMYLOIDOSIS, DUTCH TYPE	0.009313349	0.3494010002631008
SNEDDON SYNDROME	0.009313349	0.3494010002631008
NEUROCUTANEOUS MELANOCYTOSIS	0.009313349	0.3494010002631008
COOPER-JABS SYNDROME	0.009306345	0.3491382371468638
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.009299068	0.348865232121613
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.009294891	0.34870852716208667
TETRASOMY 12P	0.009285340000000001	0.3483502104112045
ACROCRANIOFACIAL DYSOSTOSIS	0.009282160000000001	0.3482309090534612
PRIMARY PULMONARY HYPOPLASIA	0.00925926	0.3473717892131089
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.3473717892131089
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.00925926	0.3473717892131089
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.3473717892131089
CONGENITAL LEFT VENTRICULAR ANEURYSM	0.00925926	0.3473717892131089
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.00925926	0.3473717892131089
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.00925926	0.3473717892131089
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.3473717892131089
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.3473717892131089
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00925926	0.3473717892131089
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.3473717892131089
MERRF	0.00925926	0.3473717892131089
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.3473717892131089
AORTIC ARCH DEFECTS	0.00925926	0.3473717892131089
PAINE SYNDROME	0.00925926	0.3473717892131089
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00925926	0.3473717892131089
HYDROXYLYSINURIA	0.00925926	0.3473717892131089
CARNOSINEMIA	0.00925926	0.3473717892131089
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00925926	0.3473717892131089
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00925926	0.3473717892131089
CARNOSINASE DEFICIENCY	0.00925926	0.3473717892131089
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.009239964	0.346647877578199
BOWEN-CONRADI SYNDROME	0.009235829	0.34649274829698246
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.009221482	0.3459545040895793
KBG SYNDROME	0.009186993000000001	0.34466060958416844
ADRENOMYODYSTROPHY	0.009175819	0.34424140412145676
DPM1-CDG	0.009175819	0.34424140412145676
CHARGE SYNDROME	0.009146049	0.3431245483289988
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.009140711	0.34292428711905115
PONTINE TEGMENTAL CAP DYSPLASIA	0.009137526	0.3428047981805568
RING CHROMOSOME 13 SYNDROME	0.009130758000000001	0.34255088887577495
PHELAN-MCDERMID SYNDROME	0.009104631	0.3415707044186184
ACRODYSOSTOSIS	0.00909064	0.34104581596069844
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.00907016	0.34027748520391177
6Q16 MICRODELETION SYNDROME	0.009058444	0.33983794598777345
CARPENTER-WAZIRI SYNDROME	0.00905684	0.3397777700827985
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00905684	0.3397777700827985
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.009043720000000002	0.3392855581917321
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.009037264	0.33904335392582313
BARAITSER-WINTER SYNDROME 2; BRWS2	0.009023879000000002	0.33854120025494483
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.009020134	0.3384007022723195
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.009020134	0.3384007022723195
PRIMARY CONGENITAL HYPOTHYROIDISM	0.009018924000000001	0.3383553077305367
PERMANENT CONGENITAL HYPOTHYROIDISM	0.009018924000000001	0.3383553077305367
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.009018924000000001	0.3383553077305367
CONGENITAL HYPOTHYROIDISM	0.009018924000000001	0.3383553077305367
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.009015999	0.338245572991103
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.009014621	0.33819387573608095
SHORT SYNDROME	0.008979230000000001	0.33686614166315926
MATERNAL PHENYLKETONURIA	0.008974153	0.33667567216842265
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.008952881000000001	0.3358776286206509
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.008951689	0.3358329093695723
CINCA SYNDROME	0.008948914	0.3357288020526737
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.008944779	0.3355736727714572
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.008924754	0.3348224118630269
SAY-BARBER-MILLER SYNDROME	0.008924754	0.3348224118630269
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00891973	0.33463393072425274
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.00891902	0.33460729425758673
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00891902	0.33460729425758673
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00891902	0.33460729425758673
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.008910366999999999	0.3342826670096143
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.008910366999999999	0.3342826670096143
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.008902993	0.3340060229177908
CHAR SYNDROME	0.008883084	0.3332591138827876
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.008866142	0.3326235152655279
CEREBROFACIOARTICULAR SYNDROME	0.008856844000000001	0.33227469010065475
FUCOSIDOSIS	0.008852753	0.33212121153004853
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.008842393	0.3317325442136272
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.008824053000000002	0.33104449801834074
2Q31.1 MICRODELETION SYNDROME	0.008808678	0.33046768720849723
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00879544	0.32997104841170316
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.008792115	0.329846307212176
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.008781448	0.32944612243763294
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.008780123	0.32939641353857324
RING CHROMOSOME 1 SYNDROME	0.00877766	0.32930401126054754
BARBER-SAY SYNDROME	0.00877766	0.32930401126054754
HSD10 DISEASE, ATYPICAL TYPE	0.00877193	0.3290890437197084
FAMILIAL PAROXYSMAL ATAXIA	0.00877193	0.3290890437197084
SPINOCEREBELLAR ATAXIA TYPE 17	0.00877193	0.3290890437197084
SPINOCEREBELLAR ATAXIA TYPE 12	0.00877193	0.3290890437197084
DIENCEPHALIC SYNDROME	0.00877193	0.3290890437197084
LOCKED-IN SYNDROME	0.00877193	0.3290890437197084
LESCH-NYHAN SYNDROME	0.00877193	0.3290890437197084
PFAPA SYNDROME	0.00877193	0.3290890437197084
HISTIDINEMIA	0.00877193	0.3290890437197084
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00877193	0.3290890437197084
CORTICOBASAL SYNDROME	0.00877193	0.3290890437197084
BREATH-HOLDING SPELLS	0.00877193	0.3290890437197084
ADULT POLYGLUCOSAN BODY DISEASE	0.00877193	0.3290890437197084
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00877193	0.3290890437197084
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00877193	0.3290890437197084
SPINOCEREBELLAR ATAXIA TYPE 21	0.00877193	0.3290890437197084
MILROY DISEASE	0.00877193	0.3290890437197084
DEAFNESS-HYPOGONADISM SYNDROME	0.00877193	0.3290890437197084
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.00877193	0.3290890437197084
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.00877193	0.3290890437197084
SPINOCEREBELLAR ATAXIA TYPE 38	0.00877193	0.3290890437197084
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00877193	0.3290890437197084
MONOAMINE OXIDASE A DEFICIENCY	0.00877193	0.3290890437197084
HUNTINGTON DISEASE	0.00877193	0.3290890437197084
KEIPERT SYNDROME	0.00877193	0.3290890437197084
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.00877193	0.3290890437197084
MENTAL RETARDATION, X-LINKED 105; MRX105	0.00877193	0.3290890437197084
KABUKI SYNDROME 1	0.008767496	0.32892269710957195
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.008753472	0.32839657061869426
PERIPHERAL HYPOTHYROIDISM	0.008753472	0.32839657061869426
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.008753472	0.32839657061869426
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.008753041	0.3283804011579435
WAARDENBURG SYNDROME TYPE 1	0.008750445	0.32828300923193676
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.008749861000000001	0.3282610998002003
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.008748148	0.3281968346348499
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.008748148	0.3281968346348499
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.008738453	0.32783311555833394
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.008738453	0.32783311555833394
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.008720623	0.32716420259966666
STICKLER SYNDROME, TYPE I	0.008699095	0.32635655491743504
TRISOMY XQ28	0.00869441	0.32618079175359005
KID SYNDROME	0.00869441	0.32618079175359005
1Q21.1 MICRODUPLICATION SYNDROME	0.008692443	0.3261069974860803
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.008678953	0.32560090461942737
HADZISELIMOVIC SYNDROME	0.008656622	0.32476313146855806
MEIER-GORLIN SYNDROME 6; MGORS6	0.00864605	0.3243665107282872
DESBUQUOIS DYSPLASIA 1	0.008620052999999999	0.323391203370661
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.008620052999999999	0.323391203370661
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.008599292	0.3226123305756587
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.008592088000000001	0.322342064229375
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.008587287	0.3221619491921029
SMITH-MAGENIS SYNDROME; SMS	0.008579606	0.3218737876421576
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.008568947	0.3214739029968164
CHIARI MALFORMATION TYPE II	0.008564558	0.3213092446134405
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.008549342	0.3207383988714842
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00851289	0.31937086016316457
DOWN SYNDROME	0.00851289	0.31937086016316457
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.008484214	0.31829504703906225
FETAL AKINESIA SYNDROME, X-LINKED	0.00848246	0.3182292437115523
TUFTED ANGIOMA	0.00847458	0.3179336164477106
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.00847458	0.3179336164477106
108450 ASYMMETRIC SHORT STATURE SYNDROME	0.00847458	0.3179336164477106
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.00847458	0.3179336164477106
X-LINKED ENDOTHELIAL CORNEAL DYSTROPHY	0.00847458	0.3179336164477106
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.00847458	0.3179336164477106
ACHALASIA-MICROCEPHALY SYNDROME	0.00847458	0.3179336164477106
PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY	0.00847458	0.3179336164477106
RADIAL RAY HYPOPLASIA WITH CHOANAL ATRESIA	0.00847458	0.3179336164477106
CENTRAL CONGENITAL HYPOTHYROIDISM	0.008473370000000001	0.31788822190592775
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.008473370000000001	0.31788822190592775
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.008473370000000001	0.31788822190592775
SMITH-MAGENIS SYNDROME	0.008473370000000001	0.31788822190592775
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.008473370000000001	0.31788822190592775
TEMTAMY SYNDROME; TEMTYS	0.008454661	0.31718633225120507
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.008446023	0.3168622677454861
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.008442138	0.3167165175018281
HEC SYNDROME	0.00840336	0.31526171622806476
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	0.31526171622806476
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00840336	0.31526171622806476
DISTAL MONOSOMY 17Q	0.00840336	0.31526171622806476
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.31526171622806476
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.31526171622806476
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.31526171622806476
INDOMETHACIN EMBRYOFETOPATHY	0.00840336	0.31526171622806476
GMS SYNDROME	0.00840336	0.31526171622806476
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.31526171622806476
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.31526171622806476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.31526171622806476
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.31526171622806476
RENAL TUBULAR DYSGENESIS	0.00840336	0.31526171622806476
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.31526171622806476
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	0.31526171622806476
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00840336	0.31526171622806476
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.31526171622806476
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.31526171622806476
RETINOPATHY OF PREMATURITY	0.00840336	0.31526171622806476
FATCO SYNDROME	0.00840336	0.31526171622806476
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	0.31526171622806476
EBSTEIN MALFORMATION	0.00840336	0.31526171622806476
KNIEST-LIKE DYSPLASIA, LETHAL	0.00840336	0.31526171622806476
OMPHALOCELE	0.00840336	0.31526171622806476
SCHISIS ASSOCIATION	0.00840336	0.31526171622806476
PEMPHIGOID GESTATIONIS	0.00840336	0.31526171622806476
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.31526171622806476
ALLAN-HERNDON-DUDLEY SYNDROME	0.008402435	0.31522701378909856
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.008400468	0.3151532195215888
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.008368948	0.3139707104662218
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.008363649	0.3137719123861334
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.008362284000000001	0.31372070284106435
FLYNN-AIRD SYNDROME	0.008358149	0.31356557355984793
JOUBERT SYNDROME 35; JBTS35	0.008320112000000001	0.31213857175340776
RENPENNING SYNDROME 1; RENS1	0.008317844	0.3120534851246776
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.008312907	0.3118682678909737
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.008312907	0.3118682678909737
AARSKOG-SCOTT SYNDROME	0.008305119	0.3115760921129535
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.008305119	0.3115760921129535
FLOATING-HARBOR SYNDROME	0.008300974000000001	0.3114205876702347
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.008271632000000001	0.3103197887900768
OHDO SYNDROME	0.008249157	0.30947661331357385
CEREBROOCULONASAL SYNDROME	0.00824864	0.30945721746390303
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.008241405	0.309185788116962
CEREBROFACIOTHORACIC DYSPLASIA	0.008221425	0.3084362154352922
HOLOPROSENCEPHALY 2; HPE2	0.008207536000000001	0.30791515362469607
SJÖGREN-LARSSON SYNDROME	0.008199933999999999	0.30762995585061925
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.008192899	0.307366029733725
LAMB-SHAFFER SYNDROME	0.008181227	0.30692814122819695
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.008179173	0.3068510830556169
OCULOCEREBROCUTANEOUS SYNDROME	0.008175069	0.30669711677505773
OROFACIODIGITAL SYNDROME XV; OFD15	0.008169220000000001	0.3064776848123407
MECKEL SYNDROME 12; MKS12	0.008169220000000001	0.3064776848123407
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.008162231	0.3062154844383572
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.008158774	0.30608579110699924
ZIMMERMANN-LABAND SYNDROME 1	0.008158752	0.3060849657516941
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.008156579	0.3060034431572362
MASA SYNDROME	0.0081497	0.3057453695597784
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.008142501	0.30547529079424585
MICROPHTHALMIA, SYNDROMIC 1	0.008137547	0.30528943578598794
%229400 FRONTOFACIONASAL DYSPLASIA;;FFND;;FRONTOFACIONASAL DYSOSTOSIS	0.00811688	0.3045140895091076
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00811688	0.3045140895091076
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.00811688	0.3045140895091076
SHPRINTZEN OMPHALOCELE SYNDROME	0.008115553000000001	0.30446430557774745
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.008090178	0.30351233326556665
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.008087225	0.3034015480739265
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.008087225	0.3034015480739265
MULTIPLE EPIPHYSEAL DYSPLASIA, LOWRY TYPE	0.008087225	0.3034015480739265
MEVALONIC ACIDURIA; MEVA	0.008081672000000002	0.30319322089167866
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.008077537000000001	0.30303809161046225
HYPERTELORISM, TEEBI TYPE	0.0080684	0.30269530654577664
EVEN-PLUS SYNDROME	0.008053994	0.30215484888550964
VERVERI-BRADY SYNDROME; VERBRAS	0.008053738	0.30214524475104976
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.008053738	0.30214524475104976
OLIVER SYNDROME	0.008037275	0.301527616369752
YUNIS-VARON SYNDROME	0.008037134	0.30152232659256906
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.008029581	0.3012389671098537
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00800521	0.30032466101250765
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.008002499	0.300222954729224
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.007995464	0.2999590286123298
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.007979332	0.29935381807675937
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.007975243	0.29920041453845364
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.007971051	0.2990431468366739
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.007956664	0.2985034019832613
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.007948829	0.29820946294618
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.007948829	0.29820946294618
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.007948829	0.29820946294618
2Q24 MICRODELETION SYNDROME	0.007948829	0.29820946294618
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.007948829	0.29820946294618
SECKEL SYNDROME 7; SCKL7	0.007948829	0.29820946294618
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.007948829	0.29820946294618
CROME SYNDROME	0.007948829	0.29820946294618
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.007948829	0.29820946294618
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.007899993000000001	0.29637732423336594
MCDONOUGH SYNDROME	0.00787992	0.2956242625497244
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.00786158	0.2949362163544379
LISSENCEPHALY 3; LIS3	0.007849607	0.2944870354876895
MYOPATHIC EHLERS-DANLOS SYNDROME	0.007816730000000001	0.2932536170164554
SPONDYLOMETAPHYSEAL DYSPLASIA, SCHMIDT TYPE	0.007816730000000001	0.2932536170164554
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.007816730000000001	0.2932536170164554
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.007816730000000001	0.2932536170164554
SPONDYLOMETAPHYSEAL DYSPLASIA, ALGERIAN TYPE	0.007816730000000001	0.2932536170164554
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.0077970900000000004	0.2925167998258651
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.0077970900000000004	0.2925167998258651
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.0077970900000000004	0.2925167998258651
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.007791934	0.29232336655526
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.007788127000000001	0.2921805425713202
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.007787799	0.29216823727404356
WHIPPLE DISEASE	0.007787799	0.29216823727404356
PORPHYRIA	0.007787799	0.29216823727404356
WOLFRAM SYNDROME	0.007787799	0.29216823727404356
ADIPOSIS DOLOROSA	0.007787799	0.29216823727404356
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.007787799	0.29216823727404356
ENCEPHALITIS LETHARGICA	0.007787799	0.29216823727404356
AUTISM, SUSCEPTIBILITY TO, 18	0.007787799	0.29216823727404356
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.00778661	0.29212363057141566
PRIMARY DYSTONIA, DYT4 TYPE	0.00778661	0.29212363057141566
CHROMOSOME 10Q26 DELETION SYNDROME	0.007772471	0.29159318972326104
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.007758747	0.2910783180774534
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.00775723	0.29102140607754884
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00775723	0.29102140607754884
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.007755420000000001	0.2909535018456258
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.007730069000000001	0.2900024299210507
POLAND SYNDROME	0.007718525	0.28956934348275254
SIALIDOSIS TYPE 1	0.007695434000000001	0.28870305805770563
5Q14.3 MICRODELETION SYNDROME	0.007690948999999999	0.28853479812390737
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.007676855	0.2880060455025133
TURNER SYNDROME	0.007676855	0.2880060455025133
MONOSOMY X	0.007676855	0.2880060455025133
MOSAIC MONOSOMY X	0.007676855	0.2880060455025133
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.007667419	0.28765204310890785
POPOV-CHANG SYNDROME; POPCHAS	0.007654299	0.2871598312178414
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.007646735	0.2868760590574735
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.007628395	0.28618801286218704
EHLERS-DANLOS SYNDROME, TYPE VI	0.007625028000000001	0.2860616959843501
VAN MALDERGEM SYNDROME 2; VMLDS2	0.007617843	0.2857921424449208
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.00761516	0.2856914866138437
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.007601674	0.2851855438117917
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.007587804	0.28466519480804997
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.007587804	0.28466519480804997
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.007587804	0.28466519480804997
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.2845100655268335
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.2845100655268335
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.007571122	0.28403935038985095
WALKER-WARBURG SYNDROME	0.007537973000000001	0.28279572752575327
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.007537973000000001	0.28279572752575327
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.0075361180000000005	0.28272613506706973
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.0075361180000000005	0.28272613506706973
NEMALINE MYOPATHY 4	0.0075361180000000005	0.28272613506706973
OSTEOGENESIS IMPERFECTA	0.007533815000000001	0.28263973537308146
COWDEN SYNDROME	0.007518498	0.2820651004999515
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.0075169550000000005	0.2820072130801409
METAPHYSEAL ACROSCYPHODYSPLASIA	0.007505115000000001	0.2815630218613736
SPONASTRIME DYSPLASIA	0.0074569449999999995	0.27975586890461507
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.007456253	0.27972990772865336
THAKKER-DONNAI SYNDROME	0.00743157	0.2788038965924344
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.007415763	0.27821087880568984
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.007412538000000001	0.27808988922118616
14Q11.2 MICRODELETION SYNDROME	0.00740741	0.2778975064027876
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.00740741	0.2778975064027876
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.007317799999999999	0.2745356841803436
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.007279532000000001	0.2731000161431995
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.007275397	0.27294488686198304
PREECLAMPSIA	0.00724638	0.27185628073065105
ADIPOSIS DOLOROSA	0.00724638	0.27185628073065105
CUSHING SYNDROME	0.00724638	0.27185628073065105
CUSHING DISEASE	0.00724638	0.27185628073065105
PERRY SYNDROME	0.00724638	0.27185628073065105
PERRY SYNDROME	0.00724638	0.27185628073065105
CARIBBEAN PARKINSONISM	0.00724638	0.27185628073065105
NEURALGIC AMYOTROPHY	0.00724638	0.27185628073065105
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.00724638	0.27185628073065105
FAMILIAL GESTATIONAL HYPERTHYROIDISM	0.00724638	0.27185628073065105
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00724638	0.27185628073065105
PANDAS	0.00724638	0.27185628073065105
CHRONIC HICCUP	0.00724638	0.27185628073065105
NOONAN SYNDROME 6; NS6	0.007227872	0.2711619318221253
MIRAGE SYNDROME; MIRAGE	0.007215147999999999	0.27068457632655135
GENITOPALATOCARDIAC SYNDROME	0.007214025000000001	0.270642445689839
VICI SYNDROME; VICIS	0.0072125110000000004	0.2705856462383851
11Q22.2Q22.3 MICRODELETION SYNDROME	0.007211083	0.2705320731758513
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.00720903	0.2704550525194215
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.0071907329999999995	0.26976861951859504
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.007181661000000001	0.2694282730036747
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.007180144	0.2693713610037701
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.0071760090000000006	0.2692162317225537
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.007139991	0.2678649750234354
INCONTINENTIA PIGMENTI; IP	0.007134339000000001	0.26765293374231447
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.007126	0.2673400865655154
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.0070922	0.26607204068761553
ATKIN-FLAITZ SYNDROME	0.0070922	0.26607204068761553
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.0070922	0.26607204068761553
BREASTS AND/OR NIPPLES, APLASIA OR HYPOPLASIA OF, 2; BNAH2	0.0070922	0.26607204068761553
FRANK-TER HAAR SYNDROME; FTHS	0.0070922	0.26607204068761553
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.0070922	0.26607204068761553
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.0070922	0.26607204068761553
SIX2-RELATED FRONTONASAL DYSPLASIA	0.0070922	0.26607204068761553
X-LINKED INTELLECTUAL DISABILITY, STOLL TYPE	0.0070922	0.26607204068761553
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.0070922	0.26607204068761553
AUTOSOMAL RECESSIVE DISTAL OSTEOLYSIS SYNDROME	0.0070922	0.26607204068761553
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.007089713	0.26597873802198424
CDAGS SYNDROME	0.007084343999999999	0.26577731381137937
ANTLEY-BIXLER SYNDROME	0.00708433	0.2657767885852761
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.007076649	0.2654886270353309
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.007055644000000001	0.2647006002996716
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.007049981	0.26448814634089796
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.007048043	0.264415440041745
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.26419810898344104
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.26419810898344104
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.26419810898344104
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00704225	0.26419810898344104
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00704225	0.26419810898344104
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00704225	0.26419810898344104
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.26419810898344104
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.26419810898344104
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.26419810898344104
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.26419810898344104
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.26419810898344104
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.26419810898344104
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00704225	0.26419810898344104
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.26419810898344104
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.26419810898344104
HUNTER-MACDONALD SYNDROME	0.007035595	0.2639484390036356
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.007029703	0.2637273938464585
LATERAL MENINGOCELE SYNDROME	0.007021929	0.2634357432945415
MESOMELIA-SYNOSTOSES SYNDROME	0.00701459	0.2631604122679762
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.00701459	0.2631604122679762
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.007013984	0.2631376774809346
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.006977079000000001	0.261753143956559
COWDEN SYNDROME 5; CWS5	0.006972944	0.2615980146753426
FOUNTAIN SYNDROME	0.006972944	0.2615980146753426
CLASSIC HOMOCYSTINURIA	0.006972944	0.2615980146753426
FLYNN-AIRD SYNDROME	0.006972944	0.2615980146753426
COWDEN SYNDROME 6; CWS6	0.006972944	0.2615980146753426
LATHOSTEROLOSIS	0.006962157	0.2611933279627714
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.006951704	0.2608011716443783
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.006946959000000001	0.2606231575115193
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.006942607999999999	0.2604599247418523
COHEN-GIBSON SYNDROME; COGIS	0.006935897	0.2602081538576338
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.006901559	0.2589199242909082
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.0068971710000000006	0.25875530342368264
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.0068971710000000006	0.25875530342368264
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.006892204000000001	0.25856896070547175
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.006889686000000001	0.25847449503918324
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.006888069	0.2584138314242553
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.006877753	0.2580268148184442
FRAGILE X SYNDROME	0.006859889	0.25735662631066897
HADDAD SYNDROME	0.006859889	0.25735662631066897
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.006854682000000001	0.25716127971640196
PSEUDODIASTROPHIC DYSPLASIA	0.0068340250000000005	0.2563863086010239
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.006826589	0.256107338507886
ROBERTS SYNDROME; RBS	0.0068230700000000005	0.2559753191752135
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.00681302	0.25559828186536454
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.006797209	0.25500511401401915
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.006797209	0.25500511401401915
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.0067814	0.2544120211949742
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.006772328	0.25407167468005387
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.006771374	0.2540358842727309
CRISPONI SYNDROME	0.006771374	0.2540358842727309
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.00676454	0.2537794989020336
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.006758006	0.25353436837640647
MARINESCO-SJOGREN SYNDROME; MSS	0.006714807	0.25191370820245984
MENTAL RETARDATION, X-LINKED 104; MRX104	0.006706583	0.2516051753829377
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.006698506	0.2513021574374999
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.006698506	0.2513021574374999
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.006696466999999999	0.25122566200717333
GLYCINE ENCEPHALOPATHY; GCE	0.006666957	0.25011856041377617
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.006666957	0.25011856041377617
HOLMES-GANG SYNDROME	0.006659274	0.24983032383153045
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.006645178999999999	0.24930153369398608
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.006640241999999999	0.2491163164602822
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.006639544000000001	0.24909013018741907
CARPENTER SYNDROME	0.00663459	0.2489042751791612
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.0066309739999999995	0.24876861677991607
MOSAIC TRISOMY 14	0.006606183	0.24783855389947182
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.0065985720000000005	0.247553018480043
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.0065985720000000005	0.247553018480043
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.006594437	0.2473978891988265
MELNICK-NEEDLES SYNDROME	0.00659292	0.24734097719892198
CENTRAL CORE DISEASE	0.00657458	0.24665293100363544
MEIER-GORLIN SYNDROME 7	0.006542049	0.24543249312038218
MONOSOMY 9Q22.3	0.006526653	0.2448548944713838
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.0065100900000000005	0.24423351447506264
WAARDENBURG SYNDROME, TYPE 1; WS1	0.0065100900000000005	0.24423351447506264
DAHLBERG-BORER-NEWCOMER SYNDROME	0.0065100900000000005	0.24423351447506264
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.0065100900000000005	0.24423351447506264
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.0065100900000000005	0.24423351447506264
SHORT SYNDROME	0.0065100900000000005	0.24423351447506264
CRANIOMETAPHYSEAL DYSPLASIA	0.0065100900000000005	0.24423351447506264
ALAR CARTILAGES HYPOPLASIA-COLOBOMA-TELECANTHUS SYNDROME	0.0065100900000000005	0.24423351447506264
AXENFELD-RIEGER SYNDROME	0.0065100900000000005	0.24423351447506264
WAARDENBURG SYNDROME	0.0065100900000000005	0.24423351447506264
WAARDENBURG-SHAH SYNDROME	0.0065100900000000005	0.24423351447506264
CYSTIC FIBROSIS-GASTRITIS-MEGALOBLASTIC ANEMIA SYNDROME	0.0065100900000000005	0.24423351447506264
TRISOMY 18-LIKE SYNDROME	0.0065100900000000005	0.24423351447506264
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.0065100900000000005	0.24423351447506264
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.0065100900000000005	0.24423351447506264
SIMOSA CRANIOFACIAL SYNDROME	0.0065100900000000005	0.24423351447506264
DEAFNESS, X-LINKED 7; DFNX7	0.0065100900000000005	0.24423351447506264
MCDONOUGH SYNDROME	0.006494715	0.2436567036652191
WIEDEMANN-STEINER SYNDROME; WDSTS	0.0064854710000000005	0.24330990437245859
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.006480748	0.24313271559490468
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00648026	0.24311440771359064
DIASTROPHIC DWARFISM	0.0064763749999999995	0.24296865746993257
TOWNES-BROCKS SYNDROME	0.0064693400000000005	0.24270473135303838
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.0064693400000000005	0.24270473135303838
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.006456277999999999	0.24221469539868543
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.006451	0.24201668515775188
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.006439127000000001	0.2415712559060269
HYPEREKPLEXIA 4; HKPX4	0.006434563000000001	0.2414000321963602
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.006434563000000001	0.2414000321963602
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.0064315250000000004	0.2412860581319501
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.0064315250000000004	0.2412860581319501
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.0064315250000000004	0.2412860581319501
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.0064315250000000004	0.2412860581319501
MUCOLIPIDOSIS III GAMMA	0.0064315250000000004	0.2412860581319501
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.0064315250000000004	0.2412860581319501
KNIEST DYSPLASIA	0.0064315250000000004	0.2412860581319501
JOUBERT SYNDROME 3; JBTS3	0.0064207380000000005	0.24088137141937893
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.006385871999999999	0.23957333332532987
MEIER-GORLIN SYNDROME 1; MGORS1	0.006378480000000001	0.23929601394280225
COSTELLO SYNDROME	0.006378480000000001	0.23929601394280225
ENDOCARDIAL FIBROELASTOSIS	0.006373869000000001	0.23912302697407456
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.006372025	0.23905384719304354
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.006372025	0.23905384719304354
NATIVE AMERICAN MYOPATHY	0.00636014	0.23860796774751572
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.006357339	0.23850288501071104
FETAL TRIMETHADIONE SYNDROME	0.006357339	0.23850288501071104
RUVALCABA SYNDROME	0.006336358	0.23771575866265732
VAN MALDERGEM SYNDROME 1; VMLDS1	0.006330843	0.23750885709411831
MENTAL RETARDATION, X-LINKED 1	0.006319717000000001	0.23709145240661794
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.006317994	0.23702681207976523
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.006309128000000001	0.23669419389179303
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.006306992	0.23661405939489377
RITSCHER-SCHINZEL SYNDROME 1	0.006305512	0.23655853549254788
MEND SYNDROME; MEND	0.006302871	0.2364594553397806
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.00628517	0.23579538196449343
PALMOPLANTAR KERATODERMA-ESOPHAGEAL CARCINOMA SYNDROME	0.00628517	0.23579538196449343
CARCINOMA OF ESOPHAGUS	0.00628517	0.23579538196449343
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.00628517	0.23579538196449343
EOSINOPHILIC ESOPHAGITIS	0.00628517	0.23579538196449343
REYNOLDS SYNDROME	0.00628517	0.23579538196449343
LIMITED CUTANEOUS SYSTEMIC SCLEROSIS	0.00628517	0.23579538196449343
DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS	0.00628517	0.23579538196449343
CHRONIC GRAFT VERSUS HOST DISEASE	0.00628517	0.23579538196449343
CODAS SYNDROME	0.006280469	0.23561901854224476
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.006277289	0.2354997171845015
MUCOPOLYSACCHARIDOSIS TYPE 4	0.0062299550000000006	0.23372392772933842
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.0062299550000000006	0.23372392772933842
FACIAL DYSMORPHISM-ANOREXIA-CACHEXIA-EYE AND SKIN ANOMALIES SYNDROME	0.0062299550000000006	0.23372392772933842
3M SYNDROME	0.0062299550000000006	0.23372392772933842
LATERAL MENINGOCELE SYNDROME	0.006210923	0.23300992035809018
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.006186467	0.2320924253879742
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.006165164	0.23129321883954523
CANAVAN DISEASE	0.006160113	0.2311037247647147
GOLDENHAR SYNDROME	0.006159025	0.2310629071932604
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.006150913000000001	0.23075857618256443
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.006150913	0.23075857618256443
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.006142689	0.23045004336304226
ALAGILLE SYNDROME	0.00610376	0.22898957715059362
LAURENCE-MOON SYNDROME	0.00610376	0.22898957715059362
FOCAL DERMAL HYPOPLASIA	0.006086505000000001	0.22834223597831077
AYME-GRIPP SYNDROME; AYGRP	0.006077489	0.2280039903678035
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.006077489	0.2280039903678035
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.006068165	0.22765418978302424
CHROMOSOME 18P DELETION SYNDROME	0.006064764	0.22752659735607936
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.006060629	0.2273714680748629
COCKAYNE SYNDROME A; CSA	0.006041109	0.2266391528223006
COCKAYNE SYNDROME	0.006041108999999999	0.22663915282230057
OSTEOPENIA-MYOPIA-HEARING LOSS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00604057	0.22661893161732466
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.006034678	0.22639788646014752
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.006028943	0.22618273133855715
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.006028433	0.22616359810193792
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.00602371	0.22598640932438405
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.006019008000000001	0.2258100083859851
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.006019008000000001	0.2258100083859851
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.006010896	0.22550567737528912
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.006004754	0.2252752531805536
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.005996677000000001	0.22497223523511584
RING CHROMOSOME 22 SYNDROME	0.005985521000000001	0.2245537050631084
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.005985521000000001	0.2245537050631084
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.005985521000000001	0.2245537050631084
HOLOPROSENCEPHALY 1; HPE1	0.005985521000000001	0.2245537050631084
17Q24.2 MICRODELETION SYNDROME	0.005970224	0.2239798205129831
POSTENCEPHALITIC PARKINSONISM	0.005947799	0.22313852084399183
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.005935632999999999	0.22268209936024833
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.005935632999999999	0.22268209936024833
FRANK-TER HAAR SYNDROME	0.005927025000000001	0.2223591603390365
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.005918418999999999	0.222036296350125
SENGERS SYNDROME	0.005902998	0.22145775979737076
STROMME SYNDROME; STROMS	0.0059016500000000005	0.22140718802685574
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.0059016500000000005	0.22140718802685574
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.0059016500000000005	0.22140718802685574
MOSAIC TRISOMY 1	0.0059016500000000005	0.22140718802685574
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.0059016500000000005	0.22140718802685574
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.005894661000000001	0.22114498765287227
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.005894661000000001	0.22114498765287227
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.005893538	0.22110285701615975
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.005893144	0.22108807565296767
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.005893144	0.22108807565296767
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.005893144	0.22108807565296767
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.005893144	0.22108807565296767
SECKEL SYNDROME 8; SCKL8	0.005893144	0.22108807565296767
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.005893144	0.22108807565296767
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.005889009000000001	0.22093294637175126
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.005889009000000001	0.22093294637175126
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.005889009000000001	0.22093294637175126
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.0058534550000000005	0.21959909716634143
NON-DISTAL TRISOMY 10Q	0.0058534550000000005	0.21959909716634143
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.0058534550000000005	0.21959909716634143
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.005841318	0.2191437636509547
HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.0058390000000000004	0.21905680121471297
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.005811785	0.2180357991861021
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.005810197999999999	0.2179762610556812
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.005807831	0.21788746032807804
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.005807831	0.21788746032807804
CHROMOSOME 16P13.2 DELETION SYNDROME	0.005807831	0.21788746032807804
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.005796468	0.21746116431297222
LOWE OCULOCEREBRORENAL SYNDROME	0.005790804	0.21724867283804838
HARROD SYNDROME	0.005790804	0.21724867283804838
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.005790780000000001	0.21724777245044283
LAMBOTTE SYNDROME	0.005790780000000001	0.21724777245044283
BENCZE SYNDROME	0.005790780000000001	0.21724777245044283
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.005778637999999999	0.21679225135430488
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.00577244	0.2165597262551563
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.0057695640000000005	0.21645182980708413
HARTSFIELD SYNDROME; HRTFDS	0.0057695640000000005	0.21645182980708413
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.005765429000000001	0.21629670052586766
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.005764182999999999	0.21624995540267639
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.005762981	0.2162048609900955
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.005759958000000001	0.21609144966793897
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.005753269	0.21584050413902559
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.005753269	0.21584050413902559
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.005739302	0.21531651606871116
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.005736968	0.21522895337406567
ALPHA-MANNOSIDOSIS	0.005734929	0.21515245794373905
COLE-CARPENTER SYNDROME	0.005734929	0.21515245794373905
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.005730794000000001	0.21499732866252264
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.005723759	0.21473340254562837
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.005714521	0.21438682834976924
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.005714521	0.21438682834976924
PELIZAEUS-MERZBACHER DISEASE	0.005714521	0.21438682834976924
NIEMANN-PICK DISEASE, TYPE C2	0.005714521	0.21438682834976924
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.005714521	0.21438682834976924
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.005712087	0.21429551404010036
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.005703481	0.2139726500511889
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.005703481	0.2139726500511889
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.005703481	0.2139726500511889
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.005703481	0.2139726500511889
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.0056851409999999995	0.21328460385590242
CHOPS SYNDROME; CHOPS	0.005678704	0.21304311239684795
RECOMBINANT 8 SYNDROME	0.005636568	0.21146233189059974
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.005622573	0.21093729336807882
CITRULLINEMIA TYPE I	0.005614559	0.21063663894010576
8P23.1 MICRODELETION SYNDROME	0.005583943	0.20948804448455005
FILIPPI SYNDROME	0.005565603	0.20879999828926354
COACH SYNDROME	0.005543071	0.2079546843921973
ATELOSTEOGENESIS TYPE I	0.0055404750000000004	0.20785729246619056
HUMERORADIAL SYNOSTOSISHUMERORADIAL/MULTIPLE SYNOSTOSIS SYNDROME	0.005536070000000001	0.207692033824411
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.005536070000000001	0.207692033824411
HYPERTELORISM-HYPOSPADIAS-POLYSYNDACTYLY SYNDROME	0.005536070000000001	0.207692033824411
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.00551921	0.20705951153147042
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.005515856	0.20693368236358653
URBAN-ROGERS-MEYER SYNDROME	0.00549969	0.20632719627890814
FREEMAN-SHELDON SYNDROME	0.005491995	0.20603850950285965
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.005487524	0.20587077479516463
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.005487014	0.20585164155854546
MUSCLE-EYE-BRAIN DISEASE	0.0054828789999999995	0.205696512277329
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00547754	0.20549621355123115
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.005465342	0.2050385915506802
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.005461253	0.20488518801237451
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.0054531760000000006	0.20458217006693674
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.0054531760000000006	0.20458217006693674
OPSISMODYSPLASIA; OPSMD	0.0054511229999999996	0.20450514941050685
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.0054401680000000004	0.20409415998469643
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.0054401680000000004	0.20409415998469643
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.0054396800000000006	0.2040758521033824
OSTEOPOROSIS-OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME	0.0054365	0.20395655074563912
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.005424333999999999	0.20350012926189562
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.005424333999999999	0.20350012926189562
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.005424333999999999	0.20350012926189562
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.0054063800000000006	0.2028265643005994
CREE MENTAL RETARDATION SYNDROME	0.005403984	0.20273667560463934
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.005394214	0.2023701428168559
LYMPHEDEMA, HEREDITARY, III	0.005386729	0.20208933443235647
MOMO SYNDROME	0.005358179	0.2010182483431837
CHIME SYNDROME	0.005358179	0.2010182483431837
SPINAL ARTERIOVENOUS METAMERIC SYNDROME	0.00534759	0.20062098982835874
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B	0.00534759	0.20062098982835874
CHST3-RELATED SKELETAL DYSPLASIA	0.00534759	0.20062098982835874
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	0.00534759	0.20062098982835874
%109500 BASILAR IMPRESSION, PRIMARY	0.00534759	0.20062098982835874
PROTEUS SYNDROME	0.00534759	0.20062098982835874
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00534759	0.20062098982835874
CERVICAL HYPERTRICHOSIS WITH UNDERLYING KYPHOSCOLIOSIS	0.00534759	0.20062098982835874
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.00534759	0.20062098982835874
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00534759	0.20062098982835874
SPINAL MUSCULAR ATROPHY, RYUKYUAN TYPE	0.00534759	0.20062098982835874
AUTOSOMAL DOMINANT BRACHYOLMIA	0.00534759	0.20062098982835874
CHARCOT-MARIE-TOOTH DISEASE TYPE 1A	0.00534759	0.20062098982835874
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL DOMINANT	0.00534759	0.20062098982835874
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.00534759	0.20062098982835874
SPONDYLOCOSTAL DYSOSTOSIS, AUTOSOMAL RECESSIVE 1	0.00534759	0.20062098982835874
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.00534759	0.20062098982835874
GERODERMA OSTEODYSPLASTICUM; GO	0.00534759	0.20062098982835874
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.00534759	0.20062098982835874
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.00534759	0.20062098982835874
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.00534759	0.20062098982835874
ANE SYNDROME	0.00534759	0.20062098982835874
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K	0.00534759	0.20062098982835874
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1; CMT2B1	0.00534759	0.20062098982835874
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A	0.00534759	0.20062098982835874
DYSSPONDYLOENCHONDROMATOSIS	0.00534759	0.20062098982835874
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.00534759	0.20062098982835874
ACROOTOOCULAR SYNDROME	0.00534759	0.20062098982835874
HYDROCEPHALUS, TALL STATURE, JOINT LAXITY, AND KYPHOSCOLIOSIS	0.00534759	0.20062098982835874
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00534759	0.20062098982835874
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00534759	0.20062098982835874
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.00534759	0.20062098982835874
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.00534759	0.20062098982835874
OROFACIODIGITAL SYNDROME XI; OFD11	0.00534759	0.20062098982835874
3Q27.3 MICRODELETION SYNDROME	0.00534759	0.20062098982835874
SPONDYLOEPIPHYSEAL DYSPLASIA, STANESCU TYPE	0.00534759	0.20062098982835874
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00534759	0.20062098982835874
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.00534759	0.20062098982835874
PARKINSON-DEMENTIA SYNDROMESUPRANUCLEAR PALSY, PROGRESSIVE ATYPICAL, INCLUDED	0.00534759	0.20062098982835874
ACRORENAL-MANDIBULAR SYNDROME	0.00534759	0.20062098982835874
MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION	0.00534759	0.20062098982835874
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.00534759	0.20062098982835874
ICHTHYOSIS--CHEEK--EYEBROW SYNDROME	0.00534759	0.20062098982835874
NEUROFIBROMA	0.00534759	0.20062098982835874
EPISODIC ATAXIA TYPE 1	0.00534759	0.20062098982835874
TETRASOMY 5P	0.005319183	0.19955526854866937
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.005311106	0.1992522506032316
KABUKI SYNDROME	0.005295764	0.19867667782634577
15Q24 MICRODELETION SYNDROME	0.005291968	0.19853426652005857
ABLEPHARON MACROSTOMIA SYNDROME	0.005282264	0.19817020979819053
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.005281309	0.1981343818747173
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.005266412	0.1975755037846855
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.005258481000000001	0.19727796319718185
RUVALCABA SYNDROME	0.0052493850000000005	0.19693671629465592
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.0052493850000000005	0.19693671629465592
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.0052493850000000005	0.19693671629465592
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.0052493850000000005	0.19693671629465592
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.005240141	0.19658991700189538
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.005227235	0.1961057335669789
TRISOMY 1Q	0.00522401	0.1959847439824752
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.00522401	0.1959847439824752
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00522401	0.1959847439824752
MECKEL SYNDROME, TYPE 1; MKS1	0.00522401	0.1959847439824752
TETRAAMELIA-MULTIPLE MALFORMATIONS SYNDROME	0.00522401	0.1959847439824752
OPTIC ATROPHY 11; OPA11	0.005221562	0.19589290444670301
MILLER-DIEKER SYNDROME	0.005218629	0.19578286957806748
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.005218629	0.19578286957806748
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.005207715	0.19537341831441665
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.005199597	0.1950688622068193
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.005191442	0.19476291800166326
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.0051893749999999995	0.19468537211913012
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.0051893749999999995	0.19468537211913012
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.0051893749999999995	0.19468537211913012
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.0051893749999999995	0.19468537211913012
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.0051893749999999995	0.19468537211913012
OTOMANDIBULAR SYNDROME	0.0051823400000000006	0.19442144600223593
HEMIFACIAL MICROSOMIA	0.0051823400000000006	0.19442144600223593
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.005162062	0.19366069350779647
JOUBERT SYNDROME 31; JBTS31	0.005162062	0.19366069350779647
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.005139586999999999	0.1928175180312935
MEIER-GORLIN SYNDROME 3; MGORS3	0.0051331499999999995	0.19257602657223902
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.005095149	0.1911503753472073
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.005091014	0.19099524606599083
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.005086869000000001	0.19083974162327208
20P13 MICRODELETION SYNDROME	0.005086869000000001	0.19083974162327208
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.005074387	0.1903714650360547
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.005074387	0.1903714650360547
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.005074387	0.1903714650360547
POLYMYOSITIS	0.00507314	0.19032468239671327
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.00507314	0.19032468239671327
DISTAL MONOSOMY 6P	0.0050534790000000005	0.18958707736696803
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.005049358	0.18943247331185487
15Q14 MICRODELETION SYNDROME	0.005049358	0.18943247331185487
COG5-CDG	0.005038389	0.18902095865994112
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.005031004	0.18874390189046508
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.005023983000000001	0.18848050099967414
LISSENCEPHALY 4	0.005023983000000001	0.18848050099967414
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.005023983000000001	0.18848050099967414
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.005023983000000001	0.18848050099967414
GABA-TRANSAMINASE DEFICIENCY	0.005023983000000001	0.18848050099967414
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.005023983000000001	0.18848050099967414
HOLOPROSENCEPHALY 7	0.005023983000000001	0.18848050099967414
ACROCARDIOFACIAL SYNDROME	0.005020049	0.18833291246465467
SIALIDOSIS TYPE 2	0.005015871	0.18817616998897813
JOUBERT SYNDROME 1	0.005001652	0.1876427278488048
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.004970302	0.1864665965389776
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.004932035	0.1850309660179837
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.004932035	0.1850309660179837
OROFACIODIGITAL SYNDROME V; OFD5	0.004932035	0.1850309660179837
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.004932035	0.1850309660179837
OROFACIODIGITAL SYNDROME TYPE 5	0.004932035	0.1850309660179837
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.004923923	0.1847266350072877
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.004915699	0.18441810218776555
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.004915699	0.18441810218776555
MOEBIUS SYNDROME	0.00491134	0.18425456928889677
ALPORT SYNDROME	0.00490816	0.18413526793115353
MENTAL RETARDATION, X-LINKED 102	0.004907622	0.1841150842423278
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE	0.004898548000000001	0.183774662695107
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00485843	0.18226958978003047
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.004846293	0.18181425626464373
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.004841175	0.18162224860774753
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00481676	0.18070629179979117
CROUZON DISEASE	0.00481676	0.18070629179979117
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.004807688	0.18036594528487085
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.004807688	0.18036594528487085
GRANT SYNDROME	0.00479842	0.1800182456045047
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.00479842	0.1800182456045047
OCULOSKELETODENTAL SYNDROME; OCSKD	0.004792219	0.17978560795690537
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.004788084	0.1796304786756889
TRISOMY 4P	0.004754345	0.1783647212829533
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.004754109	0.17835586747149815
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.004752983	0.17831362428633496
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.004752983	0.17831362428633496
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.004741943	0.17789944598775467
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.004741943	0.17789944598775467
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.004741943	0.17789944598775467
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.004741943	0.17789944598775467
STICKLER SYNDROME, TYPE II	0.00473671	0.1777031239735816
GAPO SYNDROME	0.00473671	0.1777031239735816
MULTIPLE EPIPHYSEAL DYSPLASIA	0.00473671	0.1777031239735816
PROTEUS-LIKE SYNDROME	0.00473671	0.1777031239735816
CRANIOECTODERMAL DYSPLASIA	0.00473671	0.1777031239735816
THANATOPHORIC DYSPLASIA	0.004735769	0.17766782127621167
WOLCOTT-RALLISON SYNDROME	0.004735769	0.17766782127621167
THANATOPHORIC DYSPLASIA TYPE 1	0.004735769	0.17766782127621167
THANATOPHORIC DYSPLASIA TYPE 2	0.004735769	0.17766782127621167
CHARGE SYNDROME	0.004721045	0.1771154334801703
JOHANSON-BLIZZARD SYNDROME; JBS	0.004720858	0.1771084179600766
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.004720858	0.1771084179600766
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.004717062	0.1769660066537894
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.004679375	0.17555213549993104
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.004677209999999999	0.175470913034675
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.004676008000000001	0.1754258186220941
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.004657668	0.1747377724268076
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.004645888	0.17429583217705433
PALLISTER-HALL SYNDROME	0.004641543	0.1741328245042888
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.004641543	0.1741328245042888
MENTAL RETARDATION, X-LINKED 103	0.004641543	0.1741328245042888
MYOTONIC DYSTROPHY 1	0.004627548	0.17360778598176785
LESCH-NYHAN SYNDROME; LNS	0.004627548	0.17360778598176785
SPINOCEREBELLAR ATAXIA 2; SCA2	0.004627548	0.17360778598176785
SPINOCEREBELLAR ATAXIA 1	0.004627548	0.17360778598176785
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.004616508	0.17319360768318753
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.004599873	0.17256952652404953
ISOLATED GLYCEROL KINASE DEFICIENCY	0.0045959880000000005	0.17242377628039152
LATHOSTEROLOSIS	0.004581533	0.17188148032876305
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.004580841	0.1718555191528013
CARTILAGE-HAIR HYPOPLASIA; CHH	0.0045664550000000005	0.17131581181553898
INCONTINENTIA PIGMENTI	0.004554318	0.17086047830015225
OSTEOGLOSPHONIC DYSPLASIA	0.004549595	0.17068328952259837
2P15-16.1 MICRODELETION SYNDROME	0.00454545	0.17052778507987962
FRONTONASAL DYSPLASIA WITH ALAR CLEFTS	0.00454545	0.17052778507987962
22Q11 DUPLICATION SYNDROME	0.00454545	0.17052778507987962
CRANIOECTODERMAL DYSPLASIA 3	0.00454545	0.17052778507987962
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.00454545	0.17052778507987962
SCALP-EAR-NIPPLE SYNDROME	0.00454545	0.17052778507987962
ANIRIDIA, PARTIAL, WITH UNILATERAL RENAL AGENESIS AND PSYCHOMOTORRETARDATION	0.00454545	0.17052778507987962
WAARDENBURG SYNDROME TYPE 2	0.00454545	0.17052778507987962
TELECANTHUS	0.00454545	0.17052778507987962
OROFACIODIGITAL SYNDROME X	0.00454545	0.17052778507987962
WAARDENBURG SYNDROME, TYPE 2D; WS2D	0.00454545	0.17052778507987962
WAARDENBURG SYNDROME TYPE 3	0.00454545	0.17052778507987962
DYSMORPHISM-PECTUS CARINATUM-JOINT LAXITY SYNDROME	0.00454545	0.17052778507987962
OROFACIODIGITAL SYNDROME TYPE 10	0.00454545	0.17052778507987962
CRYPTOMICROTIA-BRACHYDACTYLY-EXCESS FINGERTIP ARCH SYNDROME	0.00454545	0.17052778507987962
TERMINAL OSSEOUS DYSPLASIA; TOD	0.00454545	0.17052778507987962
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00454545	0.17052778507987962
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.00454545	0.17052778507987962
CLEFT PALATE-STAPES FIXATION-OLIGODONTIA SYNDROME	0.00454545	0.17052778507987962
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.004532968	0.17005950849266224
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.004532968	0.17005950849266224
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.004520831	0.16960417497727556
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.004520831	0.16960417497727556
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.004520831	0.16960417497727556
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.004520831	0.16960417497727556
SCHINDLER DISEASE, TYPE I	0.004520831	0.16960417497727556
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.004507939	0.16912051676846238
ALSTROM SYNDROME; ALMS	0.004507939	0.16912051676846238
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.004507939	0.16912051676846238
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.004503804	0.16896538748724593
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.004503804	0.16896538748724593
RAMON SYNDROME	0.004503804	0.16896538748724593
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.004503804	0.16896538748724593
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.004503804	0.16896538748724593
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.004503804	0.16896538748724593
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.004503804	0.16896538748724593
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.004503804	0.16896538748724593
MENTAL RETARDATION, X-LINKED 82	0.004503804	0.16896538748724593
SCARF SYNDROME	0.00449697	0.16870900211654868
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.004491638	0.16850896600350246
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.004491638	0.16850896600350246
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.004491637999999999	0.1685089660035024
CAREY-FINEMAN-ZITER SYNDROME	0.004489585	0.16843194534707262
SPINOCEREBELLAR ATAXIA TYPE 13	0.004487531	0.16835488717449257
HOLOPROSENCEPHALY 11	0.0044825640000000005	0.16816854445628165
CRANIOTELENCEPHALIC DYSPLASIA	0.0044825640000000005	0.16816854445628165
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.0044825640000000005	0.16816854445628165
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.0044825640000000005	0.16816854445628165
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.0044825640000000005	0.16816854445628165
CRANIOTELENCEPHALIC DYSPLASIA	0.0044825640000000005	0.16816854445628165
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.0044825640000000005	0.16816854445628165
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.0044825640000000005	0.16816854445628165
CURRY-JONES SYNDROME	0.0044825640000000005	0.16816854445628165
SEPTOOPTIC DYSPLASIA	0.0044825640000000005	0.16816854445628165
BEEMER-ERTBRUGGEN SYNDROME	0.00447863	0.16802095592126218
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00447863	0.16802095592126218
LISSENCEPHALY, X-LINKED, 1; LISX1	0.004478429000000001	0.1680134151750652
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.004478429000000001	0.1680134151750652
HISTIOCYTOID CARDIOMYOPATHY	0.004478429000000001	0.1680134151750652
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.004474452	0.16786421344558566
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.004470317	0.1677090841643692
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.004466757	0.16757552666953718
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.0044581510000000005	0.16725266268062577
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.0044581510000000005	0.16725266268062577
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.0044581510000000005	0.16725266268062577
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.0044581510000000005	0.16725266268062577
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.0044581510000000005	0.16725266268062577
PEHO SYNDROME; PEHO	0.0044581510000000005	0.16725266268062577
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.0044581510000000005	0.16725266268062577
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.0044581510000000005	0.16725266268062577
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.0044581510000000005	0.16725266268062577
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.0044581510000000005	0.16725266268062577
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.004456098	0.16717564202419594
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.004456098	0.16717564202419594
NON-DISTAL MONOSOMY 10Q	0.00443696	0.1664576579410229
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.004395583	0.1649053521928021
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.004391704	0.1647598270460455
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.004391704	0.1647598270460455
INFANTILE DYSTONIA-PARKINSONISM	0.004391704	0.1647598270460455
3Q29 MICRODELETION SYNDROME	0.004391704	0.1647598270460455
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.004391704	0.1647598270460455
ATYPICAL RETT SYNDROME	0.004387569	0.16460469776482906
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.004387569	0.16460469776482906
MIXED CONNECTIVE TISSUE DISEASE	0.004387569	0.16460469776482906
FRONTONASAL DYSPLASIA 2; FND2	0.0043742799999999995	0.16410614564437306
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.004366203	0.1638031276989353
CHROMOSOME 1P35 DELETION SYNDROME	0.004338613	0.16276805711398687
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.004330536	0.1624650391685491
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.004316081	0.16192274321692063
TOLUENE EMBRYOPATHY	0.004304874	0.16150229972125127
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.004304874	0.16150229972125127
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.004301694	0.16138299836350803
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.004296943	0.1612047591337476
OCULOECTODERMAL SYNDROME; OES	0.004296943	0.1612047591337476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.0042888660000000006	0.16090174118830983
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.0042888660000000006	0.16090174118830983
3Q29 MICRODUPLICATION SYNDROME	0.004278603000000001	0.16051671293846112
20P12.3 MICRODELETION SYNDROME	0.004278603000000001	0.16051671293846112
HYPERTRYPTOPHANEMIA; HYPTRP	0.004260024	0.15981970038326876
BARDET-BIEDL SYNDROME 1; BBS1	0.004260024	0.15981970038326876
FRONTOOCULAR SYNDROME	0.004260024	0.15981970038326876
KNOBLOCH SYNDROME	0.004255889	0.1596645711020523
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.00425436	0.15960720890834496
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00425436	0.15960720890834496
WIDOW'S PEAK SYNDROME	0.00425436	0.15960720890834496
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.00425436	0.15960720890834496
FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4	0.00425436	0.15960720890834496
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.00423221	0.15877622618066795
FEINGOLD SYNDROME 1; FGLDS1	0.00423221	0.15877622618066795
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00423221	0.15877622618066795
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00423221	0.15877622618066795
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.00423221	0.15877622618066795
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.00423221	0.15877622618066795
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.00423221	0.15877622618066795
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.0042299040000000005	0.158689713938229
STURGE-WEBER SYNDROME	0.004225769	0.15853458465701253
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00421269	0.15804391092810569
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.004207429	0.15784653846172605
15Q26 OVERGROWTH SYNDROME	0.0042049950000000004	0.15775522415205717
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.004200524	0.15758748944436218
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.004196389	0.15743236016314574
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.004196389	0.15743236016314574
17P13.3 MICRODUPLICATION SYNDROME	0.004182184	0.1568994432490757
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.004178049	0.15674431396785923
BARDET-BIEDL SYNDROME 8; BBS8	0.004116984	0.1544533902538369
AICA-RIBOSIDURIA	0.004112849	0.15429826097262048
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.004112849	0.15429826097262048
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.004112849	0.15429826097262048
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.004112849	0.15429826097262048
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.004112849	0.15429826097262048
DISTAL TRISOMY 18Q	0.004100124	0.15382086796089633
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.004100124	0.15382086796089633
NOONAN SYNDROME 3; NS3	0.004100124	0.15382086796089633
FANCONI ANEMIA	0.004072909	0.15279986593228553
SECKEL SYNDROME 1; SCKL1	0.004068774	0.15264473665106906
DISTAL 16P11.2 MICRODELETION SYNDROME	0.004054333	0.1521029659255439
SRD5A3-CDG	0.004054333	0.1521029659255439
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.004054319	0.1521024406994406
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.004040114	0.15156952378537059
17Q21.31 MICRODUPLICATION SYNDROME	0.004040114	0.15156952378537059
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.004035979	0.15141439450415412
FETAL GAUCHER DISEASE	0.004035979	0.15141439450415412
SMITH-KINGSMORE SYNDROME; SKS	0.004035287	0.15138843332819238
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.004021082	0.15085551641412231
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.004013151	0.1505579758266187
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.004013151	0.1505579758266187
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.004013151	0.1505579758266187
MARINESCO-SJÖGREN SYNDROME	0.004012899	0.15054852175675978
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.004012899	0.15054852175675978
TRISOMY 17P	0.004012899	0.15054852175675978
MUCOLIPIDOSIS IV; ML4	0.003979412	0.14929221843388307
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.003976232	0.1491729170761398
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.003976232	0.1491729170761398
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.003975464	0.14914410467276032
CYCLIC VOMITING SYNDROME	0.003975277	0.14913708915266663
COHEN SYNDROME	0.003972097	0.1490177877949234
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.0039623850000000006	0.14865343094385347
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.0039623850000000006	0.14865343094385347
BECKER NEVUS SYNDROME	0.0039623850000000006	0.14865343094385347
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.0039623850000000006	0.14865343094385347
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.0039623850000000006	0.14865343094385347
METATROPIC DYSPLASIA	0.0039623850000000006	0.14865343094385347
HOLT-ORAM SYNDROME	0.0039623850000000006	0.14865343094385347
TYPICAL NEMALINE MYOPATHY	0.0039623850000000006	0.14865343094385347
CLEIDOCRANIAL DYSPLASIA; CCD	0.0039623850000000006	0.14865343094385347
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.0039623850000000006	0.14865343094385347
%112350 WEISMANN-NETTER SYNDROME; WNS;;BOWING OF LEGS, ANTERIOR, WITH DWARFISM;;TOXOPACHYOSTEOSE DIAPHYSAIRE TIBIO-PERONIERE	0.0039623850000000006	0.14865343094385347
PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD	0.0039623850000000006	0.14865343094385347
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.0039623850000000006	0.14865343094385347
BRUCK SYNDROME	0.0039623850000000006	0.14865343094385347
ACRO-RENAL-MANDIBULAR SYNDROME	0.0039623850000000006	0.14865343094385347
ECTODERMAL DYSPLASIA-SENSORINEURAL DEAFNESS SYNDROME	0.0039623850000000006	0.14865343094385347
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.0039623850000000006	0.14865343094385347
SPONDYLOMETAPHYSEAL DYSPLASIA, 'CORNER FRACTURE' TYPE	0.0039623850000000006	0.14865343094385347
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.0039623850000000006	0.14865343094385347
METATROPIC DYSPLASIA	0.0039623850000000006	0.14865343094385347
PSEUDOACHONDROPLASIA	0.0039623850000000006	0.14865343094385347
CAMPOMELIC DYSPLASIA	0.0039623850000000006	0.14865343094385347
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.0039623850000000006	0.14865343094385347
SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3	0.0039623850000000006	0.14865343094385347
MORQUIO SYNDROME A	0.0039623850000000006	0.14865343094385347
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.0039623850000000006	0.14865343094385347
OSTEOGENESIS IMPERFECTA, TYPE IV	0.0039623850000000006	0.14865343094385347
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.0039623850000000006	0.14865343094385347
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.0039623850000000006	0.14865343094385347
PSEUDOACHONDROPLASIA	0.0039623850000000006	0.14865343094385347
WEISMANN-NETTER SYNDROME	0.0039623850000000006	0.14865343094385347
OSTEOGENESIS IMPERFECTA, TYPE IX	0.0039623850000000006	0.14865343094385347
HIP DYSPLASIA, BEUKES TYPE	0.0039623850000000006	0.14865343094385347
ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	0.0039623850000000006	0.14865343094385347
OSTEOMESOPYKNOSIS	0.0039623850000000006	0.14865343094385347
CAMURATI-ENGELMANN DISEASE	0.0039623850000000006	0.14865343094385347
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.003950219	0.14819700946010994
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.003946084	0.14804188017889353
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.003946084	0.14804188017889353
RAPID-ONSET DYSTONIA-PARKINSONISM	0.003941977	0.14788780134988364
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00393701	0.14770145863167272
ASPLENIA WITH CARDIOVASCULAR ANOMALIES	0.00393701	0.14770145863167272
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.00393701	0.14770145863167272
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00393701	0.14770145863167272
HYDROLETHALUS SYNDROME 1	0.00393701	0.14770145863167272
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.00393701	0.14770145863167272
OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA,HYDROCEPHALUS, AND HYPERTENSION	0.00393701	0.14770145863167272
MIRROR MOVEMENTS 1; MRMV1	0.00393701	0.14770145863167272
AGNATHIA-HOLOPROSENCEPHALY-SITUS INVERSUS SYNDROME	0.00393701	0.14770145863167272
MULTIPLE EPIPHYSEAL DYSPLASIA, AL-GAZALI TYPE	0.00393701	0.14770145863167272
SCHIZENCEPHALY	0.00393701	0.14770145863167272
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00393701	0.14770145863167272
MISMATCH REPAIR CANCER SYNDROME; MMRCS	0.00393701	0.14770145863167272
FAMILIAL CONGENITAL MIRROR MOVEMENTS	0.00393701	0.14770145863167272
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00393701	0.14770145863167272
MICROCEPHALY-POLYMICROGYRIA-CORPUS CALLOSUM AGENESIS SYNDROME	0.00393701	0.14770145863167272
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	0.00393701	0.14770145863167272
MASA SYNDROME	0.00393701	0.14770145863167272
CURRY-JONES SYNDROME	0.00393701	0.14770145863167272
SPINOCEREBELLAR ATAXIA 23; SCA23	0.00393701	0.14770145863167272
BETHLEM MYOPATHY 2; BTHLM2	0.003928898	0.14739712762097673
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.003921203	0.14710844084492825
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.003916732	0.14694070613723326
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.003916731999999999	0.14694070613723323
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.003912597	0.14678557685601684
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.003912597	0.14678557685601684
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.003912597	0.14678557685601684
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.003912597	0.14678557685601684
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.003912597	0.14678557685601684
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.003912597	0.14678557685601684
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.003912597	0.14678557685601684
X-LINKED EHLERS-DANLOS SYNDROME	0.00384615	0.1442927412214366
IDIOPATHIC PULMONARY FIBROSIS	0.00384615	0.1442927412214366
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00384615	0.1442927412214366
SANDIFER SYNDROME	0.00384615	0.1442927412214366
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX	0.00384615	0.1442927412214366
GASTROESOPHAGEAL REFLUX	0.00384615	0.1442927412214366
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00384615	0.1442927412214366
ADENOCARCINOMA OF THE ESOPHAGUS	0.00384615	0.1442927412214366
ISOLATED POLYCYSTIC LIVER DISEASE	0.00384615	0.1442927412214366
NK-CELL ENTEROPATHY	0.00384615	0.1442927412214366
MEIER-GORLIN SYNDROME 2; MGORS2	0.00384615	0.1442927412214366
MÉNÉTRIER DISEASE	0.00384615	0.1442927412214366
CONGENITAL PULMONARY LYMPHANGIECTASIA	0.00384615	0.1442927412214366
TRISOMY 8Q	0.0037971940000000003	0.1424561005705944
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.0037971940000000003	0.1424561005705944
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.0037971940000000003	0.1424561005705944
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.0037971940000000003	0.1424561005705944
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.0037971940000000003	0.1424561005705944
FILIPPI SYNDROME; FLPIS	0.003793059	0.14230097128937794
AU-KLINE SYNDROME; AUKS	0.003789117	0.14215308262515658
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.003789117	0.14215308262515658
OGDEN SYNDROME	0.003789117	0.14215308262515658
JOUBERT SYNDROME 26	0.003774662	0.1416107866735281
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.003774662	0.1416107866735281
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.003774662	0.1416107866735281
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.003770527	0.1414556573923117
STEINERT MYOTONIC DYSTROPHY	0.00375932	0.14103521389664234
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.00375614	0.1409159125388991
POLYDACTYLY-MYOPIA SYNDROME	0.00375614	0.1409159125388991
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.003755524	0.14089280259035514
MIETENS SYNDROME	0.003755524	0.14089280259035514
DISTAL MONOSOMY 9P	0.003737184	0.14020475639506863
FAMILIAL BENIGN COPPER DEFICIENCY	0.0037330490000000004	0.1400496271138522
RING CHROMOSOME 10 SYNDROME	0.0037330490000000004	0.1400496271138522
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.0037330490000000004	0.1400496271138522
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.00372602	0.13978592609385934
RENAL COLOBOMA SYNDROME	0.00371447	0.13935261455865983
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.00371447	0.13935261455865983
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.00371447	0.13935261455865983
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.00371447	0.13935261455865983
OCULOCUTANEOUS ALBINISM	0.00371447	0.13935261455865983
X-LINKED RECESSIVE OCULAR ALBINISM	0.00371447	0.13935261455865983
GASTROCUTANEOUS SYNDROME	0.00371447	0.13935261455865983
RETINAL CONE DYSTROPHY 3B	0.00371447	0.13935261455865983
ALAGILLE SYNDROME 1; ALGS1	0.00371447	0.13935261455865983
MESOMELIC DWARFISM, REINHARDT-PFEIFFER TYPE	0.00371447	0.13935261455865983
223330 DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT	0.00371447	0.13935261455865983
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00371447	0.13935261455865983
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.00371447	0.13935261455865983
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00371447	0.13935261455865983
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.0036843500000000003	0.13822262811362007
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.0036843500000000003	0.13822262811362007
INTESTINAL BOTULISM	0.00366601	0.13753458191833356
ANTISYNTHETASE SYNDROME	0.00366601	0.13753458191833356
JUVENILE DERMATOMYOSITIS	0.00366601	0.13753458191833356
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.0036549699999999996	0.13712040361975325
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.0036549699999999996	0.13712040361975325
GLYCEROL KINASE DEFICIENCY; GKD	0.003619303	0.13578231508936703
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.0036009629999999996	0.13509426889408055
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.00357143	0.133986304429228
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00357143	0.133986304429228
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.00357143	0.133986304429228
ACHARD SYNDROME	0.00357143	0.133986304429228
PFEIFFER SYNDROME TYPE 1	0.00357143	0.133986304429228
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.00357143	0.133986304429228
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00357143	0.133986304429228
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00357143	0.133986304429228
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.00357143	0.133986304429228
CLEIDOCRANIAL DYSPLASIA, RECESSIVE FORM	0.00357143	0.133986304429228
CRANIODIGITAL-INTELLECTUAL DISABILITY SYNDROME	0.00357143	0.133986304429228
COMMON VARIABLE IMMUNODEFICIENCY	0.00357143	0.133986304429228
CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS	0.00357143	0.133986304429228
GORLIN-CHAUDHRY-MOSS SYNDROME	0.00357143	0.133986304429228
ISOLATED BRACHYCEPHALY	0.00357143	0.133986304429228
CRANIOSYNOSTOSIS AND DENTAL ANOMALIES; CRSDA	0.00357143	0.133986304429228
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.003559293	0.13353097091384128
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.003559293	0.13353097091384128
HARTNUP DISEASE	0.003559293	0.13353097091384128
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.0035561129999999996	0.13341166955609804
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00355457	0.1333537821362874
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.00355457	0.1333537821362874
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.00355457	0.1333537821362874
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.00355457	0.1333537821362874
DYSTONIA-APHONIA SYNDROME	0.003525993	0.13228168311105828
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.003525993	0.13228168311105828
HSD10 DISEASE	0.003525993	0.13228168311105828
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.003525993	0.13228168311105828
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.003525993	0.13228168311105828
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.003525993	0.13228168311105828
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.003525993	0.13228168311105828
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.003525993	0.13228168311105828
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.003525993	0.13228168311105828
ADULT-ONSET DYSTONIA-PARKINSONISM	0.003525993	0.13228168311105828
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.003525993	0.13228168311105828
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.003525993	0.13228168311105828
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.003512914	0.1317910093821514
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.003512914	0.1317910093821514
FARBER DISEASE	0.003512914	0.1317910093821514
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.0035129000000000002	0.13179048415604813
MACS SYNDROME	0.003509015	0.13164473391239012
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.003508779	0.13163588010093497
SANDHOFF DISEASE	0.003508779	0.13163588010093497
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.003508779	0.13163588010093497
STEEL SYNDROME; STLS	0.0035052190000000004	0.13150232260610292
ALAZAMI SYNDROME; ALAZS	0.0035052190000000004	0.13150232260610292
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.003496613	0.1311794586171915
LISSENCEPHALY 8; LIS8	0.003496613	0.1311794586171915
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.003496613	0.1311794586171915
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.003496613	0.1311794586171915
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.003496613	0.1311794586171915
COFFIN-SIRIS SYNDROME 5	0.003496613	0.1311794586171915
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.003496613	0.1311794586171915
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.003496613	0.1311794586171915
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.003496613	0.1311794586171915
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.003496613	0.1311794586171915
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.003496613	0.1311794586171915
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.003496613	0.1311794586171915
9Q SUBTELOMERIC DELETION SYNDROME	0.00349456	0.13110243796076165
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.00349456	0.13110243796076165
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.003493868	0.1310764767847999
MENTAL RETARDATION, X-LINKED 93	0.0034755280000000003	0.13038843058951344
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.003471732	0.13024601928322618
CHROMOSOME 16Q22 DELETION SYNDROME	0.003471732	0.13024601928322618
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.003467597	0.13009089000200977
SPINOCEREBELLAR ATAXIA 47; SCA47	0.003467597	0.13009089000200977
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.003467345	0.13008143593215085
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.003467345	0.13008143593215085
BRITTLE CORNEA SYNDROME	0.003464165	0.1299621345744076
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.003464165	0.1299621345744076
SPONDYLOMETAPHYSEAL DYSPLASIA-CONE-ROD DYSTROPHY SYNDROME	0.003464165	0.1299621345744076
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.003464165	0.1299621345744076
PSEUDOXANTHOMA ELASTICUM	0.003464165	0.1299621345744076
MAFFUCCI SYNDROME	0.003434045	0.12883214812936786
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.003434045	0.12883214812936786
NEMALINE MYOPATHY 3; NEM3	0.003434045	0.12883214812936786
FRIEDREICH ATAXIA	0.003434045	0.12883214812936786
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.003434045	0.12883214812936786
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.003434045	0.12883214812936786
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.003434045	0.12883214812936786
NEMALINE MYOPATHY 1; NEM1	0.003434045	0.12883214812936786
CHIARI MALFORMATION TYPE I	0.003434045	0.12883214812936786
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.003434045	0.12883214812936786
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.003434045	0.12883214812936786
ARNOLD-CHIARI MALFORMATION TYPE I	0.003434045	0.12883214812936786
SPINOCEREBELLAR ATAXIA TYPE 1	0.003400558	0.12757584480649115
ADDUCTED THUMBS SYNDROME	0.003400558	0.12757584480649115
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.003400558	0.12757584480649115
ROIFMAN SYNDROME	0.003371178	0.12647362031262432
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.003371178	0.12647362031262432
DISTAL TRISOMY 17Q	0.003368998	0.1263918351051148
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.0033545429999999998	0.12584953915348635
10Q22.3Q23.3 MICRODELETION SYNDROME	0.0033545429999999998	0.12584953915348635
MULTIPLE SULFATASE DEFICIENCY	0.0033545429999999998	0.12584953915348635
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.0033545429999999998	0.12584953915348635
11P15.4 MICRODUPLICATION SYNDROME	0.0033545429999999998	0.12584953915348635
STT3A-CDG	0.003335511	0.12513553178223813
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.003335511	0.12513553178223813
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.003335511	0.12513553178223813
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.003335511	0.12513553178223813
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.003335511	0.12513553178223813
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.003335511	0.12513553178223813
STT3B-CDG	0.003335511	0.12513553178223813
ALG11-CDG	0.003327328	0.12482853712487554
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.0033089879999999997	0.12414049092958905
22Q11.2 MICRODUPLICATION SYNDROME	0.0033089879999999997	0.12414049092958905
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.0032938410000000005	0.12357223380199886
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.0032938410000000005	0.12357223380199886
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.0032938410000000005	0.12357223380199886
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.0032938410000000005	0.12357223380199886
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.0032938410000000005	0.12357223380199886
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.0032938410000000005	0.12357223380199886
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.0032938410000000005	0.12357223380199886
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.0032938410000000005	0.12357223380199886
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.0032938410000000005	0.12357223380199886
ADAMS-OLIVER SYNDROME 2; AOS2	0.0032938410000000005	0.12357223380199886
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.0032938410000000005	0.12357223380199886
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.003275501	0.12288418760671237
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.003275501	0.12288418760671237
TEMPLE-BARAITSER SYNDROME; TMBTS	0.003275501	0.12288418760671237
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.003275501	0.12288418760671237
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.003275501	0.12288418760671237
KETOADIPICACIDURIA	0.003275501	0.12288418760671237
METHYLMALONIC ACIDURIA, CBLA TYPE	0.003275501	0.12288418760671237
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.003275501	0.12288418760671237
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.003275501	0.12288418760671237
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.003275501	0.12288418760671237
PYRUVATE CARBOXYLASE DEFICIENCY	0.003275501	0.12288418760671237
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.003275501	0.12288418760671237
GM2-GANGLIOSIDOSIS, AB VARIANT	0.003275501	0.12288418760671237
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.003275501	0.12288418760671237
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.003275501	0.12288418760671237
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.003275501	0.12288418760671237
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.003275501	0.12288418760671237
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.003275501	0.12288418760671237
GRISCELLI SYNDROME, TYPE 1	0.003275501	0.12288418760671237
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.003275501	0.12288418760671237
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.003275501	0.12288418760671237
FOLATE MALABSORPTION, HEREDITARY	0.003275501	0.12288418760671237
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.003262595	0.12240000417179592
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.003262595	0.12240000417179592
MARSHALL-SMITH SYNDROME	0.003262595	0.12240000417179592
MULTIPLE OSTEOCHONDROMAS	0.003262595	0.12240000417179592
DESBUQUOIS SYNDROME	0.003262595	0.12240000417179592
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.00325164	0.12198901474598549
FRASER SYNDROME	0.00325164	0.12198901474598549
OMODYSPLASIA 1; OMOD1	0.00325164	0.12198901474598549
14Q24.1Q24.3 MICRODELETION SYNDROME	0.00325164	0.12198901474598549
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.00325164	0.12198901474598549
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.00325164	0.12198901474598549
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.003243563	0.12168599680054767
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.003243563	0.12168599680054767
COFFIN-SIRIS SYNDROME 10; CSS10	0.003229108	0.1211437008489192
CHITAYAT SYNDROME	0.003229108	0.1211437008489192
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.0032099700000000004	0.12042571676574622
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.0032099700000000004	0.12042571676574622
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.0032099700000000004	0.12042571676574622
MULTIMINICORE MYOPATHY	0.0032018930000000004	0.12012269882030843
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.0032018930000000004	0.12012269882030843
SOTOS SYNDROME 2	0.003201893	0.12012269882030842
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.00319163	0.11973767057045973
MULTIPLE METAPHYSEAL DYSPLASIA	0.00319163	0.11973767057045973
RIGID SPINE MUSCULAR DYSTROPHY 1	0.0031835530000000004	0.11943465262502194
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.0031835530000000004	0.11943465262502194
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.0031835530000000004	0.11943465262502194
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.003077884	0.11547035854597458
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.003077884	0.11547035854597458
FETAL HYDANTOIN SYNDROME	0.003077884	0.11547035854597458
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.003077884	0.11547035854597458
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.0030737489999999998	0.11531522926475811
XERODERMA PIGMENTOSUM	0.0030737489999999998	0.11531522926475811
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.0030737489999999998	0.11531522926475811
XQ27.3Q28 DUPLICATION SYNDROME	0.003059544	0.11478231235068807
KALLMANN SYNDROME	0.0030554090000000002	0.11462718306947163
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.0030554090000000002	0.11462718306947163
DISTAL TRISOMY 15Q	0.0030554090000000002	0.11462718306947163
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.003051613	0.11448477176318442
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.003051613	0.11448477176318442
MAN1B1-CDG	0.003051613	0.11448477176318442
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.003051613	0.11448477176318442
PETTIGREW SYNDROME	0.0030435360000000003	0.11418175381774665
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.0030435360000000003	0.11418175381774665
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.0030435360000000003	0.11418175381774665
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.0030178740000000003	0.11321901437044882
ISOLATED COMPLEX I DEFICIENCY	0.0030178740000000003	0.11321901437044882
TETRASOMY X	0.0030178740000000003	0.11321901437044882
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.003014694	0.11309971301270558
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.003014694	0.11309971301270558
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.003014694	0.11309971301270558
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.003014694	0.11309971301270558
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.003014694	0.11309971301270558
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.003014694	0.11309971301270558
LEIGH SYNDROME	0.003013739	0.11306388508923236
CONGENITAL RUBELLA SYNDROME	0.003013739	0.11306388508923236
DYSEQUILIBRIUM SYNDROME	0.003013739	0.11306388508923236
GYRATE ATROPHY OF CHOROID AND RETINA	0.003010559	0.11294458373148912
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.0029845740000000003	0.11196972656766582
SPINOCEREBELLAR ATAXIA TYPE 7	0.0029845740000000003	0.11196972656766582
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.0029845740000000003	0.11196972656766582
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.0029845740000000003	0.11196972656766582
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.0029845740000000003	0.11196972656766582
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.0029845740000000003	0.11196972656766582
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.0029845740000000003	0.11196972656766582
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.0029845740000000003	0.11196972656766582
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.0029845740000000003	0.11196972656766582
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.0029845740000000003	0.11196972656766582
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.002980439	0.11181459728644937
LIPOID PROTEINOSIS	0.002980439	0.11181459728644937
ECTODERMAL DYSPLASIA SYNDROME	0.002980439	0.11181459728644937
MYASTHENIA GRAVIS	0.002980439	0.11181459728644937
ALZHEIMER DISEASE 3; AD	0.002980439	0.11181459728644937
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.002980439	0.11181459728644937
GAUCHER DISEASE TYPE 1	0.00296736	0.11132392355754249
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00296736	0.11132392355754249
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.00296736	0.11132392355754249
CEREBROCOSTOMANDIBULAR SYNDROME	0.00296736	0.11132392355754249
IDIOPATHIC JUVENILE OSTEOPOROSIS	0.00296736	0.11132392355754249
SPONDYLOENCHONDRODYSPLASIA	0.00296736	0.11132392355754249
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00296736	0.11132392355754249
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1	0.00296736	0.11132392355754249
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00296736	0.11132392355754249
ALKAPTONURIA	0.00296736	0.11132392355754249
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.00296736	0.11132392355754249
HEART DEFECTS-LIMB SHORTENING SYNDROME	0.00296736	0.11132392355754249
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.00296736	0.11132392355754249
SCHEUERMANN DISEASE	0.00296736	0.11132392355754249
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.00296736	0.11132392355754249
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.00296736	0.11132392355754249
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00296736	0.11132392355754249
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.00296736	0.11132392355754249
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.00296736	0.11132392355754249
OROFACIODIGITAL SYNDROME III	0.00296736	0.11132392355754249
SPONDYLOPERIPHERAL DYSPLASIA	0.00296736	0.11132392355754249
RHIZOMELIC SYNDROME, URBACH TYPE	0.00296736	0.11132392355754249
MUCOPOLYSACCHARIDOSIS TYPE 6	0.00296736	0.11132392355754249
MYOPATHY, MYOFIBRILLAR, 7; MFM7	0.00296736	0.11132392355754249
FAMILIAL SCHEUERMANN DISEASE	0.00296736	0.11132392355754249
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.00296736	0.11132392355754249
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.00296736	0.11132392355754249
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B	0.00296736	0.11132392355754249
MCCUNE-ALBRIGHT SYNDROME	0.00296736	0.11132392355754249
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.00296736	0.11132392355754249
300106 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED;;SEMD, X-LINKED; SEMDX	0.00296736	0.11132392355754249
SHELDON-HALL SYNDROME	0.002959665	0.11103523678149399
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.002959665	0.11103523678149399
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.002959665	0.11103523678149399
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.002959665	0.11103523678149399
FRONTOMETAPHYSEAL DYSPLASIA	0.002959665	0.11103523678149399
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.002959665	0.11103523678149399
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.0029551939999999995	0.11086750207379899
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.0029551939999999995	0.11086750207379899
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.0029551939999999995	0.11086750207379899
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.0029551939999999995	0.11086750207379899
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.0029551939999999995	0.11086750207379899
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.0029551939999999995	0.11086750207379899
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.0029551939999999995	0.11086750207379899
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.0029551939999999995	0.11086750207379899
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.0029551939999999995	0.11086750207379899
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.0029551939999999995	0.11086750207379899
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.0029551939999999995	0.11086750207379899
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.0029551939999999995	0.11086750207379899
FAMILIAL MULTIPLE LIPOMATOSIS	0.002951059	0.11071237279258256
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.002951059	0.11071237279258256
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.002951059	0.11071237279258256
20Q13.33 MICRODELETION SYNDROME	0.002951059	0.11071237279258256
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.002951059	0.11071237279258256
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.002951059	0.11071237279258256
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.002926178	0.10977893345861728
MOSAIC TRISOMY 9	0.002827579	0.10607987856172235
WEAVER SYNDROME	0.002827579	0.10607987856172235
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.002827579	0.10607987856172235
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.002827579	0.10607987856172235
KAPUR-TORIELLO SYNDROME	0.002823444	0.10592474928050591
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.002813124	0.10553758261009388
RABSON-MENDENHALL SYNDROME	0.002813124	0.10553758261009388
OTOFACIOCERVICAL SYNDROME	0.002813124	0.10553758261009388
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.002813124	0.10553758261009388
EDINBURGH MALFORMATION SYNDROME	0.002808989	0.10538245332887744
EPILEPSY-TELANGIECTASIA SYNDROME	0.002808989	0.10538245332887744
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.0027940919999999998	0.10482357523884563
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.0027940919999999998	0.10482357523884563
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.0027940919999999998	0.10482357523884563
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.0027859090000000005	0.1045165805814831
GAPO SYNDROME; GAPOS	0.002781774	0.10436145130026661
FRIED SYNDROME	0.002767569	0.10382853438619659
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.002767569	0.10382853438619659
GERODERMA OSTEODYSPLASTICA	0.002767569	0.10382853438619659
ISOLATED SPINA BIFIDA	0.0027634340000000004	0.10367340510498015
X-LINKED CENTRONUCLEAR MYOPATHY	0.0027634340000000004	0.10367340510498015
CENTRONUCLEAR MYOPATHY	0.0027634340000000004	0.10367340510498015
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.002752422	0.10326027725860638
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.002752422	0.10326027725860638
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.002752422	0.10326027725860638
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.002752422	0.10326027725860638
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.002752422	0.10326027725860638
COFFIN-SIRIS SYNDROME 7; CSS7	0.002752422	0.10326027725860638
JOUBERT SYNDROME 14	0.002752422	0.10326027725860638
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.0027482870000000003	0.10310514797738993
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.0027482870000000003	0.10310514797738993
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.0027340820000000005	0.1025722310633199
GALACTOSE EPIMERASE DEFICIENCY	0.0027340820000000005	0.1025722310633199
JOUBERT SYNDROME 8	0.0027340820000000005	0.1025722310633199
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.0027340820000000005	0.1025722310633199
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.002734082	0.10257223106331988
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.002734082	0.10257223106331988
ARIMA SYNDROME	0.002734082	0.10257223106331988
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.002734082	0.10257223106331988
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.002734082	0.10257223106331988
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.002734082	0.10257223106331988
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.002734082	0.10257223106331988
JOUBERT SYNDROME 6	0.002734082	0.10257223106331988
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.002734082	0.10257223106331988
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.002734082	0.10257223106331988
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.002734082	0.10257223106331988
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.002734082	0.10257223106331988
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.002734082	0.10257223106331988
NIEMANN-PICK DISEASE, TYPE A	0.002734082	0.10257223106331988
METHYLMALONIC ACIDURIA, CBLB TYPE	0.002734082	0.10257223106331988
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.002734082	0.10257223106331988
HYPOTONIA-CYSTINURIA SYNDROME	0.002734082	0.10257223106331988
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.002729947	0.10241710178210343
NEURAMINIDASE DEFICIENCY	0.002729947	0.10241710178210343
MAPLE SYRUP URINE DISEASE; MSUD	0.002729947	0.10241710178210343
GLUTARIC ACIDEMIA I; GA1	0.002729947	0.10241710178210343
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.002729947	0.10241710178210343
XYLOSIDASE DEFICIENCY	0.002729947	0.10241710178210343
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.002729947	0.10241710178210343
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00253233	0.09500327272136566
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.00253233	0.09500327272136566
FLOATING-HARBOR SYNDROME	0.00253233	0.09500327272136566
SCARF SYNDROME	0.00253233	0.09500327272136566
SECKEL SYNDROME 5; SCKL5	0.00253233	0.09500327272136566
ELLIS VAN CREVELD SYNDROME	0.00253233	0.09500327272136566
X-LINKED INTELLECTUAL DISABILITY-DANDY-WALKER MALFORMATION-BASAL GANGLIA DISEASE-SEIZURES SYNDROME	0.00253233	0.09500327272136566
FANCONI ANEMIA	0.00253233	0.09500327272136566
CATARACT-INTELLECTUAL DISABILITY-ANAL ATRESIA-URINARY DEFECTS SYNDROME	0.00253233	0.09500327272136566
MATTHEW-WOOD SYNDROME	0.00251399	0.09431522652607914
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.00251399	0.09431522652607914
VELOCARDIOFACIAL SYNDROME	0.00251399	0.09431522652607914
ANIRIDIA-ABSENT PATELLA SYNDROME	0.00251399	0.09431522652607914
IMAGE SYNDROME	0.00251399	0.09431522652607914
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.00251399	0.09431522652607914
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.0025101940000000003	0.09417281521979196
ZECHI-CEIDE SYNDROME	0.0025101940000000003	0.09417281521979196
TRISOMY 12P	0.0025101940000000003	0.09417281521979196
JOUBERT SYNDROME 10	0.0025101940000000003	0.09417281521979196
SYNDROMIC DIARRHEA	0.0025101940000000003	0.09417281521979196
HEREDITARY OROTIC ACIDURIA	0.0025101940000000003	0.09417281521979196
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.0025101940000000003	0.09417281521979196
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.0025101940000000003	0.09417281521979196
ZLOTOGORA-OGUR SYNDROME	0.002506059	0.0940176859385755
HENNEKAM SYNDROME	0.002506059	0.0940176859385755
IMMUNODEFICIENCY 23; IMD23	0.002502117	0.09386979727435414
SHWACHMAN-DIAMOND SYNDROME	0.002502117	0.09386979727435414
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.002502117	0.09386979727435414
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.002502117	0.09386979727435414
RIGID SPINE SYNDROME	0.002502117	0.09386979727435414
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.002502117	0.09386979727435414
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.002497982	0.09371466799313771
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.00247232	0.09275192854583988
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00247232	0.09275192854583988
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00246914	0.09263262718809664
WEILL-MARCHESANI SYNDROME 3	0.00246914	0.09263262718809664
CATARACT, AUTOSOMAL DOMINANT, MULTIPLE TYPES 1	0.00246914	0.09263262718809664
%609259 MYOPIA 10; MYP10	0.00246914	0.09263262718809664
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.00246914	0.09263262718809664
BLEPHAROPTOSIS, MYOPIA, AND ECTOPIA LENTIS	0.00246914	0.09263262718809664
MYOPIA 15; MYP15	0.00246914	0.09263262718809664
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.00246914	0.09263262718809664
MICROCORIA, CONGENITAL	0.00246914	0.09263262718809664
LEBER CONGENITAL AMAUROSIS 15; LCA15	0.00246914	0.09263262718809664
%609256 MYOPIA 7; MYP7	0.00246914	0.09263262718809664
SVEINSSON CHORIORETINAL ATROPHY	0.00246914	0.09263262718809664
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00246914	0.09263262718809664
GLAUCOMA 1, OPEN ANGLE, A	0.00246914	0.09263262718809664
EXUDATIVE VITREORETINOPATHY 6; EVR6	0.00246914	0.09263262718809664
%609258 MYOPIA 9; MYP9	0.00246914	0.09263262718809664
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH HYPERCALCIURIA AND NEPHROCALCINOSIS WITH SEVERE OCULAR INVOLVEMENT	0.00246914	0.09263262718809664
GLAUCOMA, PRIMARY OPEN ANGLE	0.00246914	0.09263262718809664
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.00246914	0.09263262718809664
ÅLAND ISLANDS EYE DISEASE	0.00246914	0.09263262718809664
ALPORT SYNDROME, X-LINKED; ATS	0.00246914	0.09263262718809664
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00246914	0.09263262718809664
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00246914	0.09263262718809664
BLUE CONE MONOCHROMACY; BCM	0.00246914	0.09263262718809664
MYOPIA 24, AUTOSOMAL DOMINANT; MYP24	0.00246914	0.09263262718809664
GASTROCUTANEOUS SYNDROME	0.00246914	0.09263262718809664
POLYDACTYLY, POSTAXIAL, WITH PROGRESSIVE MYOPIA	0.00246914	0.09263262718809664
BRITTLE CORNEA SYNDROME 2; BCS2	0.00246914	0.09263262718809664
GLAUCOMA-RELATED PIGMENT DISPERSION SYNDROME; GPDS1	0.00246914	0.09263262718809664
HEMORRHAGIC FEVER-RENAL SYNDROME	0.00246914	0.09263262718809664
RETINAL CAPILLARY MALFORMATION	0.00246914	0.09263262718809664
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00246914	0.09263262718809664
XYLT1-CDG	0.00246914	0.09263262718809664
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.00246914	0.09263262718809664
CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	0.00246914	0.09263262718809664
XP22.3 MICRODELETION SYNDROME	0.00246914	0.09263262718809664
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.00246914	0.09263262718809664
CATARACT, POSTERIOR POLAR, 1 CTPA CATARACT, CONGENITAL TOTAL, INCLUDED	0.00246914	0.09263262718809664
FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, RECESSIVE FORM	0.00246914	0.09263262718809664
USHER SYNDROME TYPE 2	0.00246914	0.09263262718809664
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00246914	0.09263262718809664
BLEPHAROPTOSIS-MYOPIA-ECTOPIA LENTIS SYNDROME	0.00246914	0.09263262718809664
SPONDYLOEPIPHYSEAL DYSPLASIA AND SPONDYLOEPIMETAPHYSEAL DYSPLASIA	0.00246914	0.09263262718809664
STICKLER SYNDROME TYPE 1	0.00246914	0.09263262718809664
CATARACT-MICROCORNEA SYNDROME	0.00246914	0.09263262718809664
RETINAL DYSTROPHY AND OBESITY; RDOB	0.00246914	0.09263262718809664
VAN BOGAERT-HOZAY SYNDROME	0.00246914	0.09263262718809664
MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA	0.00246914	0.09263262718809664
RETINAL DEGENERATION-NANOPHTHALMOS-GLAUCOMA SYNDROME	0.00246914	0.09263262718809664
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.00246914	0.09263262718809664
OPHTHALMOPLEGIA, EXTERNAL, AND MYOPIA	0.00246914	0.09263262718809664
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.00246914	0.09263262718809664
MICROSPHEROPHAKIA WITH HERNIA	0.00246914	0.09263262718809664
MYOPIA, INFANTILE SEVERE	0.00246914	0.09263262718809664
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00246914	0.09263262718809664
MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA; MSPKA	0.00246914	0.09263262718809664
%310460 MYOPIA 1, X-LINKED; MYP1	0.00246914	0.09263262718809664
RETINITIS PIGMENTOSA AND ERYTHROCYTIC MICROCYTOSIS; RPEM	0.00246914	0.09263262718809664
ALAND ISLAND EYE DISEASE	0.00246914	0.09263262718809664
MICROPHTHALMIA, ISOLATED, WITH CORECTOPIA	0.00246914	0.09263262718809664
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.00246914	0.09263262718809664
%609257 MYOPIA 8; MYP8	0.00246914	0.09263262718809664
RETINITIS PIGMENTOSA 1	0.00246914	0.09263262718809664
USHER SYNDROME	0.00246914	0.09263262718809664
SPINOCEREBELLAR DEGENERATION WITH MACULAR CORNEAL DYSTROPHY, CONGENITALCATARACTS, AND MYOPIA	0.00246914	0.09263262718809664
BARDET-BIEDL SYNDROME 21; BBS21	0.00246914	0.09263262718809664
EPIDERMOLYSIS BULLOSA SIMPLEX WITH ANODONTIA/HYPODONTIA	0.00246914	0.09263262718809664
MULTIPLE EPIPHYSEAL DYSPLASIA, BEIGHTON TYPE	0.00246914	0.09263262718809664
SPONDYLO-OCULAR SYNDROME	0.00246914	0.09263262718809664
CONE-ROD DYSTROPHY, X-LINKED, 3	0.00246914	0.09263262718809664
STICKLER SYNDROME TYPE 2	0.00246914	0.09263262718809664
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00246914	0.09263262718809664
RETINITIS PIGMENTOSA 75; RP75	0.00246914	0.09263262718809664
CHOROIDEREMIA	0.00246914	0.09263262718809664
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.00246914	0.09263262718809664
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00243902	0.09150264074305689
GENERALIZED ERUPTIVE KERATOACANTHOMA	0.00243902	0.09150264074305689
ODONTOMA-DYSPHAGIA SYNDROME	0.00243902	0.09150264074305689
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.00243902	0.09150264074305689
NEUROLEPTIC MALIGNANT SYNDROME	0.00243902	0.09150264074305689
PRIMARY PROGRESSIVE FREEZING GAIT	0.00243902	0.09150264074305689
SPINOCEREBELLAR ATAXIA 42	0.00243902	0.09150264074305689
ANAPLASTIC THYROID CARCINOMA	0.00243902	0.09150264074305689
ODONTOMATOSIS-AORTAE ESOPHAGUS STENOSIS SYNDROME	0.00243902	0.09150264074305689
MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE	0.00243902	0.09150264074305689
WILSON DISEASE	0.00243902	0.09150264074305689
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.00243902	0.09150264074305689
DYSTONIA 16	0.00243902	0.09150264074305689
PLUMMER-VINSON SYNDROME	0.00243902	0.09150264074305689
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.00243902	0.09150264074305689
KUFOR-RAKEB SYNDROME	0.00243902	0.09150264074305689
CRYPTOSPORIDIOSIS	0.00243902	0.09150264074305689
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.00243902	0.09150264074305689
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.00243902	0.09150264074305689
RECURRENT RESPIRATORY PAPILLOMATOSIS	0.00243902	0.09150264074305689
VOCAL CORD AND PHARYNGEAL DISTAL MYOPATHY	0.00243902	0.09150264074305689
AUTOSOMAL DOMINANT LIMB-GIRDLE MUSCULAR DYSTROPHY TYPE 1A	0.00243902	0.09150264074305689
VISCERAL MYOPATHY; VSCM	0.00243902	0.09150264074305689
LARYNGEAL ABDUCTOR PARALYSIS	0.00243902	0.09150264074305689
DYSFERLIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R2	0.00243902	0.09150264074305689
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.00243902	0.09150264074305689
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00243902	0.09150264074305689
EOSINOPHILIC GASTROENTERITIS	0.00243902	0.09150264074305689
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00243902	0.09150264074305689
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.00243902	0.09150264074305689
PARATHYROID CARCINOMA	0.00243902	0.09150264074305689
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00243902	0.09150264074305689
FACIAL PALSY, CONGENITAL, WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION; FPVEPD	0.00243902	0.09150264074305689
SPINOCEREBELLAR ATAXIA 44; SCA44	0.00243902	0.09150264074305689
MOHR-TRANEBJAERG SYNDROME	0.00243902	0.09150264074305689
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	0.00243902	0.09150264074305689
CARNEY-STRATAKIS SYNDROME	0.00243902	0.09150264074305689
THYROID LYMPHOMA	0.00243902	0.09150264074305689
PARAMYOTONIA CONGENITA OF VON EULENBURG	0.00243902	0.09150264074305689
PROGRESSIVE SUPRANUCLEAR PALSY	0.00243902	0.09150264074305689
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.00243902	0.09150264074305689
AMYOTROPHIC LATERAL SCLEROSIS 15 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS15	0.00243902	0.09150264074305689
TOXIC EPIDERMAL NECROLYSIS	0.00243902	0.09150264074305689
AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24; ALS24	0.00243902	0.09150264074305689
SPINOCEREBELLAR ATAXIA TYPE 36	0.00243902	0.09150264074305689
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.00243902	0.09150264074305689
ESOPHAGITIS, EOSINOPHILIC, 1; EOE1	0.00243902	0.09150264074305689
ALPHA-B CRYSTALLIN-RELATED LATE-ONSET MYOPATHY	0.00243902	0.09150264074305689
PARKINSON DISEASE 20, EARLY-ONSET; PARK20	0.00243902	0.09150264074305689
MYASTHENIA GRAVIS; MG	0.00243902	0.09150264074305689
FACIAL ONSET SENSORY AND MOTOR NEURONOPATHY	0.00243902	0.09150264074305689
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00243902	0.09150264074305689
AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2	0.00243902	0.09150264074305689
MYOTONIA PERMANENS	0.00243902	0.09150264074305689
KINDLER SYNDROME	0.00243902	0.09150264074305689
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.00243902	0.09150264074305689
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.00243902	0.09150264074305689
MYOTONIA FLUCTUANS	0.00243902	0.09150264074305689
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00243902	0.09150264074305689
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00243902	0.09150264074305689
ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME	0.00243902	0.09150264074305689
WOUND BOTULISM	0.00243902	0.09150264074305689
BOTULISM	0.00243902	0.09150264074305689
%601846 VACUOLAR NEUROMYOPATHY;;MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT, WITH RIMMED VACUOLES; MDRV	0.00243902	0.09150264074305689
ESOPHAGEAL RING, LOWER	0.00243902	0.09150264074305689
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.00243902	0.09150264074305689
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00243902	0.09150264074305689
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3	0.00243902	0.09150264074305689
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4	0.00243902	0.09150264074305689
JUVENILE PRIMARY LATERAL SCLEROSIS	0.00243902	0.09150264074305689
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00243902	0.09150264074305689
MACHADO-JOSEPH DISEASE; MJD	0.00243902	0.09150264074305689
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E	0.00243902	0.09150264074305689
GAMMA-HEAVY CHAIN DISEASE	0.00243902	0.09150264074305689
STEVENS-JOHNSON SYNDROME	0.00243902	0.09150264074305689
HEREDITARY ANGIOEDEMA TYPE 1	0.00243902	0.09150264074305689
WILD TYPE ABETA2M AMYLOIDOSIS	0.00243902	0.09150264074305689
PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ	0.00243902	0.09150264074305689
TOXIN-MEDIATED INFECTIOUS BOTULISM	0.00243902	0.09150264074305689
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00243902	0.09150264074305689
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.00243902	0.09150264074305689
ESOPHAGITIS, EOSINOPHILIC, 2; EOE2	0.00243902	0.09150264074305689
POSTPOLIOMYELITIS SYNDROME	0.00243902	0.09150264074305689
SPINOCEREBELLAR ATAXIA 14	0.00243902	0.09150264074305689
FOODBORNE BOTULISM	0.00243902	0.09150264074305689
GENERALIZED DOMINANT DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00243902	0.09150264074305689
PRIMARY LATERAL SCLEROSIS	0.00243902	0.09150264074305689
BULBAR PALSY, PROGRESSIVE, OF CHILDHOOD	0.00243902	0.09150264074305689
PRIMARY PARATHYROID HYPERPLASIA	0.00243902	0.09150264074305689
AUTOSOMAL DOMINANT STRIATAL NEURODEGENERATION	0.00243902	0.09150264074305689
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 31	0.00243902	0.09150264074305689
THYMOMA	0.00243902	0.09150264074305689
HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA,AND PALLIDAL DEGENERATION	0.00243902	0.09150264074305689
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00243902	0.09150264074305689
DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2	0.00243902	0.09150264074305689
ACETAZOLAMIDE-RESPONSIVE MYOTONIA	0.00243902	0.09150264074305689
MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A	0.00243902	0.09150264074305689
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.00243902	0.09150264074305689
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.00243902	0.09150264074305689
INCLUSION BODY MYOSITIS	0.00243902	0.09150264074305689
GASTROINTESTINAL STROMAL TUMOR	0.00243902	0.09150264074305689
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.00243902	0.09150264074305689
SPINOCEREBELLAR ATAXIA 37; SCA37	0.00243902	0.09150264074305689
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.00243902	0.09150264074305689
MEDULLARY THYROID CARCINOMA	0.00243902	0.09150264074305689
SPINOCEREBELLAR ATAXIA 48; SCA48	0.00243902	0.09150264074305689
GOOD SYNDROME	0.00243902	0.09150264074305689
PRIMARY LATERAL SCLEROSIS, ADULT	0.00243902	0.09150264074305689
MYOPATHY, SPHEROID BODY	0.00243902	0.09150264074305689
DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4	0.00243902	0.09150264074305689
SPINOCEREBELLAR ATAXIA TYPE 11	0.00243902	0.09150264074305689
DYSTONIA 16; DYT16	0.00243902	0.09150264074305689
TETANUS	0.00243902	0.09150264074305689
AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	0.00243902	0.09150264074305689
MAST SYNDROME	0.00243902	0.09150264074305689
PLEURAL MESOTHELIOMA	0.00243902	0.09150264074305689
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00243902	0.09150264074305689
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.00243902	0.09150264074305689
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.00243902	0.09150264074305689
SPINOCEREBELLAR ATAXIA TYPE 6	0.00243902	0.09150264074305689
IATROGENIC BOTULISM	0.00243902	0.09150264074305689
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00243902	0.09150264074305689
MADRAS MOTOR NEURON DISEASE	0.00243902	0.09150264074305689
DNAJB6-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY D1	0.00243902	0.09150264074305689
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00243902	0.09150264074305689
SPINOCEREBELLAR ATAXIA TYPE 8	0.00243902	0.09150264074305689
DYSTONIA 12; DYT12	0.00243902	0.09150264074305689
IMMUNODEFICIENCY 58; IMD58	0.00243902	0.09150264074305689
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.00240964	0.09040041624919007
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00240964	0.09040041624919007
MECKEL SYNDROME, TYPE 4; MKS4	0.00240964	0.09040041624919007
ANIRIDIA	0.00240964	0.09040041624919007
%611252 SPASTIC PARAPLEGIA 32, AUTOSOMAL RECESSIVE; SPG32	0.00240964	0.09040041624919007
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.00240964	0.09040041624919007
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 66	0.00240964	0.09040041624919007
CHROMOSOME 13Q14 DELETION SYNDROME	0.00240964	0.09040041624919007
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.00240964	0.09040041624919007
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 32	0.00240964	0.09040041624919007
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 74	0.00240964	0.09040041624919007
LEUKOENCEPHALOPATHY-PALMOPLANTAR KERATODERMA SYNDROME	0.00240964	0.09040041624919007
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.00240964	0.09040041624919007
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.0023739729999999997	0.08906232771880385
17Q12 MICRODELETION SYNDROME	0.0023739729999999997	0.08906232771880385
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.0023739729999999997	0.08906232771880385
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.0023739729999999997	0.08906232771880385
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.0023739729999999997	0.08906232771880385
CATEL-MANZKE SYNDROME; CATMANS	0.0023739729999999997	0.08906232771880385
8P11.2 DELETION SYNDROME	0.0023739729999999997	0.08906232771880385
PITUITARY STALK INTERRUPTION SYNDROME	0.0023739729999999997	0.08906232771880385
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.0023739729999999997	0.08906232771880385
OPTIC PATHWAY GLIOMA	0.002332303	0.08749902973856458
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.002332303	0.08749902973856458
CHROMOSOME 19P13.13 DELETION SYNDROME	0.002332303	0.08749902973856458
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.002332303	0.08749902973856458
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.002332303	0.08749902973856458
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.002332303	0.08749902973856458
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.002332303	0.08749902973856458
CONGENITAL DISORDER OF GLYCOSYLATION	0.002332303	0.08749902973856458
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.002332303	0.08749902973856458
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.002332303	0.08749902973856458
XQ21 MICRODELETION SYNDROME	0.002332303	0.08749902973856458
MENTAL RETARDATION, X-LINKED 101; MRX101	0.002332303	0.08749902973856458
2P21 MICRODELETION SYNDROME	0.002313963	0.0868109835432781
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.002313963	0.0868109835432781
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.002313963	0.0868109835432781
MEVALONIC ACIDURIA	0.002313963	0.0868109835432781
MAPLE SYRUP URINE DISEASE	0.002313963	0.0868109835432781
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.002313963	0.0868109835432781
DPAGT1-CDG	0.002313963	0.0868109835432781
GALACTOSEMIA	0.002313963	0.0868109835432781
15Q11Q13 MICRODUPLICATION SYNDROME	0.002313963	0.0868109835432781
ALG3-CDG	0.002313963	0.0868109835432781
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.002313963	0.0868109835432781
FREE SIALIC ACID STORAGE DISEASE	0.002313963	0.0868109835432781
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.002313963	0.0868109835432781
TRISOMY X	0.002313963	0.0868109835432781
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.002313963	0.0868109835432781
LEBER CONGENITAL AMAUROSIS	0.002313963	0.0868109835432781
TAY-SACHS DISEASE	0.002313963	0.0868109835432781
DISTAL MONOSOMY 19P13.3	0.002313963	0.0868109835432781
MULTIPLE CARBOXYLASE DEFICIENCY	0.002313963	0.0868109835432781
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.002313963	0.0868109835432781
GRISCELLI SYNDROME	0.002313963	0.0868109835432781
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.002313963	0.0868109835432781
DIPHALLIA	0.002282025	0.08561279273711342
PRUNE BELLY SYNDROME	0.002282025	0.08561279273711342
SPONDYLOCOSTAL DYSOSTOSIS-ANAL ATRESIA-GENITOURINARY MALFORMATION SYNDROME	0.002282025	0.08561279273711342
AUTOSOMAL DOMINANT POPLITEAL PTERYGIUM SYNDROME	0.002282025	0.08561279273711342
ISOLATED HEMIHYPERPLASIA	0.002282025	0.08561279273711342
WAGR SYNDROME	0.002282025	0.08561279273711342
FETAL AKINESIA DEFORMATION SEQUENCE	0.002282025	0.08561279273711342
LARSEN SYNDROME	0.002282025	0.08561279273711342
NOONAN SYNDROME 4; NS4	0.002282025	0.08561279273711342
GORDON SYNDROME	0.002282025	0.08561279273711342
CAUDAL REGRESSION SEQUENCE	0.002282025	0.08561279273711342
ACHONDROGENESIS TYPE 1A	0.00226757	0.08507049678548495
CONGENITAL HEART DEFECT-ROUND FACE-DEVELOPMENTAL DELAY SYNDROME	0.00226757	0.08507049678548495
CRANIORHINY	0.00226757	0.08507049678548495
ACHONDROGENESIS TYPE 2	0.00226757	0.08507049678548495
SCALP-EAR-NIPPLE SYNDROME; SENS	0.00226757	0.08507049678548495
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3; HKLLS3	0.00226757	0.08507049678548495
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00226757	0.08507049678548495
ACHONDROGENESIS TYPE 1B	0.00226757	0.08507049678548495
FIBROCHONDROGENESIS 2; FBCG2	0.00226757	0.08507049678548495
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00226757	0.08507049678548495
ACHONDROGENESIS	0.00226757	0.08507049678548495
DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	0.00226757	0.08507049678548495
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00226757	0.08507049678548495
FEINGOLD SYNDROME	0.00226757	0.08507049678548495
THREE M SYNDROME 2; 3M2	0.00226757	0.08507049678548495
CHUDLEY-LOWRY-HOAR SYNDROME	0.00226757	0.08507049678548495
HYDROPS FETALIS, NONIMMUNE, WITH GRACILE BONES AND DYSMORPHIC FEATURES	0.00226757	0.08507049678548495
FIBROCHONDROGENESIS 1; FBCG1	0.00226757	0.08507049678548495
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00226757	0.08507049678548495
227320 FACIOTHORACOGENITAL SYNDROME	0.00226757	0.08507049678548495
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.00226757	0.08507049678548495
ACROMICRIC DYSPLASIA	0.00226757	0.08507049678548495
NEONATAL HEMOCHROMATOSIS	0.00226757	0.08507049678548495
RAMOS-ARROYO SYNDROME	0.00226757	0.08507049678548495
RHINY	0.00226757	0.08507049678548495
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.00226757	0.08507049678548495
RING CHROMOSOME 8 SYNDROME	0.00226757	0.08507049678548495
INTELLECTUAL DISABILITY-SHORT STATURE-HYPERTELORISM SYNDROME	0.00226757	0.08507049678548495
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.00226757	0.08507049678548495
OTODENTAL DYSPLASIA	0.00226757	0.08507049678548495
FAMILIAL INTESTINAL MALROTATION	0.00226757	0.08507049678548495
RHOMBENCEPHALOSYNAPSIS	0.00226757	0.08507049678548495
OTODENTAL SYNDROME	0.00226757	0.08507049678548495
ACROMICRIC DYSPLASIA	0.00226757	0.08507049678548495
FAMILIAL VISCERAL MYOPATHY	0.00226757	0.08507049678548495
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.002248538	0.08435648941423672
SIFRIM-HITZ-WEISS SYNDROME	0.002248538	0.08435648941423672
X-LINKED MYOTUBULAR MYOPATHY-ABNORMAL GENITALIA SYNDROME	0.002248538	0.08435648941423672
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.002248538	0.08435648941423672
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.002248538	0.08435648941423672
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.002248538	0.08435648941423672
SPINOCEREBELLAR ATAXIA TYPE 25	0.0022403550000000003	0.08404949475687416
IVIC SYNDROME	0.0022403550000000003	0.08404949475687416
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.0022403550000000003	0.08404949475687416
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.0022403550000000003	0.08404949475687416
LERI PLEONOSTEOSIS	0.0022403550000000003	0.08404949475687416
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.0022403550000000003	0.08404949475687416
IVIC SYNDROME	0.0022403550000000003	0.08404949475687416
AASE-SMITH SYNDROME	0.0022403550000000003	0.08404949475687416
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.0022403550000000003	0.08404949475687416
ODONTOCHONDRODYSPLASIA	0.0022403550000000003	0.08404949475687416
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.0022403550000000003	0.08404949475687416
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.002222015	0.08336144856158766
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.002222015	0.08336144856158766
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.002222015	0.08336144856158766
FRYNS-SMEETS-THIRY SYNDROME	0.002222015	0.08336144856158766
PURE MITOCHONDRIAL MYOPATHY	0.002222015	0.08336144856158766
MUCOPOLYSACCHARIDOSIS TYPE 7	0.002222015	0.08336144856158766
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.002206868	0.08279319143399745
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.002206868	0.08279319143399745
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.002206868	0.08279319143399745
ARTERIAL TORTUOSITY SYNDROME	0.0021885280000000003	0.08210514523871097
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.0021885280000000003	0.08210514523871097
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.0021885280000000003	0.08210514523871097
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.0021885280000000003	0.08210514523871097
JOUBERT SYNDROME 5	0.0021885280000000003	0.08210514523871097
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.0021885280000000003	0.08210514523871097
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	0.0021885280000000003	0.08210514523871097
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.0021885280000000003	0.08210514523871097
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.0021885280000000003	0.08210514523871097
ATONIC-ASTATIC SYNDROME OF FOERSTER	0.0021885280000000003	0.08210514523871097
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.0021885280000000003	0.08210514523871097
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.0021885280000000003	0.08210514523871097
GLYCOGEN STORAGE DISEASE IXC	0.0021885280000000003	0.08210514523871097
LYSINURIC PROTEIN INTOLERANCE; LPI	0.0021885280000000003	0.08210514523871097
SPINOCEREBELLAR ATAXIA 13	0.0021885280000000003	0.08210514523871097
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.0021885280000000003	0.08210514523871097
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.0021885280000000003	0.08210514523871097
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.0021885280000000003	0.08210514523871097
PIERSON SYNDROME	0.0021885280000000003	0.08210514523871097
CEREBELLAR HYPOPLASIA	0.0021885280000000003	0.08210514523871097
GLYCOGEN STORAGE DISEASE IV	0.0021885280000000003	0.08210514523871097
GLYCOGEN STORAGE DISEASE II	0.0021885280000000003	0.08210514523871097
PORPHYRIA, ACUTE HEPATIC	0.0021885280000000003	0.08210514523871097
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.0021885280000000003	0.08210514523871097
NEMALINE MYOPATHY 7; NEM7	0.0021885280000000003	0.08210514523871097
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.0021885280000000003	0.08210514523871097
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.0021885280000000003	0.08210514523871097
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.0021885280000000003	0.08210514523871097
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.0021885280000000003	0.08210514523871097
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.0021885280000000003	0.08210514523871097
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.0021885280000000003	0.08210514523871097
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.0021885280000000003	0.08210514523871097
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.0021885280000000003	0.08210514523871097
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.002081998	0.07810854975431236
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.002081998	0.07810854975431236
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.002081998	0.07810854975431236
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.002081998	0.07810854975431236
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.002081998	0.07810854975431236
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.0020485110000000003	0.07685224643143568
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.0020485110000000003	0.07685224643143568
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.0020485110000000003	0.07685224643143568
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.0020485110000000003	0.07685224643143568
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.0020485110000000003	0.07685224643143568
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.0020485110000000003	0.07685224643143568
INFANTILE LIVER FAILURE SYNDROME 1	0.0020485110000000003	0.07685224643143568
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.0020485110000000003	0.07685224643143568
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.0020485110000000003	0.07685224643143568
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.0020485110000000003	0.07685224643143568
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.0020485110000000003	0.07685224643143568
N-ACETYLASPARTATE DEFICIENCY; NACED	0.0020485110000000003	0.07685224643143568
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.0020485110000000003	0.07685224643143568
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.0020485110000000003	0.07685224643143568
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.0020485110000000003	0.07685224643143568
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.0020485110000000003	0.07685224643143568
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.0020485110000000003	0.07685224643143568
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.0020485110000000003	0.07685224643143568
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.0020485110000000003	0.07685224643143568
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.0020485110000000003	0.07685224643143568
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.0020485110000000003	0.07685224643143568
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.0020485110000000003	0.07685224643143568
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.0020485110000000003	0.07685224643143568
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.0020485110000000003	0.07685224643143568
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.0020485110000000003	0.07685224643143568
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.0020485110000000003	0.07685224643143568
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.0020485110000000003	0.07685224643143568
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.0020485110000000003	0.07685224643143568
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.0020485110000000003	0.07685224643143568
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.0020485110000000003	0.07685224643143568
IMMUNODEFICIENCY 49; IMD49	0.0020485110000000003	0.07685224643143568
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.0020485110000000003	0.07685224643143568
SULFOCYSTEINURIA	0.0020485110000000003	0.07685224643143568
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.0020485110000000003	0.07685224643143568
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.0020485110000000003	0.07685224643143568
TIMOTHY SYNDROME; TS	0.0020485110000000003	0.07685224643143568
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.0020485110000000003	0.07685224643143568
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.0020485110000000003	0.07685224643143568
LUSCAN-LUMISH SYNDROME; LLS	0.0020485110000000003	0.07685224643143568
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.0020485110000000003	0.07685224643143568
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.0020485110000000003	0.07685224643143568
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.0020485110000000003	0.07685224643143568
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.0020485110000000003	0.07685224643143568
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.0020485110000000003	0.07685224643143568
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.0020485110000000003	0.07685224643143568
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.0020485110000000003	0.07685224643143568
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.0020485110000000003	0.07685224643143568
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.0020485110000000003	0.07685224643143568
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.0020485110000000003	0.07685224643143568
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.0020485110000000003	0.07685224643143568
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.0020485110000000003	0.07685224643143568
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.0020485110000000003	0.07685224643143568
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.0020485110000000003	0.07685224643143568
GRISCELLI SYNDROME TYPE 1	0.0020485110000000003	0.07685224643143568
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.0020485110000000003	0.07685224643143568
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.0020485110000000003	0.07685224643143568
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.0020485110000000003	0.07685224643143568
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.0020485110000000003	0.07685224643143568
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.0020485110000000003	0.07685224643143568
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.0020485110000000003	0.07685224643143568
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.0020485110000000003	0.07685224643143568
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.0020485110000000003	0.07685224643143568
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.0020485110000000003	0.07685224643143568
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.0020485110000000003	0.07685224643143568
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.0020485110000000003	0.07685224643143568
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.0020485110000000003	0.07685224643143568
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.0020485110000000003	0.07685224643143568
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.00196464	0.07370572939518302
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.00196464	0.07370572939518302
PFEIFFER SYNDROME	0.00196464	0.07370572939518302
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.00196464	0.07370572939518302
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.00196464	0.07370572939518302
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.00196464	0.07370572939518302
MULIBREY NANISM	0.00196464	0.07370572939518302
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00196464	0.07370572939518302
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.00196464	0.07370572939518302
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00196464	0.07370572939518302
ZECHI-CEIDE SYNDROME	0.00196464	0.07370572939518302
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE SYNDROME	0.00196464	0.07370572939518302
OTOPALATODIGITAL SYNDROME TYPE 1	0.00196464	0.07370572939518302
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.00196464	0.07370572939518302
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00196464	0.07370572939518302
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.00196464	0.07370572939518302
RING CHROMOSOME 6 SYNDROME	0.00196464	0.07370572939518302
CRANIODIAPHYSEAL DYSPLASIA	0.00196464	0.07370572939518302
600736 VELOFACIOSKELETAL SYNDROME	0.00196464	0.07370572939518302
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.00196464	0.07370572939518302
HYPERTELORISM, TEEBI TYPE; TBHS	0.00196464	0.07370572939518302
ISOLATED TRIGONOCEPHALY	0.00196464	0.07370572939518302
ADULT SYNDROME	0.00196464	0.07370572939518302
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.00196464	0.07370572939518302
608028 THAI SYMPHALANGISM SYNDROME	0.00196464	0.07370572939518302
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.00196464	0.07370572939518302
DEAFNESS-CRANIOFACIAL SYNDROME	0.00196464	0.07370572939518302
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00196464	0.07370572939518302
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.00196464	0.07370572939518302
BOOMERANG DYSPLASIA	0.00196464	0.07370572939518302
OCULOMAXILLOFACIAL DYSOSTOSIS	0.00196464	0.07370572939518302
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.00196464	0.07370572939518302
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.00196464	0.07370572939518302
MEGALENCEPHALY	0.00196464	0.07370572939518302
DIAMOND-BLACKFAN ANEMIA 8	0.00196464	0.07370572939518302
CHARLIE M SYNDROME	0.00196464	0.07370572939518302
DEAFNESS-CRANIOFACIAL SYNDROME	0.00196464	0.07370572939518302
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00196464	0.07370572939518302
BRACHYDACTYLY-PREAXIAL HALLUX VARUS SYNDROME	0.00196464	0.07370572939518302
DILATED CARDIOMYOPATHY-HYPERGONADOTROPIC HYPOGONADISM SYNDROME	0.00196464	0.07370572939518302
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00196464	0.07370572939518302
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.001956563	0.07340271144974524
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.001956563	0.07340271144974524
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.001956563	0.07340271144974524
GIANT AXONAL NEUROPATHY	0.001956563	0.07340271144974524
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.001956563	0.07340271144974524
MICROTRIPLICATION 11Q24.1	0.001956563	0.07340271144974524
OSTEOGENESIS IMPERFECTA, TYPE X	0.001956563	0.07340271144974524
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.001956563	0.07340271144974524
CLASSIC MULTIMINICORE MYOPATHY	0.001956563	0.07340271144974524
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.001956563	0.07340271144974524
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.001956563	0.07340271144974524
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.001956563	0.07340271144974524
MYASTHENIC SYNDROME, CONGENITAL, 13	0.001956563	0.07340271144974524
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.001956563	0.07340271144974524
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.001956563	0.07340271144974524
LIG4 SYNDROME	0.001832554	0.06875037117541137
MCKUSICK-KAUFMAN SYNDROME	0.001832554	0.06875037117541137
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.001832554	0.06875037117541137
PSEUDOAMINOPTERIN SYNDROME	0.001832554	0.06875037117541137
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.001832554	0.06875037117541137
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.001832554	0.06875037117541137
CHROMOSOME 15Q25 DELETION SYNDROME	0.001832554	0.06875037117541137
ALAZAMI-YUAN SYNDROME	0.001832554	0.06875037117541137
NOONAN SYNDROME 2; NS2	0.001832554	0.06875037117541137
7P22.1 MICRODUPLICATION SYNDROME	0.001832554	0.06875037117541137
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.001832554	0.06875037117541137
EAR-PATELLA-SHORT STATURE SYNDROME	0.001832554	0.06875037117541137
NOONAN SYNDROME 5; NS5	0.001832554	0.06875037117541137
MENTAL RETARDATION, X-LINKED 106; MRX106	0.001832554	0.06875037117541137
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.001832554	0.06875037117541137
%300712 CRANIOFACIOSKELETAL SYNDROME	0.001832554	0.06875037117541137
NOONAN SYNDROME 9; NS9	0.001832554	0.06875037117541137
CULLER-JONES SYNDROME; CJS	0.001832554	0.06875037117541137
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.001832554	0.06875037117541137
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.001828419	0.06859524189419494
SANJAD-SAKATI SYNDROME	0.001828419	0.06859524189419494
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.001828419	0.06859524189419494
47,XYY SYNDROME	0.001828419	0.06859524189419494
RETINITIS PIGMENTOSA 59; RP59	0.001828419	0.06859524189419494
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.001828419	0.06859524189419494
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.001828419	0.06859524189419494
224250 DYSMYELINATION WITH JAUNDICE	0.001828419	0.06859524189419494
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.001790884	0.06718707319517211
THAUVIN-ROBINET-FAIVRE SYNDROME	0.001790884	0.06718707319517211
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.001790884	0.06718707319517211
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.001790884	0.06718707319517211
NEPHRONOPHTHISIS 11; NPHP11	0.001790884	0.06718707319517211
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.001790884	0.06718707319517211
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.001790884	0.06718707319517211
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.001790884	0.06718707319517211
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.001790884	0.06718707319517211
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.001790884	0.06718707319517211
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.001790884	0.06718707319517211
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.001790884	0.06718707319517211
SENIOR-LOKEN SYNDROME 9	0.001790884	0.06718707319517211
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.001790884	0.06718707319517211
DISTAL TRISOMY 6P	0.001790884	0.06718707319517211
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.001790884	0.06718707319517211
RICHARDS-RUNDLE SYNDROME; RRNS	0.001790884	0.06718707319517211
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.001786749	0.06703194391395567
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.001786749	0.06703194391395567
CONGENITAL HYDROCEPHALUS	0.001786749	0.06703194391395567
MENTAL RETARDATION, X-LINKED 21	0.001786749	0.06703194391395567
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.001786749	0.06703194391395567
RENPENNING SYNDROME	0.001786749	0.06703194391395567
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.001786749	0.06703194391395567
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.001786749	0.06703194391395567
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.001786749	0.06703194391395567
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.001786749	0.06703194391395567
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.001786749	0.06703194391395567
GAUCHER DISEASE, TYPE IIIC	0.001786749	0.06703194391395567
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.001786749	0.06703194391395567
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.001786749	0.06703194391395567
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.001772544	0.06649902699988562
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.001772544	0.06649902699988562
THYROID ECTOPIA	0.001772544	0.06649902699988562
ATHYREOSIS	0.001772544	0.06649902699988562
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.001772544	0.06649902699988562
GALACTOSE EPIMERASE DEFICIENCY	0.001772544	0.06649902699988562
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.001772544	0.06649902699988562
ALG6-CDG	0.001772544	0.06649902699988562
FAMILIAL THYROID DYSHORMONOGENESIS	0.001772544	0.06649902699988562
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.001772544	0.06649902699988562
THYROID HEMIAGENESIS	0.001772544	0.06649902699988562
THYROID HYPOPLASIA	0.001772544	0.06649902699988562
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.001772544	0.06649902699988562
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.001772544	0.06649902699988562
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.001772544	0.06649902699988562
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.001772544	0.06649902699988562
TRANSKETOLASE DEFICIENCY	0.001772544	0.06649902699988562
WAARDENBURG-SHAH SYNDROME	0.001772544	0.06649902699988562
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.001772544	0.06649902699988562
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.001772544	0.06649902699988562
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.001772544	0.06649902699988562
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.001772544	0.06649902699988562
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.001772544	0.06649902699988562
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.001772544	0.06649902699988562
THANATOPHORIC DYSPLASIA, TYPE I	0.001772544	0.06649902699988562
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.001772544	0.06649902699988562
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.001772544	0.06649902699988562
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.001772544	0.06649902699988562
1P36 MICRODELETION SYNDROME	0.001768409	0.06634389771866918
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.001768409	0.06634389771866918
HYPOPHOSPHATASIA	0.001768409	0.06634389771866918
FAMILIAL COLORECTAL CANCER TYPE X	0.001768409	0.06634389771866918
MPDU1-CDG	0.001768409	0.06634389771866918
ACUTE ADRENAL INSUFFICIENCY	0.001768409	0.06634389771866918
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.001768409	0.06634389771866918
INFANTILE NEUROAXONAL DYSTROPHY	0.001768409	0.06634389771866918
ALG9-CDG	0.001768409	0.06634389771866918
TRIPLE A SYNDROME	0.001768409	0.06634389771866918
ONDINE SYNDROME	0.001768409	0.06634389771866918
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.001768409	0.06634389771866918
CAMOS SYNDROME	0.001768409	0.06634389771866918
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.001768409	0.06634389771866918
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001768409	0.06634389771866918
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.001768409	0.06634389771866918
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.001768409	0.06634389771866918
KRABBE DISEASE	0.001768409	0.06634389771866918
WOLF-HIRSCHHORN SYNDROME	0.001768409	0.06634389771866918
BETA-KETOTHIOLASE DEFICIENCY	0.001768409	0.06634389771866918
CRIGLER-NAJJAR SYNDROME	0.001768409	0.06634389771866918
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.001768409	0.06634389771866918
LYNCH SYNDROME	0.001768409	0.06634389771866918
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.001768409	0.06634389771866918
BENIGN FAMILIAL INFANTILE EPILEPSY	0.001768409	0.06634389771866918
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.001768409	0.06634389771866918
CEREBELLOFACIODENTAL SYNDROME	0.001540579	0.05779659321091989
HYPERMANGANESEMIA WITH DYSTONIA 2	0.001540579	0.05779659321091989
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.001540579	0.05779659321091989
OTOPALATODIGITAL SYNDROME TYPE 2	0.001540579	0.05779659321091989
OCULOFACIOCARDIODENTAL SYNDROME	0.001540579	0.05779659321091989
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.001540579	0.05779659321091989
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.001540579	0.05779659321091989
DUCHENNE MUSCULAR DYSTROPHY	0.001540579	0.05779659321091989
ATYPICAL JUVENILE PARKINSONISM	0.001536444	0.05764146392970345
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.001536444	0.05764146392970345
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.001536444	0.05764146392970345
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.001536444	0.05764146392970345
FRAGILE X MENTAL RETARDATION SYNDROME	0.001536444	0.05764146392970345
RETT SYNDROME	0.001536444	0.05764146392970345
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.001536444	0.05764146392970345
TETRASOMY 18P	0.001536444	0.05764146392970345
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.001536444	0.05764146392970345
NEUROFIBROMATOSIS, TYPE I	0.001536444	0.05764146392970345
NEVUS COMEDONICUS SYNDROME	0.001536444	0.05764146392970345
FAMILIAL MULTIPLE NEVI FLAMMEI	0.001536444	0.05764146392970345
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.001536444	0.05764146392970345
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.001507092	0.05654028988804318
SPINOCEREBELLAR ATAXIA TYPE 29	0.001507092	0.05654028988804318
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.001507092	0.05654028988804318
NOONAN SYNDROME 11; NS11	0.001507092	0.05654028988804318
CEREBELLAR ATAXIA, CAYMAN TYPE	0.001507092	0.05654028988804318
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.001507092	0.05654028988804318
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.001507092	0.05654028988804318
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.001507092	0.05654028988804318
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.001507092	0.05654028988804318
WARSAW BREAKAGE SYNDROME; WABS	0.001507092	0.05654028988804318
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.001507092	0.05654028988804318
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.001507092	0.05654028988804318
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.001507092	0.05654028988804318
CHROMOSOME 4Q21 DELETION SYNDROME	0.001507092	0.05654028988804318
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.001507092	0.05654028988804318
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.001507092	0.05654028988804318
PEROXISOME BIOGENESIS DISORDER 5B	0.001507092	0.05654028988804318
AL-RAQAD SYNDROME; ARS	0.001507092	0.05654028988804318
JOUBERT SYNDROME 24	0.001507092	0.05654028988804318
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.001507092	0.05654028988804318
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.001507092	0.05654028988804318
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.001507092	0.05654028988804318
SPINOCEREBELLAR ATAXIA 5; SCA5	0.001507092	0.05654028988804318
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.001507092	0.05654028988804318
JOUBERT SYNDROME 25	0.001507092	0.05654028988804318
MENTAL RETARDATION, X-LINKED 99	0.001507092	0.05654028988804318
JOUBERT SYNDROME 28	0.001507092	0.05654028988804318
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.001507092	0.05654028988804318
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.001507092	0.05654028988804318
JOUBERT SYNDROME 27	0.001507092	0.05654028988804318
DESBUQUOIS DYSPLASIA 2; DBQD2	0.001507092	0.05654028988804318
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.001507092	0.05654028988804318
JOUBERT SYNDROME 15	0.001507092	0.05654028988804318
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.001507092	0.05654028988804318
PEROXISOME BIOGENESIS DISORDER 10B	0.001507092	0.05654028988804318
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.001507092	0.05654028988804318
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.001507092	0.05654028988804318
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.001507092	0.05654028988804318
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.001507092	0.05654028988804318
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.001507092	0.05654028988804318
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.001507092	0.05654028988804318
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.001507092	0.05654028988804318
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.001507092	0.05654028988804318
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.001507092	0.05654028988804318
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.001507092	0.05654028988804318
DIAPHANOSPONDYLODYSOSTOSIS	0.001507092	0.05654028988804318
JOUBERT SYNDROME 32; JBTS32	0.001507092	0.05654028988804318
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.001507092	0.05654028988804318
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.001507092	0.05654028988804318
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.001507092	0.05654028988804318
NAVAJO NEUROHEPATOPATHY	0.001507092	0.05654028988804318
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.001502957	0.05638516060682674
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.001502957	0.05638516060682674
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001502957	0.05638516060682674
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.001502957	0.05638516060682674
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.001502957	0.05638516060682674
HUNTINGTON DISEASE-LIKE 1	0.001502957	0.05638516060682674
EPISODIC ATAXIA, TYPE 6	0.001502957	0.05638516060682674
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.001502957	0.05638516060682674
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.001502957	0.05638516060682674
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.001502957	0.05638516060682674
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.001502957	0.05638516060682674
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.001502957	0.05638516060682674
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.001502957	0.05638516060682674
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.001502957	0.05638516060682674
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.001502957	0.05638516060682674
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.001502957	0.05638516060682674
PSEUDO-TORCH SYNDROME 2	0.001502957	0.05638516060682674
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.001502957	0.05638516060682674
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.001502957	0.05638516060682674
TAY-SACHS DISEASE; TSD	0.001502957	0.05638516060682674
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.001502957	0.05638516060682674
SUDDEN CARDIAC FAILURE, INFANTILE	0.001502957	0.05638516060682674
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.001502957	0.05638516060682674
MEACHAM SYNDROME	0.001287	0.04828328535080245
AROMATASE DEFICIENCY	0.001287	0.04828328535080245
MICROPHTHALMIA WITH LIMB ANOMALIES	0.001287	0.04828328535080245
184800 STERNUM, PREMATURE OBLITERATION OF SUTURES OF	0.001287	0.04828328535080245
ABRUZZO-ERICKSON SYNDROME	0.001287	0.04828328535080245
HYPOGONADOTROPIC HYPOGONADISM 22 WITH OR WITHOUT ANOSMIA; HH22	0.001287	0.04828328535080245
TIBIAL HEMIMELIA	0.001287	0.04828328535080245
WT LIMB-BLOOD SYNDROME	0.001287	0.04828328535080245
MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME	0.001287	0.04828328535080245
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.001287	0.04828328535080245
PARTIAL ANDROGEN INSENSITIVITY SYNDROME	0.001287	0.04828328535080245
46,XY DISORDER OF SEX DEVELOPMENT DUE TO ISOLATED 17,20-LYASE DEFICIENCY	0.001287	0.04828328535080245
CONGENITAL ADRENAL HYPERPLASIA DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.001287	0.04828328535080245
BLOOM SYNDROME	0.001287	0.04828328535080245
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.001287	0.04828328535080245
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.001287	0.04828328535080245
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.001287	0.04828328535080245
BARDET-BIEDL SYNDROME	0.001287	0.04828328535080245
BARDET-BIEDL SYNDROME 4; BBS4	0.001287	0.04828328535080245
HYPOSMIA-NASAL AND OCULAR HYPOPLASIA-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.001287	0.04828328535080245
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.001287	0.04828328535080245
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.001287	0.04828328535080245
BOOMERANG DYSPLASIA	0.001287	0.04828328535080245
CONGENITAL ADRENAL HYPERPLASIA	0.001287	0.04828328535080245
PHOCOMELIA, SCHINZEL TYPE	0.001287	0.04828328535080245
ANKYLOBLEPHARON FILIFORME ADNATUM-IMPERFORATE ANUS SYNDROME	0.001287	0.04828328535080245
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.001287	0.04828328535080245
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.001287	0.04828328535080245
KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA	0.001287	0.04828328535080245
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.001287	0.04828328535080245
ICHTHYOSIS, X-LINKED	0.001287	0.04828328535080245
OROFACIAL CLEFT 15	0.001287	0.04828328535080245
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.001287	0.04828328535080245
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.001287	0.04828328535080245
LEYDIG CELL HYPOPLASIA	0.001287	0.04828328535080245
ANDROGEN INSENSITIVITY SYNDROME	0.001287	0.04828328535080245
46,XY DISORDER OF SEX DEVELOPMENT DUE TO 5-ALPHA-REDUCTASE 2 DEFICIENCY	0.001287	0.04828328535080245
46,XY DISORDER OF SEX DEVELOPMENT DUE TO 17-BETA-HYDROXYSTEROID DEHYDROGENASE 3 DEFICIENCY	0.001287	0.04828328535080245
258040 OEIS COMPLEX;;OMPHALOCELE-EXSTROPHY-IMPERFORATE ANUS-SPINAL DEFECTS	0.001287	0.04828328535080245
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.001287	0.04828328535080245
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.001287	0.04828328535080245
THROMBOCYTOPENIA WITH CONGENITAL DYSERYTHROPOIETIC ANEMIA	0.001287	0.04828328535080245
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.001287	0.04828328535080245
ADRENAL HYPOPLASIA, CONGENITAL	0.001287	0.04828328535080245
TESTICULAR GERM CELL TUMOR; TGCT	0.001287	0.04828328535080245
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.001287	0.04828328535080245
OCHOA SYNDROME	0.001287	0.04828328535080245
OLIVER-MCFARLANE SYNDROME	0.001287	0.04828328535080245
LEPRECHAUNISM	0.001287	0.04828328535080245
46,XY PARTIAL GONADAL DYSGENESIS	0.001287	0.04828328535080245
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.001287	0.04828328535080245
N SYNDROME	0.001287	0.04828328535080245
CRANIOSYNOSTOSIS WITH FIBULAR APLASIA	0.001287	0.04828328535080245
AUTOSOMAL RECESSIVE AMELIA	0.001287	0.04828328535080245
ELLIS-VAN CREVELD SYNDROME	0.001287	0.04828328535080245
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.001287	0.04828328535080245
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.001287	0.04828328535080245
RECESSIVE X-LINKED ICHTHYOSIS	0.001287	0.04828328535080245
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.001287	0.04828328535080245
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.001287	0.04828328535080245
LUMBAR SYNDROME	0.001287	0.04828328535080245
COLOBOMA-OBESITY-HYPOGENITALISM-MENTAL RETARDATION SYNDROME	0.001287	0.04828328535080245
UROFACIAL SYNDROME	0.001287	0.04828328535080245
CARDIAC-UROGENITAL SYNDROME; CUGS	0.001287	0.04828328535080245
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.001287	0.04828328535080245
AUTOSOMAL DOMINANT OMODYSPLASIA	0.001287	0.04828328535080245
601095 HARROD SYNDROME	0.001287	0.04828328535080245
PERSISTENT MÜLLERIAN DUCT SYNDROME	0.001287	0.04828328535080245
PENILE AGENESIS	0.001287	0.04828328535080245
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.001287	0.04828328535080245
NOONAN SYNDROME 10; NS10	0.001287	0.04828328535080245
TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR	0.001287	0.04828328535080245
REIFENSTEIN SYNDROME	0.001287	0.04828328535080245
ULNAR-MAMMARY SYNDROME	0.001287	0.04828328535080245
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.001287	0.04828328535080245
SCHNECKENBECKEN DYSPLASIA	0.001287	0.04828328535080245
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.001287	0.04828328535080245
HYPOGONADOTROPIC HYPOGONADISM 8 WITH OR WITHOUT ANOSMIA; HH8	0.001287	0.04828328535080245
BECKWITH-WIEDEMANN SYNDROME	0.001287	0.04828328535080245
HYPOGONADOTROPIC HYPOGONADISM 16 WITH OR WITHOUT ANOSMIA; HH16	0.001287	0.04828328535080245
19Q13.11 MICRODELETION SYNDROME	0.001287	0.04828328535080245
ULBRIGHT-HODES SYNDROME	0.001287	0.04828328535080245
FANCONI ANEMIA, COMPLEMENTATION GROUP O	0.001287	0.04828328535080245
OMODYSPLASIA	0.001287	0.04828328535080245
HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA	0.001287	0.04828328535080245
HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA; HH6	0.001287	0.04828328535080245
VACTERL WITH HYDROCEPHALUS	0.001287	0.04828328535080245
NOONAN SYNDROME 8; NS8	0.001287	0.04828328535080245
VERLOOVE VANHORICK-BRUBAKK SYNDROME	0.001287	0.04828328535080245
DISTAL TRISOMY 5Q	0.001287	0.04828328535080245
MMEP SYNDROME	0.001287	0.04828328535080245
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.001287	0.04828328535080245
46,XX OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.001287	0.04828328535080245
CAUDAL DUPLICATION	0.001287	0.04828328535080245
HYPOGONADOTROPIC HYPOGONADISM 12 WITH OR WITHOUT ANOSMIA	0.001287	0.04828328535080245
TETRAGAMETIC CHIMERISM	0.001287	0.04828328535080245
FETAL MINOXIDIL SYNDROME	0.001287	0.04828328535080245
HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA	0.001287	0.04828328535080245
MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	0.001287	0.04828328535080245
NON-DISTAL TRISOMY 13Q	0.001287	0.04828328535080245
POPLITEAL PTERYGIUM SYNDROME	0.001287	0.04828328535080245
COMPLETE ANDROGEN INSENSITIVITY SYNDROME	0.001287	0.04828328535080245
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.001287	0.04828328535080245
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.001287	0.04828328535080245
HEART DEFECT-TONGUE HAMARTOMA-POLYSYNDACTYLY SYNDROME	0.001287	0.04828328535080245
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.001287	0.04828328535080245
8P23.1 DELETION SYNDROME	0.001287	0.04828328535080245
HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA; HH7	0.001287	0.04828328535080245
PARTIAL CHROMOSOME Y DELETION	0.001287	0.04828328535080245
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.001287	0.04828328535080245
HEART-HAND SYNDROME TYPE 2	0.001287	0.04828328535080245
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.001287	0.04828328535080245
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00124533	0.04671998737056319
GLUTATHIONURIA	0.00124533	0.04671998737056319
HEMIFACIAL HYPERPLASIA WITH STRABISMUS	0.00124533	0.04671998737056319
WOOLLY HAIR	0.00124533	0.04671998737056319
PETERS ANOMALY	0.00124533	0.04671998737056319
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00124533	0.04671998737056319
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.00124533	0.04671998737056319
CATARACT 9, MULTIPLE TYPES; CTRCT9	0.00124533	0.04671998737056319
HAND-FOOT-GENITAL SYNDROME	0.00124533	0.04671998737056319
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.00124533	0.04671998737056319
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.00124533	0.04671998737056319
BRANCHIOGENIC DEAFNESS SYNDROME	0.00124533	0.04671998737056319
PSEUDOXANTHOMA ELASTICUM-LIKE SKIN MANIFESTATIONS WITH RETINITIS PIGMENTOSA	0.00124533	0.04671998737056319
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 36	0.00124533	0.04671998737056319
%153880 MACULAR EDEMA, CYSTOID;;CYSTOID MACULAR DYSTROPHY; CYMD;;MACULAR DYSTROPHY, DOMINANT CYSTOID; MDDC;;DCMD	0.00124533	0.04671998737056319
GROENOUW TYPE I CORNEAL DYSTROPHY	0.00124533	0.04671998737056319
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00124533	0.04671998737056319
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00124533	0.04671998737056319
MICROPHTHALMIA, ISOLATED, WITH CATARACT 1	0.00124533	0.04671998737056319
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.00124533	0.04671998737056319
PROGEROID SYNDROME, PETTY TYPE	0.00124533	0.04671998737056319
OCULOCUTANEOUS ALBINISM TYPE 4	0.00124533	0.04671998737056319
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00124533	0.04671998737056319
OCULOCUTANEOUS ALBINISM TYPE 1B	0.00124533	0.04671998737056319
OCULOCUTANEOUS ALBINISM TYPE 3	0.00124533	0.04671998737056319
ACRO-RENAL-OCULAR SYNDROME	0.00124533	0.04671998737056319
OCULOCUTANEOUS ALBINISM TYPE 2	0.00124533	0.04671998737056319
CRANIOSYNOSTOSIS-DANDY-WALKER MALFORMATION-HYDROCEPHALUS SYNDROME	0.00124533	0.04671998737056319
JACKSON-WEISS SYNDROME	0.00124533	0.04671998737056319
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00124533	0.04671998737056319
METAPHYSEAL DYSOSTOSIS-INTELLECTUAL DISABILITY-CONDUCTIVE DEAFNESS SYNDROME	0.00124533	0.04671998737056319
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00124533	0.04671998737056319
SPINOCEREBELLAR ATAXIA TYPE 27	0.00124533	0.04671998737056319
STIFF SKIN SYNDROME	0.00124533	0.04671998737056319
183800 SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS;;NYSTAGMUS-SPLIT HAND SYNDROME;;KARSCH-NEUGEBAUER SYNDROME; KNS	0.00124533	0.04671998737056319
NANOPHTHALMOS	0.00124533	0.04671998737056319
MORNING GLORY DISC ANOMALY	0.00124533	0.04671998737056319
OCULAR ALBINISM	0.00124533	0.04671998737056319
EXTERNAL AUDITORY CANAL ATRESIA-VERTICAL TALUS-HYPERTELORISM SYNDROME	0.00124533	0.04671998737056319
RETINOBLASTOMA	0.00124533	0.04671998737056319
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.00124533	0.04671998737056319
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00124533	0.04671998737056319
%193003 NYSTAGMUS 4, CONGENITAL, AUTOSOMAL DOMINANT; NYS4;;VESTIBULOCEREBELLAR DISORDER WITH PREDOMINANT OCULAR SIGNS	0.00124533	0.04671998737056319
PTOSIS, STRABISMUS, AND ECTOPIC PUPILS	0.00124533	0.04671998737056319
CROSSED POLYSYNDACTYLY	0.00124533	0.04671998737056319
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00124533	0.04671998737056319
%300589 NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5	0.00124533	0.04671998737056319
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00124533	0.04671998737056319
NEPHRONOPHTHISIS 18; NPHP18	0.00124533	0.04671998737056319
X-LINKED RETINAL DYSPLASIA	0.00124533	0.04671998737056319
BUSCHKE-OLLENDORFF SYNDROME	0.00124533	0.04671998737056319
HIDROTIC ECTODERMAL DYSPLASIA	0.00124533	0.04671998737056319
SPASTIC PARAPLEGIA 16, X-LINKED	0.00124533	0.04671998737056319
ABDUCENS PALSY	0.00124533	0.04671998737056319
COATS DISEASE	0.00124533	0.04671998737056319
LEBER CONGENITAL AMAUROSIS 16	0.00124533	0.04671998737056319
EEM SYNDROME	0.00124533	0.04671998737056319
FETAL IODINE SYNDROME	0.00124533	0.04671998737056319
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00124533	0.04671998737056319
PELVISCAPULAR DYSPLASIA	0.00124533	0.04671998737056319
VITREORETINOCHOROIDOPATHY; VRCP	0.00124533	0.04671998737056319
RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE	0.00124533	0.04671998737056319
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00124533	0.04671998737056319
OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	0.00124533	0.04671998737056319
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.00124533	0.04671998737056319
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00124533	0.04671998737056319
OPTIC ATROPHY 1; OPA1	0.00124533	0.04671998737056319
ALBINISM, OCULOCUTANEOUS, TYPE III	0.00124533	0.04671998737056319
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.00124533	0.04671998737056319
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.04671998737056319
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.00124533	0.04671998737056319
FOVEAL HYPOPLASIA-PRESENILE CATARACT SYNDROME	0.00124533	0.04671998737056319
PROXIMAL SYMPHALANGISM	0.00124533	0.04671998737056319
PETERS ANOMALY	0.00124533	0.04671998737056319
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.00124533	0.04671998737056319
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00124533	0.04671998737056319
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00124533	0.04671998737056319
17Q21.31 RECURRENT MICRODELETION SYNDROME	0.00122699	0.046031941175276696
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.00122699	0.046031941175276696
REFSUM DISEASE	0.00122699	0.046031941175276696
NEUHAUSER-EICHNER-OPITZ SYNDROME	0.00122699	0.046031941175276696
HYPOMYELINATION NEUROPATHY-ARTHROGRYPOSIS SYNDROME	0.00122699	0.046031941175276696
PRADER-WILLI SYNDROME (TYPE 2)	0.00122699	0.046031941175276696
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.00122699	0.046031941175276696
FETAL METHYLMERCURY SYNDROME	0.00122699	0.046031941175276696
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.00122699	0.046031941175276696
KEARNS-SAYRE SYNDROME	0.00122699	0.046031941175276696
PROXIMAL SPINAL MUSCULAR ATROPHY	0.00122699	0.046031941175276696
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00122699	0.046031941175276696
PRADER-WILLI SYNDROME (TYPE 1)	0.00122699	0.046031941175276696
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.00122699	0.046031941175276696
OPSISMODYSPLASIA	0.00122699	0.046031941175276696
HYPERCALCEMIA, INFANTILE 2	0.00122699	0.046031941175276696
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 4; CEMCOX4	0.00122699	0.046031941175276696
SHORT STATURE-VALVULAR HEART DISEASE-CHARACTERISTIC FACIES SYNDROME	0.00122699	0.046031941175276696
KYPHOMELIC DYSPLASIA	0.00122699	0.046031941175276696
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.00122699	0.046031941175276696
B4GALT1-CDG	0.00122699	0.046031941175276696
COG7-CDG	0.00122699	0.046031941175276696
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00122699	0.046031941175276696
PEARSON SYNDROME	0.00122699	0.046031941175276696
KENNEDY DISEASE	0.00122699	0.046031941175276696
HYPOTONIA-CYSTINURIA SYNDROME	0.00122699	0.046031941175276696
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00122699	0.046031941175276696
NEONATAL SEVERE PRIMARY HYPERPARATHYROIDISM	0.00122699	0.046031941175276696
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.00122699	0.046031941175276696
INFANTILE SYSTEMIC HYALINOSIS	0.00122699	0.046031941175276696
HAWKINSINURIA	0.00122699	0.046031941175276696
TRIOSE PHOSPHATE-ISOMERASE DEFICIENCY	0.00122699	0.046031941175276696
ISOTRETINOIN SYNDROME	0.00122699	0.046031941175276696
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.00122699	0.046031941175276696
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.00122699	0.046031941175276696
IMMUNODEFICIENCY 9; IMD9	0.00122699	0.046031941175276696
LAMBERT SYNDROME	0.00122699	0.046031941175276696
CARDIOMYOPATHY-HYPOTONIA-LACTIC ACIDOSIS SYNDROME	0.00122699	0.046031941175276696
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.00122699	0.046031941175276696
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.00122699	0.046031941175276696
AUTOSOMAL DOMINANT CONGENITAL BENIGN SPINAL MUSCULAR ATROPHY	0.00122699	0.046031941175276696
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00122699	0.046031941175276696
HYDROCEPHALY-CEREBELLAR AGENESIS SYNDROME	0.00122699	0.046031941175276696
ABETALIPOPROTEINEMIA	0.00122699	0.046031941175276696
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.00122699	0.046031941175276696
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.040779042368001395
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.001086973	0.040779042368001395
L1 SYNDROME	0.001086973	0.040779042368001395
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.001086973	0.040779042368001395
NEPHROGENIC DIABETES INSIPIDUS	0.001086973	0.040779042368001395
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.040779042368001395
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001086973	0.040779042368001395
17Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 91; MRX91	0.001086973	0.040779042368001395
WAISMAN SYNDROME; WSMN	0.001086973	0.040779042368001395
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.040779042368001395
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001086973	0.040779042368001395
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001086973	0.040779042368001395
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001086973	0.040779042368001395
CLASSIC PHENYLKETONURIA	0.001086973	0.040779042368001395
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.001086973	0.040779042368001395
MACDERMOT-WINTER SYNDROME	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.001086973	0.040779042368001395
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001086973	0.040779042368001395
CITRULLINEMIA, CLASSIC	0.001086973	0.040779042368001395
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.001086973	0.040779042368001395
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.040779042368001395
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001086973	0.040779042368001395
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001086973	0.040779042368001395
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.001086973	0.040779042368001395
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.040779042368001395
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.001086973	0.040779042368001395
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001086973	0.040779042368001395
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001086973	0.040779042368001395
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.040779042368001395
EAST SYNDROME	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001086973	0.040779042368001395
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001086973	0.040779042368001395
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001086973	0.040779042368001395
ARGININOSUCCINIC ACIDURIA	0.001086973	0.040779042368001395
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001086973	0.040779042368001395
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 9	0.001086973	0.040779042368001395
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.001086973	0.040779042368001395
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.040779042368001395
GLASS SYNDROME	0.001086973	0.040779042368001395
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001086973	0.040779042368001395
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.001086973	0.040779042368001395
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001086973	0.040779042368001395
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001086973	0.040779042368001395
NARP SYNDROME	0.001086973	0.040779042368001395
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001086973	0.040779042368001395
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001086973	0.040779042368001395
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001086973	0.040779042368001395
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001086973	0.040779042368001395
HARTNUP DISORDER	0.001086973	0.040779042368001395
ISOVALERIC ACIDEMIA	0.001086973	0.040779042368001395
ALSTRÖM SYNDROME	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.001086973	0.040779042368001395
KEUTEL SYNDROME	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001086973	0.040779042368001395
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001086973	0.040779042368001395
GRACILE BONE DYSPLASIA; GCLEB	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.001086973	0.040779042368001395
CENTRAL BILATERAL MACROGYRIA	0.001086973	0.040779042368001395
NETHERTON SYNDROME	0.001086973	0.040779042368001395
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.040779042368001395
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.001086973	0.040779042368001395
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001086973	0.040779042368001395
CITRULLINEMIA TYPE II	0.001086973	0.040779042368001395
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001086973	0.040779042368001395
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.040779042368001395
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001086973	0.040779042368001395
PFEIFFER SYNDROME TYPE 2	0.001086973	0.040779042368001395
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.040779042368001395
PHACE ASSOCIATION	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.001086973	0.040779042368001395
ALG1-CDG	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.040779042368001395
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.040779042368001395
HYDRANENCEPHALY	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.040779042368001395
FOIX-CHAVANY-MARIE SYNDROME	0.001086973	0.040779042368001395
SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	0.000995025	0.03732950738631097
PENTALOGY OF CANTRELL	0.000995025	0.03732950738631097
FRONTOMETAPHYSEAL DYSPLASIA	0.000995025	0.03732950738631097
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.000995025	0.03732950738631097
ACROCAPITOFEMORAL DYSPLASIA	0.000995025	0.03732950738631097
ODONTOCHONDRODYSPLASIA; ODCD	0.000995025	0.03732950738631097
PYCNODYSOSTOSIS	0.000995025	0.03732950738631097
TIBIAL TORSION, BILATERAL MEDIAL	0.000995025	0.03732950738631097
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.000995025	0.03732950738631097
ULNAR HEMIMELIA	0.000995025	0.03732950738631097
SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE; SMDCF	0.000995025	0.03732950738631097
SPRENGEL DEFORMITY	0.000995025	0.03732950738631097
SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 1	0.000995025	0.03732950738631097
BRACHYDACTYLY TYPE A1	0.000995025	0.03732950738631097
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 4	0.000995025	0.03732950738631097
POSTERIOR COLUMN ATAXIA	0.000995025	0.03732950738631097
BRACHYOLMIA, MAROTEAUX TYPE	0.000995025	0.03732950738631097
TOWNES-BROCKS SYNDROME 2; TBS2	0.000995025	0.03732950738631097
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.000995025	0.03732950738631097
ENG-STROM SYNDROME	0.000995025	0.03732950738631097
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.000995025	0.03732950738631097
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.000995025	0.03732950738631097
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA	0.000995025	0.03732950738631097
CAMPTODACTYLY-FIBROUS TISSUE HYPERPLASIA-SKELETAL DYSPLASIA SYNDROME	0.000995025	0.03732950738631097
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.000995025	0.03732950738631097
SYRINGOMYELIA, ISOLATED	0.000995025	0.03732950738631097
CATEL-MANZKE SYNDROME	0.000995025	0.03732950738631097
HEREDITARY NEUROPATHY WITH LIABILITY TO PRESSURE PALSIES	0.000995025	0.03732950738631097
THORACOLARYNGOPELVIC DYSPLASIA	0.000995025	0.03732950738631097
PYLE DISEASE; PYL	0.000995025	0.03732950738631097
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.000995025	0.03732950738631097
CAMPTODACTYLY-TALL STATURE-SCOLIOSIS-HEARING LOSS SYNDROME	0.000995025	0.03732950738631097
EPIPHYSEAL DYSPLASIA, MULTIPLE, 7; EDM7	0.000995025	0.03732950738631097
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.000995025	0.03732950738631097
ATAXIA WITH VITAMIN E DEFICIENCY	0.000995025	0.03732950738631097
CAMURATI-ENGELMANN DISEASE	0.000995025	0.03732950738631097
ABSENCE DEFORMITY OF LEG-CATARACT SYNDROME	0.000995025	0.03732950738631097
ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.000995025	0.03732950738631097
MELNICK-NEEDLES SYNDROME	0.000995025	0.03732950738631097
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.000995025	0.03732950738631097
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.000995025	0.03732950738631097
JUBERG-HAYWARD SYNDROME	0.000995025	0.03732950738631097
CHARCOT-MARIE-TOOTH DISEASE TYPE 1B	0.000995025	0.03732950738631097
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.000995025	0.03732950738631097
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 28	0.000995025	0.03732950738631097
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 13	0.000995025	0.03732950738631097
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.000995025	0.03732950738631097
HEMIHYPERPLASIA, ISOLATED	0.000995025	0.03732950738631097
ISOLATED KLIPPEL-FEIL SYNDROME	0.000995025	0.03732950738631097
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.000995025	0.03732950738631097
PRIMARY CILIARY DYSKINESIA	0.000995025	0.03732950738631097
231970 GLUTEAL MUSCLES, ABSENCE OF	0.000995025	0.03732950738631097
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.000995025	0.03732950738631097
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3	0.000995025	0.03732950738631097
SYMBRACHYDACTYLY OF HANDS AND FEET	0.000995025	0.03732950738631097
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.000995025	0.03732950738631097
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.000995025	0.03732950738631097
MARFANOID HYPERMOBILITY SYNDROME	0.000995025	0.03732950738631097
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1B	0.000995025	0.03732950738631097
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.000995025	0.03732950738631097
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 10	0.000995025	0.03732950738631097
ACROGERIA	0.000995025	0.03732950738631097
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.000995025	0.03732950738631097
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	0.000995025	0.03732950738631097
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.000995025	0.03732950738631097
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.000995025	0.03732950738631097
ATELOSTEOGENESIS, TYPE II	0.000995025	0.03732950738631097
COLE-CARPENTER SYNDROME 1; CLCRP1	0.000995025	0.03732950738631097
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.000995025	0.03732950738631097
MUCOLIPIDOSIS III ALPHA/BETA	0.000995025	0.03732950738631097
NAIL-PATELLA SYNDROME	0.000995025	0.03732950738631097
TRISOMY 5P	0.000995025	0.03732950738631097
MYOPATHY, DISTAL, 1; MPD1	0.000995025	0.03732950738631097
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.000995025	0.03732950738631097
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.000995025	0.03732950738631097
PSEUDODIASTROPHIC DYSPLASIA	0.000995025	0.03732950738631097
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	0.000995025	0.03732950738631097
KUSKOKWIM SYNDROME	0.000995025	0.03732950738631097
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.000995025	0.03732950738631097
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.000995025	0.03732950738631097
X-LINKED SKELETAL DYSPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000995025	0.03732950738631097
SPONDYLOCOSTAL DYSOSTOSIS 5	0.000995025	0.03732950738631097
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.000995025	0.03732950738631097
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.000995025	0.03732950738631097
LERI-WEILL DYSCHONDROSTEOSIS	0.000995025	0.03732950738631097
LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	0.000995025	0.03732950738631097
OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD	0.000995025	0.03732950738631097
DYSTONIA, DOPA-RESPONSIVE; DRD	0.000995025	0.03732950738631097
NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2	0.000995025	0.03732950738631097
%217100 CONSTRICTING BANDS, CONGENITAL;;AMNIOTIC BAND SEQUENCE; ABS;;STREETER ANOMALYADAM COMPLEX, INCLUDED;;TERMINAL TRANSVERSE DEFECTS OF ARM, INCLUDED;;AMPUTATION, CONGENITAL, INCLUDED	0.000995025	0.03732950738631097
DIASTEMATOMYELIA	0.000995025	0.03732950738631097
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.000995025	0.03732950738631097
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.000995025	0.03732950738631097
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L	0.000995025	0.03732950738631097
MYOPATHY, MYOFIBRILLAR, 6; MFM6	0.000995025	0.03732950738631097
XFE PROGEROID SYNDROME; XFEPS	0.000995025	0.03732950738631097
BRADDOCK SYNDROME	0.000995025	0.03732950738631097
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.000995025	0.03732950738631097
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	0.000995025	0.03732950738631097
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.000995025	0.03732950738631097
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.000995025	0.03732950738631097
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D; CMT2D	0.000995025	0.03732950738631097
GNATHODIAPHYSEAL DYSPLASIA	0.000995025	0.03732950738631097
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.000995025	0.03732950738631097
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.000995025	0.03732950738631097
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.000995025	0.03732950738631097
SPASTIC PARAPLEGIA-OPTIC ATROPHY-NEUROPATHY SYNDROME	0.000995025	0.03732950738631097
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.000995025	0.03732950738631097
MADELUNG DEFORMITY	0.000995025	0.03732950738631097
OCULOAURICULOFRONTONASAL SYNDROME	0.000995025	0.03732950738631097
TERMINAL TRANSVERSE LIMB DEFECT	0.000995025	0.03732950738631097
NEU-LAXOVA SYNDROME 2; NLS2	0.000995025	0.03732950738631097
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S; CMT2S	0.000995025	0.03732950738631097
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1	0.000995025	0.03732950738631097
GAMMA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R5	0.000995025	0.03732950738631097
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.000995025	0.03732950738631097
SALIH MYOPATHY; SALMY	0.000995025	0.03732950738631097
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.000995025	0.03732950738631097
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.000995025	0.03732950738631097
SHOX-RELATED SHORT STATURE	0.000995025	0.03732950738631097
SILLENCE SYNDROME	0.000995025	0.03732950738631097
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.000995025	0.03732950738631097
ACRODYSPLASIA SCOLIOSIS	0.000995025	0.03732950738631097
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.000995025	0.03732950738631097
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.000995025	0.03732950738631097
OSTEOGENESIS IMPERFECTA, TYPE XIX; OI19	0.000995025	0.03732950738631097
SPONDYLOCAMPTODACTYLY SYNDROME	0.000995025	0.03732950738631097
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.000995025	0.03732950738631097
MYOPATHY, SCAPULOHUMEROPERONEAL	0.000995025	0.03732950738631097
BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH	0.000995025	0.03732950738631097
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3	0.000995025	0.03732950738631097
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4	0.000995025	0.03732950738631097
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.000995025	0.03732950738631097
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.000995025	0.03732950738631097
LOEYS-DIETZ SYNDROME	0.000995025	0.03732950738631097
ACROCAPITOFEMORAL DYSPLASIA; ACFD	0.000995025	0.03732950738631097
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.000995025	0.03732950738631097
CHRONIC NONBACTERIAL OSTEOMYELITIS/CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.000995025	0.03732950738631097
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.000995025	0.03732950738631097
EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM	0.000995025	0.03732950738631097
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.000995025	0.03732950738631097
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.000995025	0.03732950738631097
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.000995025	0.03732950738631097
CENANI-LENZ SYNDROME	0.000995025	0.03732950738631097
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE, LEROY-SPRANGERTYPE	0.000995025	0.03732950738631097
TRICHODERMODYSPLASIA-DENTAL ALTERATIONS SYNDROME	0.000995025	0.03732950738631097
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.000995025	0.03732950738631097
LAING EARLY-ONSET DISTAL MYOPATHY	0.000995025	0.03732950738631097
NEU-LAXOVA SYNDROME	0.000995025	0.03732950738631097
CZECH DYSPLASIA, METATARSAL TYPE	0.000995025	0.03732950738631097
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.000995025	0.03732950738631097
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.000995025	0.03732950738631097
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	0.000995025	0.03732950738631097
CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.000995025	0.03732950738631097
SPONDYLOCOSTAL DYSOSTOSIS 6, AUTOSOMAL RECESSIVE; SCDO6	0.000995025	0.03732950738631097
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.000995025	0.03732950738631097
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.000995025	0.03732950738631097
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H	0.000995025	0.03732950738631097
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.000995025	0.03732950738631097
SPONDYLOCAMPTODACTYLY	0.000995025	0.03732950738631097
HYPOPHOSPHATEMIC RICKETS	0.000995025	0.03732950738631097
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.000995025	0.03732950738631097
PACHYDERMOPERIOSTOSIS	0.000995025	0.03732950738631097
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.000995025	0.03732950738631097
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.000995025	0.03732950738631097
CRANIOLENTICULOSUTURAL DYSPLASIA	0.000995025	0.03732950738631097
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.000995025	0.03732950738631097
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.0009615380000000001	0.03607320406343426
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.0009615380000000001	0.03607320406343426
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.0009615380000000001	0.03607320406343426
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.0009615380000000001	0.03607320406343426
MYOPATHY, CENTRONUCLEAR, 5	0.0009615380000000001	0.03607320406343426
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.0009615380000000001	0.03607320406343426
MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY	0.0009615380000000001	0.03607320406343426
JUVENILE POLYPOSIS OF INFANCY	0.0009615380000000001	0.03607320406343426
LEGIUS SYNDROME	0.0009615380000000001	0.03607320406343426
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.0009615380000000001	0.03607320406343426
JOUBERT SYNDROME 4	0.0009615380000000001	0.03607320406343426
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.0009615380000000001	0.03607320406343426
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.0009615380000000001	0.03607320406343426
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.0009615380000000001	0.03607320406343426
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.0009615380000000001	0.03607320406343426
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.0009615380000000001	0.03607320406343426
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.0009615380000000001	0.03607320406343426
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.0009615380000000001	0.03607320406343426
SYDENHAM CHOREA	0.0009615380000000001	0.03607320406343426
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.0009615380000000001	0.03607320406343426
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.0009615380000000001	0.03607320406343426
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.0009615380000000001	0.03607320406343426
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.0009615380000000001	0.03607320406343426
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.0009615380000000001	0.03607320406343426
SPINOCEREBELLAR ATAXIA TYPE 2	0.0009615380000000001	0.03607320406343426
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.0009615380000000001	0.03607320406343426
SPINOCEREBELLAR ATAXIA TYPE 14	0.0009615380000000001	0.03607320406343426
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.0009615380000000001	0.03607320406343426
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.0009615380000000001	0.03607320406343426
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.0009615380000000001	0.03607320406343426
CAP MYOPATHY	0.0009615380000000001	0.03607320406343426
NEUTRAL LIPID STORAGE MYOPATHY	0.0009615380000000001	0.03607320406343426
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.0009615380000000001	0.03607320406343426
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.0009615380000000001	0.03607320406343426
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.0009615380000000001	0.03607320406343426
ACETYL-COA CARBOXYLASE DEFICIENCY	0.0009615380000000001	0.03607320406343426
COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS; COMMAD	0.0009615380000000001	0.03607320406343426
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.0009615380000000001	0.03607320406343426
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.0009615380000000001	0.03607320406343426
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.0009615380000000001	0.03607320406343426
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.03607320406343426
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.0009615380000000001	0.03607320406343426
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.0009615380000000001	0.03607320406343426
ETHANOLAMINOSIS	0.0009615380000000001	0.03607320406343426
PEROXISOME BIOGENESIS DISORDER 11B	0.0009615380000000001	0.03607320406343426
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.0009615380000000001	0.03607320406343426
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 43	0.0009615380000000001	0.03607320406343426
MENTAL RETARDATION, X-LINKED 12; MRX12	0.0009615380000000001	0.03607320406343426
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.0009615380000000001	0.03607320406343426
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO GRID2 DEFICIENCY	0.0009615380000000001	0.03607320406343426
LIVER FAILURE, INFANTILE, TRANSIENT	0.0009615380000000001	0.03607320406343426
GLYCOGEN STORAGE DISEASE IXB	0.0009615380000000001	0.03607320406343426
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.0009615380000000001	0.03607320406343426
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	0.0009615380000000001	0.03607320406343426
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.0009615380000000001	0.03607320406343426
DYSTONIA 11, MYOCLONIC	0.0009615380000000001	0.03607320406343426
HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	0.0009615380000000001	0.03607320406343426
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.020467085824608922
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.020467085824608922
ICF SYNDROME	0.000545554	0.020467085824608922
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.020467085824608922
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000545554	0.020467085824608922
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.020467085824608922
USHER SYNDROME TYPE 1	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.000545554	0.020467085824608922
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.020467085824608922
AUSTRALIA ANTIGEN	0.000545554	0.020467085824608922
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.020467085824608922
CONGENITAL VARICELLA SYNDROME	0.000545554	0.020467085824608922
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.020467085824608922
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.020467085824608922
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.020467085824608922
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.020467085824608922
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.020467085824608922
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.000545554	0.020467085824608922
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.020467085824608922
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.000545554	0.020467085824608922
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.020467085824608922
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.020467085824608922
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.020467085824608922
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.020467085824608922
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.000545554	0.020467085824608922
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.020467085824608922
MEDULLOBLASTOMA	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.020467085824608922
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.020467085824608922
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.020467085824608922
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.020467085824608922
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.000545554	0.020467085824608922
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.020467085824608922
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.020467085824608922
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.020467085824608922
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.020467085824608922
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.020467085824608922
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.020467085824608922
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000545554	0.020467085824608922
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.020467085824608922
ZEBRA BODY MYOPATHY	0.000545554	0.020467085824608922
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.020467085824608922
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.020467085824608922
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.000545554	0.020467085824608922
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.020467085824608922
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.020467085824608922
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.020467085824608922
FORSYTHE-WAKELING SYNDROME; FWS	0.000545554	0.020467085824608922
PROPIONIC ACIDEMIA	0.000545554	0.020467085824608922
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.020467085824608922
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.020467085824608922
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.020467085824608922
48,XYYY SYNDROME	0.000545554	0.020467085824608922
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.020467085824608922
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.020467085824608922
8P23.1 DUPLICATION SYNDROME	0.000545554	0.020467085824608922
HOYERAAL-HREIDARSSON SYNDROME	0.000545554	0.020467085824608922
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.020467085824608922
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.020467085824608922
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 2	0.000545554	0.020467085824608922
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.020467085824608922
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.020467085824608922
HYPERTRICHOSIS CUBITI	0.000545554	0.020467085824608922
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.020467085824608922
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.020467085824608922
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.020467085824608922
FRIAS SYNDROME	0.000545554	0.020467085824608922
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.020467085824608922
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.020467085824608922
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.020467085824608922
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.020467085824608922
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.020467085824608922
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.020467085824608922
OXOGLUTARIC ACIDURIA	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.020467085824608922
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.020467085824608922
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000545554	0.020467085824608922
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.020467085824608922
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.020467085824608922
SILVER-RUSSELL SYNDROME; SRS	0.000545554	0.020467085824608922
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.020467085824608922
CURRARINO SYNDROME	0.000545554	0.020467085824608922
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.020467085824608922
SENIOR-LOKEN SYNDROME	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000545554	0.020467085824608922
MICROVILLUS INCLUSION DISEASE	0.000545554	0.020467085824608922
PHENOBARBITAL EMBRYOPATHY	0.000545554	0.020467085824608922
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.020467085824608922
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.020467085824608922
LOWRY-MACLEAN SYNDROME	0.000545554	0.020467085824608922
HYDROXYKYNURENINURIA	0.000545554	0.020467085824608922
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.020467085824608922
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.020467085824608922
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.020467085824608922
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.020467085824608922
ATELOSTEOGENESIS TYPE III	0.000545554	0.020467085824608922
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000545554	0.020467085824608922
SECKEL SYNDROME 9; SCKL9	0.000545554	0.020467085824608922
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.000545554	0.020467085824608922
PELLAGRA-LIKE SYNDROME	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.020467085824608922
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.020467085824608922
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.020467085824608922
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.020467085824608922
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000545554	0.020467085824608922
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.000545554	0.020467085824608922
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.020467085824608922
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.020467085824608922
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.020467085824608922
MECKEL SYNDROME 13; MKS13	0.000545554	0.020467085824608922
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000545554	0.020467085824608922
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000545554	0.020467085824608922
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000545554	0.020467085824608922
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.020467085824608922
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.020467085824608922
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.020467085824608922
SAUL-WILSON SYNDROME; SWILS	0.000545554	0.020467085824608922
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.000545554	0.020467085824608922
REVESZ SYNDROME	0.000545554	0.020467085824608922
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.020467085824608922
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.020467085824608922
OROTIC ACIDURIA	0.000545554	0.020467085824608922
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.020467085824608922
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.020467085824608922
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.020467085824608922
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.020467085824608922
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.020467085824608922
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.020467085824608922
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.020467085824608922
WOLMAN DISEASE	0.000545554	0.020467085824608922
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.020467085824608922
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.020467085824608922
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.020467085824608922
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.020467085824608922
JAWAD SYNDROME	0.000545554	0.020467085824608922
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.020467085824608922
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.020467085824608922
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.020467085824608922
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000545554	0.020467085824608922
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.020467085824608922
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.020467085824608922
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.020311956543392476
PARTINGTON SYNDROME	0.000541419	0.020311956543392476
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.000541419	0.020311956543392476
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.020311956543392476
PARIETAL FORAMINA	0.000541419	0.020311956543392476
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.020311956543392476
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.020311956543392476
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392476
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.020311956543392476
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.020311956543392476
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.020311956543392476
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.020311956543392476
ROSAÏ-DORFMAN DISEASE	0.000541419	0.020311956543392476
CYSTATHIONINURIA	0.000541419	0.020311956543392476
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000541419	0.020311956543392476
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.020311956543392476
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.020311956543392476
MOYNAHAN SYNDROME	0.000541419	0.020311956543392476
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.020311956543392476
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.020311956543392476
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 47	0.000541419	0.020311956543392476
PHENYLKETONURIA	0.000541419	0.020311956543392476
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.020311956543392476
RIFT VALLEY FEVER	0.000541419	0.020311956543392476
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.020311956543392476
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.020311956543392476
LUJO HEMORRHAGIC FEVER	0.000541419	0.020311956543392476
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.020311956543392476
EPISODIC ATAXIA TYPE 6	0.000541419	0.020311956543392476
ACUTE BILIRUBIN ENCEPHALOPATHY	0.000541419	0.020311956543392476
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.020311956543392476
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.020311956543392476
GITELMAN SYNDROME	0.000541419	0.020311956543392476
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.020311956543392476
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.020311956543392476
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.020311956543392476
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.020311956543392476
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.020311956543392476
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.020311956543392476
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.020311956543392476
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.020311956543392476
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.020311956543392476
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.000541419	0.020311956543392476
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.020311956543392476
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000541419	0.020311956543392476
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.000541419	0.020311956543392476
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.020311956543392476
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.020311956543392476
PERRAULT SYNDROME 3	0.000541419	0.020311956543392476
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.020311956543392476
DERMOTRICHIC SYNDROME	0.000541419	0.020311956543392476
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392476
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.020311956543392476
CENTRAL DIABETES INSIPIDUS	0.000541419	0.020311956543392476
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.020311956543392476
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.020311956543392476
FAMILIAL MEDITERRANEAN FEVER	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.020311956543392476
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.020311956543392476
RECURRENT ACUTE PANCREATITIS	0.000541419	0.020311956543392476
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.020311956543392476
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.020311956543392476
THREONINEMIA	0.000541419	0.020311956543392476
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.020311956543392476
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.020311956543392476
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.020311956543392476
ANGELMAN SYNDROME (TYPE 1)	0.000541419	0.020311956543392476
THYROCEREBRORENAL SYNDROME	0.000541419	0.020311956543392476
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.020311956543392476
ANGELMAN SYNDROME (TYPE 2)	0.000541419	0.020311956543392476
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.020311956543392476
THYROCEREBRORETINAL SYNDROME	0.000541419	0.020311956543392476
NIPAH VIRUS DISEASE	0.000541419	0.020311956543392476
LASSA FEVER	0.000541419	0.020311956543392476
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.020311956543392476
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000541419	0.020311956543392476
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000541419	0.020311956543392476
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392476
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.020311956543392476
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.020311956543392476
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.020311956543392476
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.020311956543392476
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.020311956543392476
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.020311956543392476
EPILEPSY, READING	0.000541419	0.020311956543392476
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.020311956543392476
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.020311956543392476
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.020311956543392476
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.020311956543392476
INSULINOMA	0.000541419	0.020311956543392476
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.020311956543392476
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.020311956543392476
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.020311956543392476
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.020311956543392476
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.000541419	0.020311956543392476
WORSTER-DROUGHT SYNDROME	0.000541419	0.020311956543392476
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000541419	0.020311956543392476
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.020311956543392476
LHERMITTE-DUCLOS DISEASE	0.000541419	0.020311956543392476
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.020311956543392476
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.020311956543392476
PAPILLORENAL SYNDROME	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.020311956543392476
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.020311956543392476
GALACTOSIALIDOSIS	0.000541419	0.020311956543392476
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.020311956543392476
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.000541419	0.020311956543392476
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.000541419	0.020311956543392476
DARIER-WHITE DISEASE; DAR	0.000541419	0.020311956543392476
CHILDHOOD DISINTEGRATIVE DISORDER	0.000541419	0.020311956543392476
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.020311956543392476
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.020311956543392476
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.020311956543392476
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.020311956543392476
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.000541419	0.020311956543392476
KUFOR-RAKEB SYNDROME	0.000541419	0.020311956543392476
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.020311956543392476
PROLACTINOMA	0.000541419	0.020311956543392476
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.020311956543392476
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.020311956543392476
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.020311956543392476
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.020311956543392476
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.020311956543392476
GURRIERI SYNDROME	0.000541419	0.020311956543392476
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.020311956543392476
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.000541419	0.020311956543392476
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000541419	0.020311956543392476
TYROSINEMIA TYPE 2	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
BEHÇET DISEASE	0.000541419	0.020311956543392476
KEARNS-SAYRE SYNDROME; KSS	0.000541419	0.020311956543392476
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.020311956543392476
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.020311956543392476
KIFAFA SEIZURE DISORDER	0.000541419	0.020311956543392476
KEUTEL SYNDROME; KTLS	0.000541419	0.020311956543392476
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000541419	0.020311956543392476
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.020311956543392476
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.020311956543392476
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.020311956543392476
ALG2-CDG	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000541419	0.020311956543392476
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.020311956543392476
MOGS-CDG	0.000541419	0.020311956543392476
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.000541419	0.020311956543392476
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.020311956543392476
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.020311956543392476
ADDISON DISEASE	0.000541419	0.020311956543392476
HYPER-BETA-ALANINEMIA	0.000541419	0.020311956543392476
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.020311956543392476
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.020311956543392476
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
CRONKHITE-CANADA SYNDROME	0.000541419	0.020311956543392476
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.020311956543392476
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.020311956543392476
PORPHYRIA VARIEGATA	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.020311956543392476
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.020311956543392476
FOUNTAIN SYNDROME	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.020311956543392476
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.020311956543392476
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392476
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.020311956543392476
HEREDITARY FRUCTOSE INTOLERANCE	0.000541419	0.020311956543392476
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.020311956543392476
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.020311956543392476
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.020311956543392476
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.020311956543392476
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.020311956543392476
PORENCEPHALY	0.000541419	0.020311956543392476
DIAMINOPENTANURIA	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.020311956543392476
GRISCELLI SYNDROME TYPE 2	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.020311956543392476
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.020311956543392476
HYPERPROLINEMIA, TYPE II	0.000541419	0.020311956543392476
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.020311956543392476
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.020311956543392476
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.020311956543392476
EPILEPSY-TELANGIECTASIA	0.000541419	0.020311956543392476
RAMON SYNDROME	0.000541419	0.020311956543392476
AUTISM	0.000541419	0.020311956543392476
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.020311956543392476
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.020311956543392476
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.020311956543392476
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.020311956543392476
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.020311956543392476
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.020311956543392476
SUPRABULBAR PARESIS, CONGENITAL	0.000541419	0.020311956543392476
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.020311956543392476
SYMMETRICAL THALAMIC CALCIFICATIONS	0.000541419	0.020311956543392476
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.020311956543392476
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.020311956543392476
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.020311956543392476
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.000541419	0.020311956543392476
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.020311956543392476
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.020311956543392476
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.020311956543392476
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.020311956543392476
EPISODIC ATAXIA TYPE 3	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.020311956543392476
STURGE-WEBER SYNDROME	0.000541419	0.020311956543392476
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.020311956543392476
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000541419	0.020311956543392476
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000541419	0.020311956543392476
CADASIL	0.000541419	0.020311956543392476
MOYAMOYA DISEASE	0.000541419	0.020311956543392476
FABRY DISEASE	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.020311956543392476
MICROSPORIDIOSIS	0.000541419	0.020311956543392476
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.020311956543392476
SNEDDON SYNDROME	0.000541419	0.020311956543392476
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.020311956543392476
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.020311956543392476
RABIES	0.000541419	0.020311956543392476
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.020311956543392476
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.020311956543392476
WHIM SYNDROME	0.000541419	0.020311956543392476
NOCARDIOSIS	0.000541419	0.020311956543392476
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.000541419	0.020311956543392476
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.020311956543392476
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.000541419	0.020311956543392476
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.000541419	0.020311956543392476
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000541419	0.020311956543392476
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.020311956543392476
INHERITED CREUTZFELDT-JAKOB DISEASE	0.000541419	0.020311956543392476
SYSTEMIC SCLEROSIS	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.020311956543392476
HEREDITARY COPROPORPHYRIA	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000541419	0.020311956543392476
ACUTE INTERMITTENT PORPHYRIA	0.000541419	0.020311956543392476
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.020311956543392476
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.020311956543392476
ISOLATED BILIARY ATRESIA	0.000541419	0.020311956543392476
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.020311956543392476
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.020311956543392476
BETA-MANNOSIDOSIS	0.000541419	0.020311956543392476
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.020311956543392476
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.020311956543392476
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.020311956543392476
ALEXANDER DISEASE	0.000541419	0.020311956543392476
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.020311956543392476
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.020311956543392476
TSH-SECRETING PITUITARY ADENOMA	0.000541419	0.020311956543392476
SUBEPENDYMOMA	0.000541419	0.020311956543392476
EPENDYMOMA	0.000541419	0.020311956543392476
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.000541419	0.020311956543392476
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.020311956543392476
CEREBROTENDINOUS XANTHOMATOSIS	0.000541419	0.020311956543392476
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.000541419	0.020311956543392476
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.020311956543392476
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.020311956543392476
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000541419	0.020311956543392476
HYPERPROLINEMIA TYPE 1	0.000541419	0.020311956543392476
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000541419	0.020311956543392476
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.020311956543392476
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.020311956543392476
